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Dr. Baldridg e (center): an increasing emphasis on research in the basic sciences
at TJU. Trustee Orville H. Bullitt is at left.
"Ours is a medically-oriented Univer-
sity, and as a University is characterized
by its commitment to an intellectual life
of inquiry and transmission of knowl-
edge-research is an endeavor ranking
with education." So spoke President Pe-
ter A. Herbut in a report on University
policies and their impact on research at
the December, 1975 meeting of the
Board of Trustees.
His report was an outcome of a series
of studies which began following the
publication in December, 1972 of the Re-
port of the Master Planning Committee
of the Board of Trustees. At that time,
members of the faculty noted that the
Master Planning Report, while spelling
out in detail the status and future needs of
our educational and patient care pro-
grams , did not emphasize the role of re-
search in our University. In response, Mr.
Frederic L. Ballard, Trustee Chairman
of the Committee, appointed a Task
Force on Research chaired by Trustee
James W. Stratton to study the matter.
The members of the Task Force were :
Trustee Dr. Orville H. Bullitt, andfac-
ulty members Drs. Robert C. Bal-
dridge, Robert L. Brent, Stephen I. Bu-
lova, Joseph S.Gonnella, George F. Kalf,
Simon Kramer, Hyman Menduk e, Abra-
ham E. Rakoff,Jussi I. Saukkonen and
Martin Wingate.
The Task Force, meeting monthly for
over a year, reviewed the organization
Dr. Baldridge was appointed Dean of
the College of Graduate Studies in
March, 1970. He is an honorary member
ofJefferson 's Alumni Association.
TO BIOMEDICAL RESEARCH
by Robert C. Baldridge, Ph.D.
for and administration of research, the
University commitment to research, the
role of students in research and the
available methods for evaluation of re-
search. The report of the Task Force,
including a series of recommendations,
was discussed and debated at several
meetings of the Master Planning Com-
mittee, and as an outcome, a series of
recommendations were transmitted to
the Board of Trustees.
Following is a summary of the resolu-
tion based on the recommendations that
was approved by the Board at its June,
1975 meeting.
1. The Medical College Committee and
the College of Graduate Studies Com-
mittee should accept increased respon-
sibilitiesfor research.The members of
these Board Committees are urged to
devise procedures, with the assistance
of the appropriate Deans, to become
more informed and aware of the re-
search activities of the University. The
Executive Committee at its meetings
will receive reports of these two com-
mitteesand share appropriate reports
with the full Board.
2. The members of the Finance Com-
mittee and of the Resources Com-
mitteeshould determine the feasibility
of allocating internally derived funds
and of raising additional funds from ex-
ternal sources for intramural research.
3. Th e President should be urged to ap -
point a University faculty advisory
committee on research to assist him
in presenting annually at a meeting of
the full Board of Trustees, a report of
the status of research in the Univer-
sity and the impact of University pol-
icies on the research ac tivi ties of the
faculty. This rep or t wou ld include a
summary of steps taken to enhance
the research capabilities of the Uni-
versity. The report should also in-
clu de a review of federal policies re-
garding the funding of research
grants and resea rch training grants.
Steps are being taken to implement
these resolutions: members of the fac-
ulty are meeting with the Board Com-
mittee to describe their ongo ing re-
search projects; and the Resources
Committee of the Board will consider
the feasibili ty of including funds espe-
cially earmarked for research as one of
the goa ls of Phase II of the Sesquicen-
tennial Campaign.
In his report, Dr. Herbut noted that
nationally, federal funding of research
via the National Institutes of Health
(NIH), has leve led off over the past five
years in terms of constant dollars. The
funding of direct costs of sponsored re-
search (mainly NIH research grants and
contracts) at Jefferson was some 40%
greater in 1974-1975 than that in 1971-
1972, and has at least paralleled and
perhaps slightly exceeded the increased
costs of research. The number of funded
research projects has held fairly steady
the past three yea rs. Members of the
faculty in most departments have been
diligent in preparing detailed proposals
for research support.
University policies have been devel-
oped to maximize opportunities for fac-
ulty members to compete for extramural
funding. The creation of physical facil-
ities for research such as laboratory and
officespace and animal quarters and spec-
Vice-Presid ent f or Planning and Research
Task Force member George M. Norwood.
Mr. No rwood has been app ointed Interim
Presid ent of Tj U f ol/owin g the death of Dr.
Peter A. llerbut (see page 48).
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James W. Stratton .was Chairman of the Task Force on Research, Master
Planning Committee, Board of Trustees. The College also has a Standing
Committee on Research of which Dr. Paul A. Liberti is presently Chairman.
cialized equipment such as electron mi-
croscopes and computer terminals, are
taken as institutional responsibilities, al-
though the funding for equipment isof-
ten obtained via proposals initiated by in-
dividual members of the faculty. A recent
example is the University 's expenditures
in support of research facilities for the
Cardeza Foundation. The new facilities
in the Curtis Clinic are a vast improve-
ment over the old.
Currently, patient care activities are
being moved out of the Curtis Clinic to
provide additional space for the expan-
sion of clinical departments and allow
for increased research activities. Among
the expanded facilities are those re-
cently developed for the Departments
of Surgery, Neurosurgery, Orthopaedic
Surgery and Medicine. Others will be
completed as funds become available.
This expansion, coupled with the facil-
ities available to the basic scientists in
Jefferson Alumni Hall, will place Jeffer-
son in the enviable position among med-
ical schools of having adequate research
space for both basic and clinical depart-
mental research.
Productive scholarly activity is ex-
pected of each member of the faculty.
Nowhere is this idea more clearly ex-
pressed than in the criteria for appoint-
4
ment and promotion of faculty mem-
bers of Jefferson Medical College.
Research accomplishment, as evidenced
by scholarly publications, is required for
promotion at all steps, with increasing
productivity at each level.
A University policy affecting research
output, vis-a-vis that of other institu-
tions, is that we shall have a relatively
large medical student body with a rela-
tively small number of full-time faculty.
Jefferson ranks in the lowest quarter of
American medical colleges in terms of
the full-time faculty/ student ratio. Es-
sentially all members of the volunteer
faculty generate their income from pri-
vate practice and hence have limited
time to conduct research projects.
A related policy is dictated by the ne-
cessity to replace our obsolete clinical fa-
cilities. At this time our resources are
being severely taxed to accommodate
the need for capital funds for the new
Hospital. Although it is regrettable that
we could not reach the ultimate goal of
the Sesquicentennial Campaign within
the two-year period the funds that have
been collected make possible the freeing
of some space for expanded clinical re-
search by moving patients to the newly
acquired Health Sciences Center at Ninth
and Sansom Streets. Just as the avail -
ability of Jefferson Alumni Hall has
made possible the acquisition and reten-
tion of research oriented basic scientists
the completion of our renovation and
building programs will enhance the po-
tential for clinical research. Hopefully ,
budgetary limitations will not delay
these renovations of the Curtis Clinic.
Also the lack of a clinical research center
is indeed a deficiency. How ever , the pol-
icy of maintaining fiscal stability requires
that we cannot operate such a high cost
facility in the absence of extramural
funding. Rapidly rising costs including
such items as fuel, elec trici ty and wages
of service personnel cause additional dif-
ficultie s for researchers. Th ese are trou-
bled times for all institutions of higher
learning especially those private univer-
sities conducting sizeable research pro-
grams. Inflationary pressures that im-
pinge on all colleges and universities
especially affect medical centers. The
lack of intramural or University funds for
new faculty members also is a limiting
factor. Thus item two of the Board reso-
lution is most heartening.
Th ere has been an increasing empha-
sis on resear ch in the basic sciences in
the past few decades at Jefferson. Exam-
ples of research activities in these de-
partments follow :
Anatomy: cytophysiology; comparative
anatomy; comparative, experimental
and reproductive endocrinology; neu-
roendocrinology; lip id metabolism ; ex-
perimental embryology and teratology;
fetal and perinatal anatomy; experi-
mental neuroanatomy; tissue culture.
Biochemistry : immunochemistry (na-
ture of antigen-antibody interaction; ge-
netic control of immune respo nse); en-
zymology; cell biology; metabolism of
amino acids , carbohydrates, lipids, nu-
cleic acids , and vitamin B-12.
Microbiology:microbial physiology and
genetics; virolo gy, mycology; para-
sitology ; pathogenesis of infectious dis-
ease; immunology; and clini cal
microbiology.
Pathology: renal pathology; radiation
patholo!,ry; cytochemical and ult ra-
structural studies of the nucleolus; regu -
lation of cellular growth; use of en-
zymes to control tumor growth.
Pharmacology: toxicology (including
biochemical toxicology);dru g metabo-
Historic Research and Modem Science
lism; neuropharmacology; psychophar-
macology.
Physiology: neurophysiology of sleep
and gast rointestinal function; physiol-
ogy of renal failure; physiology of
edema; cardiovascular physiology and
shock; metabolic effects of ischem ia;
contractile processes in smooth muscle.
In the documentation provided to
President Herbut, the University Advis-
ory Committee on Research concluded
by noting that a true university must rank
research with teaching and public serv-
ice including patient care. Attainment of
excellence in research requires great ef-
fort by all parts of the institution. The
possible leveling off of support for re-
search and the lossof major federal grants
in support of medical education portend
difficult times ahead. Present facilities
must be built up and supplemented as
new education programs and responsi-
bilities evolve. The specter of having to
freeze unfilled positions and impose addi-
tional teaching and service responsi-
bilities is difficult to contemplate. Ways
must be found to continue to attain a cri t-
ical mass of productive researchers and to
promote an environment conducive to
creative scholarship.
Finally on the national scene it should
be noted that the Congress recently
overrode the President's veto of a bill
appropriating increased funds for bio-
medical research. Our elected represen-
tatives undoubtedly were impressed by
the stand of Organized Medicine. Fol-
lowing are paragraphs from a recent
resolution regarding the matter passed
by the American Medical Association:
o The support of biomedical re-
search is the responsibility of both gov-
ernment and private resources. The fed-
eral government, for its part, must
sustain, with high priority, major appro-
priations to all federal agencies that
have responsibility for the support of
biomedical research, including training
for this research. Such support is war-
ranted not only for humanitarian but
also for economic reasons. The cost ben-
efits of medical research are dramati-
cally illustrated by the investments
made in virus research that led to sev-
eral effective vaccines against infectious
disease. At today's hospital costs , for ex-
ample, the nation saves $2 billion per
year because of the vaccine against
poliomyeli tis. Equally large savings
have result ed from chem otherapy for
tuberculosis. Indee d it has been sug-
gested that one dollar invested in re-
search saves many dollars in subsequen t
medical ca re costs.
o Inflation and increasingly soph is-
ticated technology have increased medi-
cal research costs dramatically. It is
inappropriate to compare today's re-
search expenditures with those of an
earlier period in absolute dollar
amounts. Government appropriations
and au tho riza tion for biomedical re-
search and training must take these fac-
tors into account; at a minimum, sup-
port for research and training should be
established and sustained at a level that
will bear some consistent relation to the
nation's total expenditure for health.
o Federal appropriations to pro-
mote research in specifically designated
disease categories should be limited and
made cautiously. Concentrating re-
search funds in one disease area, such as
cancer, may not be beneficial either to
the total biomedical research effort or
A recent abstract by members of
the Cardeza Institute in the De-
partment of Medicine serves to il-
luminate the historic relationship
between the basic sciences and
modern clinical research. The pa-
per, entitled, "The Effect of In
Vitro Carbamylation on Red
Blood Cell Function," by T. A.
Lane and E. R. Burka, appeared in
Clinical Research, 22:701A (1974).
The initial work on which this
study was based began in the year
of Jefferson's founding. In that
year, 1824, Frederick Wohler , in
Germany, first synthesized an "or-
ganic compound" (urea) from an
"inorganic compound" (silver
cyanate), and thus founded the sci-
ence of Organic Chemistry, a cor-
nerstone in modern biomedical re-
search. Some 148 years later urea
was tested as a possible therapeu-
tic agent for the treatment of
sickle ce ll anemia. It was noted
even to cancer research itself.
o Funds should be specifically ap-
propriated to train personnel in bio-
medical research. Without adequate
numbers of pe rsonnel trained in both
basic and applied biomedical research,
new discoveries for the prevention and
care of disease wili be unlikely. Inden-
tured service or financial or other penal-
ties that encumber the use of research
training funds by either institutional or
individual awardees, are undesirable.
o The American Medical Associ-
ation will accept responsibility for in-
forming the public on the relevance of
basic and clinical research to the deliv-
ery of quality medical care. It is impor-
tant that the public be familiar with the
goals and methods of biom edical science
so that the people and their representa-
tive s can effect sound scientific policy.
In closing I should like to urge that
each member of the medical com-
munity keep in contact with our elected
representatives and assure them that re-
sources allocated for biomedical re-
search represents a sound investment in
the health of the American people.
subsequently that cyanate ions are
present in aqueous solutions of
urea, and that cyanate is an effec-
tive carbamylating agent; it reacts
with the N-terminal amino acids
of the ,a-chains of sickle cell he-
moglobin and prevents aggrega-
tion, the cause of the devastati ng
clinical picture. Sodium cyanate
now is being tested clini cally as a
possible therapeuti c agent, and
the study conducted at the Card-
eza Foundation is one of those
concerned with det ermining its ef-
fects on enzyme syste ms in the red
blood cell.
It is of interest that Wohler 's
work of a century and a half ago
was performed in his " teaching
laboratory" in Cettingen, just as
biomedical research is conducted
today in the teaching laboratories
of Thomas Jefferson University
and other academic medical cen-
ters throughout the world.
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TJU Research: Activity and Productivity
Jefferson scientists detailcurrent
projects in five representative
research areas.
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by Paul H. Maurer, Ph.D.
Using Polymers of Amino Acids
to Study Genetic Control
of the Immune Response
For the past 20 years or so we have em-
ployed synthetic polymers of amino
acids as molecular models for proteins
to study many parameters of the im-
mune response. Th e synthe tic polym ers
that have been used have contained one
to thr ee and sometimes four amino
acids, either polymer ized in random
fashion or most recently as sequential
polymers of amino acids wherein we
know the exact sequences of the three
to four am ino ac ids repeated in the
polymeric chain. Th e initial emphasis
for this resear ch was to study some of
the parameters responsible for the prop-
erty of immunogenicity, i.e. the ability
of macromolecules which had the size
of proteins, to elici t an immune re-
sponse in many different species. Associ-
ated with this was the goal to develop a
protein-like material that could serve as
a synthe tic plasma volume expa nder
and not elici t immune responses. Al-
though this goa l was not reached, many
othe r studies in our own laboratories, as
well as in several oth ers throughout the
world , have yielded information about
many of the molecular properties of
macromolecules which contribute to
the enhancement or the depression of
immune responses.
During our studies with experimenta l
animals it became obvious that one of the
major components responsible for the
ability of a host to respond immunologi-
cally was associated with the "genetic
background of the individual." Since
then many studies with random and in-
bred spec ies such as mice, guinea pigs,
rats and monkeys have indicat ed that the
capacity to form speci fic immune re-
sponses isgove rned by the product of in-
dividual dominant (termed immune re-
sponse [Ir]) genes locat ed in the genome
Dr. Maurer is Professor of Biochemistry
and Chairman of the Department.
in close relationship with the genes cod-
ing for the molecules responsible for the
histocompatibility specificities.
Th e major advantage of using syn-
thetic polypeptides for immunological
studies is that we have been able to
present the host with a protein-like
molecule having "limited structural het-
erogeneity." As is known, proteins are
complicated molecules and a host can
usually respond against many different
areas on the macromolecule. However ,
by employing the synthetic polypep-
tides and measuring the immune re-
sponses by a variety of techniques it has
been possible, in a relatively short time,
to demonstrate that the responses to a
wide variety of antigens are under the
control of what is now call ed dominant
histocompatibility-linked immune re-
sponse genes. Because of the exceed-
ingly complex nature of the immune re-
sponse and the immune phenomena,
this kind of finding was a surprise to us
and other immunologists.
Before proceeding furth er , it is im-
portant to recognize that many of the
studies are collaborative in nature. Al-
though the earliest observations were
made with the late Dr. Paul Pinchuck,
who was associated with us at Jefferson
for a short time, during the past seven
years oth er faculty, such as Dr. Carmen
F. Mer ryman and Dr. Allen R. Zeiger ,
and a number of postdoctoral and pre-
doctoral students here at Jefferson have
contributed greatly to the fi eld. Th e col-
laborative effor ts of many are necessary
because of our multifaceted approach.
In ord er to und erstand the subsequent
discussion, it is necessary to know a littl e
about the present conce pt of the immune
response. It is acknowledged that there is
a conside rable complexity in the cellular
events associat ed with an antibody re-
sponse to an antigen. The humoral (anti-
body) response must involve at least two ,
and probably three, cell populations; the
B cell lymphocytes deriv ed from the
bone marrow, the T cell lymphocytes of
thymus origin , and the macrophages.The
Bcell can manufacture antibody after it
has come in appropriate contac t with
some determinants on the specificanti-
gen. It is now well established tha t this
event does not occur in isolation but isde-
pendent on some kind of signal emitted
only if there is a recognition of "carrier"
determinants on the antigen by the T cell
or a T cell product. Whil e the role of the
macrophage has not been clearly de-
fined, it appears to be act ing by acquiring
a sur face receptor from the T cell so that
it combines antige n for presentation to
the Bcell. This has been refer red to as the
collaboration between these three cells,
the T cell, the Bcell and the macrophage,
in elici ting an immune response.
Generally, in all of our studies we use
several different parameters to measure
the immune response. First and fore-
most, we measure the amount of spe-
cific antibody in the serum employing
radioactively labelled antigens and
some standa rd radioimmunoassay
pro cedures. This humoral response mea-
sures the B cell function. However, de-
pending upon the spec ies being studied,
we also measure othe r parameters of the
immune response, such as the presence
of sensitized T cells. In the guinea pig,
we employ skin testing of the animal
with the antigen and look for a delayed
reaction as a measure of T cell response.
However , in the mouse, rat and guinea
pig studies we also isolate the T cells
and measure the ability of the T cells to
respond in tissue culture to antigen as
an indirect measure of the state of those
T cells in the immunized animal.
As mentioned before, our initia l find-
ings with polymers of amino acids indi-
cated that there must be some genetic
component associated with the re-
sponses against the fairly simple "pro-
teins." With a number of the polymers,
such as those conta ining glutamic acid
and lysine (GL), glutamic acid , alanine
and tyrosine (GAT), glutamic acid, ly-
sine and alanine (GLA) and glutamic
acid, lysine and phenylalanine (GLp) , as
well as a number of the sequential poly-
mers of amino acids, it is apparen t that
one can divide any population of a spe-
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cies studied into "responders" and "non-
responders" to the specific immunogen.
One of our major goals is to learn why
some animals are responders and others
nonresponders. We also are interested in
the nature of the receptors on T cells and
on Bcells responsible for the interaction
with the antigen and in what kinds of mo-
lecular changes might occur during the
interaction of antigen with antibody ei-
ther in vitro or in vivo. Much of the in
vitro research in the Department iscon-
ducted by Drs. Paul A. Liberti and Hugh
J. Callahan who are studying how anti-
bodies interact with antigens and what
kinds of conformational changes might
be occurring in the interacting molecules
at the cellular level. The interacting
molecules are responsible for the trans-
mission of "signals" to the appropriate
lymphoid cells to proliferate and to rec-
ognize more antigen.
Although not all of the questions about
the immune response genes work have
been answered, we,as well as many oth-
ers,are clarifyingsome aspects of the
genes' mechanism of action, and at the
same time are uncovering many other un-
solved problems in immunology.
Our earliest studies involved the ran-
domly bred Hartley guinea pig. Al-
though there were genetic clues, in order
to prove more conclusively that there in-
deed was a genetic component associ-
ated with the immune response, we
eventually had to use inbred strains of
guinea pigs. However, there are avail-
able in the world only two highly inbred
strains of guinea pigs, the strain 2 or the
strain 13 guinea pig. The remarkable
findings observed then and which are still
being uncovered today with a number of
our polymers is the tremendous differ-
ence in response patterns of these two in-
bred strains of guinea pigs against some
of our polymers. For instance, the ran-
dom polymers of glutamic acid and ly-
sine (GL) and glutamic acid and alanine
(GA) can elicit responses only in the in-
bred strain 2 guinea pigs. In contrast to
this, the polymer of glutamic acid and
tyrosine (GT) can elicit responses only in
the strain 13 guinea pigs. The exquisit e
sensitivity of the animal's recognition
mechanism to subtle changes in structure
of a polymer has been shown in our labo-
ratory with the sequential polymers syn-
thesized by Dr. Allen R. Zeiger. A poly-
mer having the repeating sequence of
tyrosine, glutamic acid, alanine and gly-
cine elicits responses only in the strain 13
guinea pig, whereas the polymer of tyro-
sine, alanine, glutamic acid and glycine
elicits responses only in the strain 2
guinea pig.
Since these earl y studies with guinea
pigs, we and other international investi -
gators have contributed information
which indicates that there must be at least
30-40 immune response genes controlling
responses in the mouse,guinea pig, rat,
monkey and man .Th ese genes are domi-
nant and they determine both the cellu lar
and humoral immune responses.
In studying the immune response pat -
terns of inbred mice against a numb er of
the polymers, however , we made the re-
markable observation that the responses
were not only und er genetic control,
but they also were linked to ano ther
group of antigens, the complex of histo-
compatibility antigens. Th ese histo-
compatibility antigens are located on
the surfaces of cells and although their
normal functions are unknown, it is
known that they are the antigens most
responsible for the rejection of trans-
planted organs. Th e major initial advan-
tage of using the mouse in studying the
immune responses was the availability
of man y different strains. The develop-
ment of these many highly inbred
strains took place because of the growth
of another branch of imm unology deal-
ing with elucidation of the mechanisms
of the graft vs. host phenomena (trans-
plantation immunology). It was shown
that in every species there are impor-
tant histocompatibility genes and gene
Dr. Paul H. Maur er: basic studies revealing many of the param eters of immrlllogenicity.
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products, known as the antigens, which
are the basis for immunological individ-
uality and determine whether an indi-
vidual will reject a graft as foreign. Dur-
ing the past ten years, based upon the
chance observation made initially by
Dr. McDevitt of Stanford, we have
learned not only that the immune re-
sponse is under genetic control, but that
the ability to respond or not to respond
is linked to the nature of the major his-
tocompatibility complex of the mouse.
This also has proven the case in studies
using many other species. The concept
of genetic linkage means that the genes,
such as those governing immune re-
sponses and those responsible for the ex-
pression of histocompatibility antigens,
are transmitted together from parent to
progeny; therefore both of these genes
are likely to be close together on the
same chromosome. Employing what are
now the tools of a new area in immunol-
ogy, immunogenetics, we have been
able to "map" the area in the chromo-
some responsible for the recognition of
the antigen. The mouse has truly been
the most rewarding species for the study
of these histocompatibility-linked im-
mune response genes both because of
the number of inbred strains developed
by the students of tissue transplantation,
and because we have available specific
lines of mice which have slight differ-
ences in this histocompatibility complex
(H-2). By studying the response patterns
of many similar mice it has been pos-
sible to determine the chromosomal seg-
ment in the gene complex responsible
for these responses, which immunolog-
ists have termed the 'I region:
In an area of research which moves as
rapidly as the fieldsof immunology, im-
munochemistry and immunogenetics,
surprise findings are occurring all the
time, that suggest future research.
We were puzzled, for instance, when
our observations in determining the lo-
cation on the mouse chromosome of the
gene controlling the response against
the polymer of glutamic acid, lysine and
phenylalanine were incompatible with
our previous findings and those of oth-
ers studying a similar system. Upon fur-
ther investigation it became apparent
that with this polymer the responses
were controlled by at least two genes
acting in a complementary fashion
rather than by a single gene. In other
words, it appears that two genes are
needed to control responses (multigenic
control) against some of the polymers, a
finding that has been corroborated with
different kinds of polymers by several
laboratories throughout the world.
From our research it has become
clear that the responses specified by
these immune response genes involve
the activities of the T lymphocytes. As
indicated before, there are two major
classes of lymphocytes which partici-
pate in the immune responses. The B
cells are the precursors of the antibody
secreting cells and are responsible for
humoral immunity. The T cells are the
effectors of cellular immunity and may
act directly to destroy foreign antigens
including transplanted organs. They
also regulate antibody production either
by helping or suppressing B cell activi-
ties. It therefore appears that the im-
mune response genes to which we have
been referring are expressed mainly on
the T lymphocytes and actually may be
involved with the receptors for the anti-
gen. In other words, one of the impor-
tant mechanisms we know today is that
the T cells which recognize antigen
help the B cell produce the humoral im-
mune response.
The explanation that we and others
had offered a number of years ago (to
explain responsiveness and nonrespon-
siveness) was that the inability to re-
spond against a specific immunogen was
related to a defect in the T cell recogni-
tion of the antigen. That is, nonrespon-
ders were lacking T cells that could
help the B cells. However, a few years
ago in collaboration with Dr. Richard
Gershon of Yale University we were
able to show that the nonresponding an-
imals could also " recognize" the anti-
gen even at the T cell level, but that this
recognition involved interaction with
another class of cells now termed sup-
pressor T cells. It is now apparent that
associated with the complexity of the
immune system is the importance not
just of T cells , but of different kinds of T
cells-those that can help the B cell,
those that can suppress the B cell.
An important part of our studies is
therefore to separate the various popu-
lations of lymphoid cells within an ani-
mal for in vitro tissue culture studies.
Dr. David J. Ganfield in our research
group is attempting to fractionate lym-
phoid cells and isolate the T cells from
an immunized animal and employ them
in tissue culture techniques to deter-
mine the responses of the T cells to
challenge with antigen. We and others
have demonstrated that responder T
cells can reco gnize the antigen in vitro,
proliferate and eventually characterize
the nature of this receptor.
Although there is little controversy
about the nature of the reco gnition
molecules for antigens (receptors) on
the B cell (they are antibody molecules),
the question of the identity of the re-
ceptors for the antigen on T cell is in
considerable dispute. Some investiga-
tors believe that the T cells have recep-
tor s consisting of the immunoglobulin
(antibody) molecules, and othe rs can
find no evide nce for their presence. We
are involved in a great effort to isolate
from the sur faces of T cells macromole-
cul es which might be responsible for the
in vivo recognition of the antigen. This
is literally more difficult than looking
for a needle in a haystack ; even after
one finds the needle, one must deter-
mine wheth er this needl e (receptor) has
come from the T ce lls or from some
oth er lymphoid cell.
Although almost all of our research
can be considered basic and has in-
volved laboratory animals, there are im-
portant implications of our research
which may contribute to a bett er under-
standing of human diseases. Although
we have found that the responses
against a number of antigens are con-
trolled by genes which are closely
linked with the major histocompatibi-
lity complex in a number of species, the
all important question is: "Does this
have any relevance to man?" First of
all , in animals, associations have been
shown between the nature of H an tigens
and diseases such as autoimmune thy-
roiditis in mice , the susceptibility of rats
to experimental allergic ence phalo-
myelitis, and the susceptibility of mice
to the pathogeneic effects of lymphocy-
tic choriomeningitis virus . Wh at about
man? A number of investigators have
been showing associations between a
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number of human diseases and the spe-
cific histocompatibility antigens of man
(HLA). Most of the diseases are associ-
ated with defective or aberrant immune
responses and many are thought to be of
"autoimmune origin," i.e. they may be
caused by an immune system attack on
the body 's own tissues. They include an-
kylosing spondylitis, Reiter's disease,
psoriasis, Graves' disease, multiple scle-
rosis and ragweed fever. In addition,
there appears to be an important role
for these histocompatibility linked Ir
genes in the development of tumor im-
munity and tumor rejection, not only in
experimental animals but possibly also
in man. It is known that malignant neo-
plasms bear distinct and new tumor spe-
cific surface antigens which are respon-
sible for the stimulation of tumor
immunity. The immune responses to tu-
mor specific antigens are recognized as
being very complex, involving cellular
immunity, cytotoxic and blocking anti-
bodies and the possible involvement of
the class of T cells we referred to before
Devel opmental Biology
and Radiation
Embryology at the
Stein Research Center
by
Robert L. Brent, M.D., Ph.D.
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as suppressor cells. In fact, for reasons
unrelated to the study of tumor immu-
nity per se, it has been shown that there
are genetic factors controlling the sus-
ceptibility to Gross virus leukemoge-
nesis in inbred mouse strains and that
even in the mouse these genes are
. closely linked to the mouse H-2 gen-
otype. Similarly, in mice, the suscepti-
bility to Friend virus leukemia is also
linked to the H-2 complex.
Observations of this kind have led to
another collaborative study with Dr.
Dan Moore of the Institute for Medical
Research in Camden, who has been
studying the transmission of the breast
cancer virus from mother to offspring
via the milk in inbred strains of mice.
Dr. Merryman and I are now involved
with Dr. Moore in investigating the pos-
sible role of the H-2 complex of the
mouse in determining resistance or sus-
ceptibility of a mouse strain to murine
breast cancer. Again, the implications in
human breast cancer are great.
The possible relationship between tu-
The Stein Research Center houses clini-
cal research and teaching programs of
the Departments of Radiology and
Radiation Therapy. At present, there
are three major activities housed at the
center: 1) the Medical Physics Division
of the Radiology Departments; 2) a por-
tion of the Radiation Biology section of
the Department of Radiation Therapy
and Nuclear Medicine and; 3) the Radi-
ation Biology and Developmental Biol-
ogy programs of the Radiation Biology
section of the Department of Radiology.
Actually three-quarters of the space and
personnel are devoted to programs in
developmental biology and radiation
embryology, and since I am intimately
involved in these programs, I shall con-
centrate on these activities.
The goals of the faculty and research
staff members are multifaceted. We
have always encouraged medical stu-
dent participation in our research pro-
Dr. Brent is Professor of Pediatrics and
Chairman of the Department, Professor
of Radiology (Radiation Biology), Pro-
fessor of Anatomy and Director of the
Stein Research Center .
mor susceptibility and HLA genotype
might be explained by the absence or
presence of the appropriate immune re-
sponse genes in a susceptible individual
which could render the person inca-
pable of developing an adequate im-
mune response against the tumor spe-
cific antigen. In fact, the immune
system, which is a unique immune sur-
veillance machinery, is believed to be
important in removing tumor cells.
What started about 25 years ago as a
study associated with an applied prob-
lem, the development of a synthetic
plasma expander, has moved through a
number of basic studies and revealed
many of the parameters of immunogen-
icity. By understanding the role of genes
in controlling immune responses, we
hope it will be possible to apply these
findings to the enhancement or depres-
sion of the immune response, depending
upon the specific problem at hand, i.e.,
to enhance the response to cancer anti-
gens and to reduce the response to
transplantation antigens.
grams even when a student indicated he
just wanted a "taste" of research. It is
just as important for a medical student
to know that he is not suited for an in-
vestigative career as it is to know that
he wishes to devote the remainder of his
life to creative research. Predoctoral
candidates from the Departments of
Anatomy, Physiology, Biochemistry and
Pharmacology have conducted their in-
vestigative programs at the Stein Re-
search Center as part of the require-
ment for the Doctor of Philosophy
degree. Postdoctoral candidates from
diverse fields such as pediatrics, obstet-
rics and gynecology, endocrinology,
pharmacology, anatomy. medical phys-
ics and biomedical engineering have
trained here.
The development of a research phi-
losophy and the establishment of under-
graduate and graduate research pro-
grams cannot be undertaken and cannot
be characterized as quality programs
without the presence of ongoing re-
search programs conducted by the per-
manent staff at the Stein Center or any
research center.
The developmental biology and radi-
Dr. Robert L. Brent : Our radiation embryology studies haoe clarified quan-
titati ve aspects of tile effects of rad iation on tile develop ing embryo.
ation biology programs ar e supported by
outside govern mental agencies and non-
profit foundations. Research support for
present and past programs has been ob-
tained from The National Foundation",
The Royal Societ y of Medicine, The Na-
tional Institute of Child Health·, The Fo-
garty International Center, The Atomic
Energy Commission,The Energy Re-
source and Development Agency" , The
ational Institute of Environmental
Health Science" and Smith, Kline and
French Laboratori es.
Although the developmental biology
programs can be considered modest, the
total budget from outside agencies since
I came to Jefferson amounts to more
than three million dollars. Besides the
research fundin g, the developmental
biology pro grams at the Stein Center
receive othe r support. Without some
faculty support from the Jefferson Med-
ical Co llege the Stein Center could
never have been developed . Th e gener-
ous gift of Mr. and Mrs. Loui s Stein, the
Eleanor Roosevelt Foundation and the
NIH permitted the structure to be built.
Dr. Philip J. Hodes, Em eritus Professor
of Radiology, spe nt much of his time
and ene rgy in conce iving and working
for the crea tion of a Radiology Depart-
ment resear ch institute. Ongoing unre-
stricted support has come from a group
of dedicated donors such as the Harry
Bock Chari ties and the League of the
Harry Bock Charities. These groups
hav e work ed tirelessly to support the
program at the Stein Center and, in
fact , the developmental biochemistry
laboratories on the second floor are
known as the Har ry Bock Laboratories.
Th e resea rch programs of the develop-
men tal biology gro ups include problems
in radiati on embryo logy, fetal physiol-
ogy, plac ental transport developmental
immunology, embryo culture, effects of
microwave radiation, fetal endocrinol-
ogy, teratol ogy and legal medicine.
Studies in radiation embryology hav e
been con duc ted continuously at Jeffer-
son since 1957. The results of these stud-
ies have clarified the quant itative as-
pect s of the effects of radiati on on the
develop ing mammalian embryo. Some
"Present li] supporting research or educa-
tional programs in developm ental biol-
ogy and radiati on biology.
important conce pts that have devel-
oped from thi s research include:
1) Embryonic and fetal growth retarda-
tion are intimately associated with
malformations produced by radiation.
2) Th e embryo, whil e very sensitive to
radiation , also has sophisticated re-
pair mechanisms whi ch can prevent
the effec ts of radiation if the dose
rat e and dose are very low.
3) The preimplantation peri od of mam-
malian development is a stage that is
resistant to the teratogenic and
growth retarding effect s of radiation.
4) X-ray exposures below ten rads hav e
no ability to produ ce gross malforrna-
tions in this mammalian embryo.
Th ese and other radi ati on studies
have permitted the staff to become
quite sophisticated in the eva luatio n of
human radiation hazards to the preg-
nant wom an. As a result , our laboratory
is a center for the evaluation of radi -
ation effects in exposed potentially
pregnant or pregnant women. We re-
ceive approximat ely 100 calls each year
from all over the United States pertain-
ing to such radiation ha zards. Besides
calls about radiation hazards we receive
requests for information about drug and
chemica l hazards during pregnancy.
Developmental immunology research
hasbeen conduc ted by Marcela Jensen,
Dr.Christoph er C. K. Leung, Dr . Thomas
R. Koszalka and Dr. Ronald P.Jensh for
manyyears. In 1961 we first reported the
production of congenita lmalformations
by injecting het erol ogousanti-rat kidney
anti serum into pre!:,rnant rats. Thiswas the
first rep ort that a specific immunoglobu-
lin could be a potent teratogen. While
othe r investigators had repor ted congeni-
tal malformations Following exposure to
foreign ant ibodies, none of the findings
was corroborated. This discovery led to
the reali zati on tha t the teratogenic an-
tiserum was locali zed in the yolk sac. Dr.
Koszalka, Dr. Jensh, Dr. Leungand Ms.
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Jensen have begun extensive investiga-
tions dealing wi th yolk sac function, pla-
cental transport, collagen synthesis in the
developingyolk sac and are attempting to
isolate yolk sac and kidney antigens. Since
the human hasa vestigial yolk sac when
compared to the rodent, this line of inves-
tigation has raised an interestingque s-
tion. If the yolk sac isa critical organ in rat
teratogenesis, are rats or other rodents ap-
propriate species to utilize for screening
drugs and chemicals for potential human
teratogenesis?
Dr. Koszalka, who is Professor of Radi-
ology and Biochemistry and Director of
the Developmental Biochemistry Labo-
ratories,works with all members of the
developmental biology staff and is in-
volved in his own program of placental
transport and muscle biochemistry. He
has continued wi th his studies dealing
with the mechanism of creatinuria fol-
lowing X-irradiation and the fact that in-
sulin can reverse the creatinuria of radi-
ation injury. His expertise in creatine
metabolism has permitted us to study
normal and abnormal transport in pla-
centa and the transport of agents which
result in transplacental carcinogenesis.
Dr. Jensh, whoisAssociate Professor of
Anatomy and Radiology, was the first
Ph.D .graduate supportedby thedevel-
opmental biology program and has main-
tained his interest in teratology and de-
velopmental biology. In 19700ur
laboratory reported that high exposure
microwave radiation could cause inter-
ruption of pregnancy. Because of exper-
(right) Home: These enclosures of Dr.
Brent 's contrivance are fitt ed at the
top with inexpensive lab bottles,
allowing their experimental rat
inhabitants a ready and clean source
of water. (far right) Technicians in
Dr. Wh eelock 's lab remove mice
spleens. Transfer of spleen cells from
FL V infected mice in large numbers
to normal mice produces FL V
erythroleuk emia.
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tise in this area, Dr. Jensh received a grant
from the National Institute of Environ-
mental Health Service to study the effects
of microwave radiation on the develop-
ing embryo. Dr. Wolfgang Vogel isan in-
timate partner in the areaof animal
psychological testing. Mr. Irvin Wein-
berg,a biomedical engineer, has designed
the anechoic chamber and microwave
equipmentfor the project (seecover).
Other contributions of the develop-
mental biology program include:
1) The production of congenital malfor-
mations utilizing the technique of
uterine vascular clamping;
2) The report that the individual em-
bryo was frequently an erroneous
sample in teratologic testing;
3) The preparation, at government
request, of a soon-to-be released
monograph entitled, "The Preven-
tion of Embryonic Fetal and Perina-
tal Disease;"
4) The refocus of embryonic nutrition as
an important area for developmental
biologists for the next decade;
5) The analysis of the basis of malprac-
tice litigation involving congenital
malformations and the development
of a national plan to decrease mal-
practice litigation;
6) The training of developmental bio-
logists who have gone on to head
their own programs at other major
medical centers;
7) The attraction of other develop-
mental biologists to Jefferson.
I would like to elaborate on the last
point. Dr. E. Marshall Johnson is Chair-
man of the Anatomy department and is
well-known in the field of teratology.
He has been a long -term colleague of
mine . With his coming to Jefferson in
1972 and the creation of a solid contin-
gent of dev elopmental biologists in the
Department of Anatomy, the Med ical
College now has one of the stro ngest
multidisciplinary programs in develop-
mental biology in the country. Further-
more, the pro gram is now attracting the
interest of other faculty mem bers and
there is an excellent possibility that re-
search programs will be init iated that
will cross departmental lines and be
able to answer the multitude of ques-
tions that pertain to the mysteries of
embryonic development. For those who
may consider basic embryology and te-
ratology to be esote ric and far from
clinical medicine, let me point out tha t
congenital malformations, mental retar-
dation and genetics contribute an
inordinate burden to mankind. The cost
of custodial care for children and adu lts
with prenatal disease is staggering. The
recent advances in genetic counseling,
cytogenetics, transplacental carcinoge-
nesis, amniocentesis and perin atal care
make our efforts in the developmental
biology laboratory even more mean-
ingful. Twent y years ago no one could
have imagined that ther e would be so
many clinical advances in the field of
applied developmental biology, which
is just another name for ped iatri cs and
obstetrics and gynecology,
• • • • • •
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by E. Frederick Wheelock, M.D., Ph.D.
Understanding the Tumor Dormant State
Current treatment of human cance r
consists of surgery, che mothe rapy, X-ir-
radia tion, immunotherapy or combina-
tions thereof. A common measure of
successful tr eatment is fi ve-year survival
witho ut recurrence of tum or. All too of-
ten, however , tumor cells reappear eve n
after prolonged clini cal remission. Such
tumor cells hav e, by some as ye t un-
known mechanism, escaped destruction
during the remission period despite
being held in chec k. To dat e, few if any
studies have directl y addressed them-
selves to thi s question of tumor dor-
mancy. Thi s is sur prising, since it is the
inability to eradica te residu al tum or
cells completely that often thwarts our
best attempts to achieve a can cer cure .
The present lack of knowledge with re-
spect to the forces involved in main-
taining and breaking tumor dormancy
hind ers our ability to do mor e during
this cru cial period.
Th e principal objec tive of the re-
search conducted in my laboratory has
been to understand this relati onship be-
tween host and dormant tumor cells and
manipulate it in favor of the host. W e
have developed two major experimental
animal model systems, one a virus in-
duced leukemia of mice and the other a
chemically induced transplantable lyrn-
phoma of mice. These experimental
models are highly manipulatable and
will permit an analysis of the tumor-
dormant state .
Friend Leukemia Virus
Friend leuk emia virus (FLV) is one of
a number of antigenically relat ed leu-
kemia viruses of mice. Infection of adult
inbred mice with this virus produces
ery throleukemia in 100% of mice char-
acterized by hepatosplenomegaly and
large numbers of erythroblasts in the
circulation within 21 days. All leukemi c
mice ar e dead within ten weeks after in-
fection. FLV infects many cell types in
the host , including lymphocytes, and in-
fecti on leads to a rapid suppression of
both humoral and cellular immunity.
Reasoning that the immunodepression
induced by FLV might be essential for
its leukemogenicity, we sought ways to
restore immune competence to FLV in-
fected mice and thereby permit the host
to mount an immune response to the
virus.
W e found that 100% of DBA /2 mice
were vire mic and had large numbers of
leuk emic cells in their spleens by the
third day after virus inoculation. An ex-
tensive search was made for a drug or
other biologic agent that could suppress
FLV erythroleukemia when adminis-
tered three days after FLV inoculation.
Such an agent was found in an extract of
virus infected Penicillium stoloniferum
fungal cultures . Th is extract, called
stat olon, could, when combined with
another adjuvant, CO AM (chlorite oxi-
diz ed oxyamylose) suppress erythroleu-
kemi a in 90% of FV infec ted mice . We
found that COA M-statolon treatment
results in int erferon production and a
transient suppression of FLV replica-
tion. Virus is cleared from the blood and
the mice produce an antibody which
neutrali zes the virus and kills leukemic
cells, in vitro. Sta tolon treated mice sup-
press their FLV infecti on and are clini-
cally normal displaying no gross patho-
logic, clini cal , or hematologic manifes-
tations of leuk emia for their entire two-
year lifespan. However , FLV emerges
spontaneously lat e in life in some of the
mice to produce charac teristic eryth-
roleuk emi a indicat ing that the virus was
present in a dormant sta te during the
prolonged clinical remission. Attempts
to isolate infective FLV from the blood
or spleen of these mice during remission
hav e be en unsuccessful. However, trans -
fer of their spleen cells in large numbers
to normal mice produces FLV eryth-
roleuk emi a indicat ing that the virus
and/ or leuk em ic cells were present in
the clin ically normal mice.
Th e persistence of F LV infected
spleen cells in clinica lly normal mice
for man y months could be explained by
two possible mechanisms.
1) Large numbers of spleen cells are
infect ed and contain the genetic infor-
mati on for FLV integrated into their
cellular 0 A. Random reactivation of
the virus may occ ur in dormantly in-
fected cells resulting in virus replication
and producti on of new virus-induced
antigens on the surface of tra nsformed
cells. Fri end virus cytotoxic antibody
present in the extracellular fluid at suf-
ficient levels recognizes these foreign
viral an tige ns and destroys the trans-
forme d cells as they are formed. How-
eve r, as mice age, an tibody levels de-
cl ine and F LV transformed cells break
through to prod uce overt leukemia.
Dr. W7leelock is Prof essor of Micro-
biology.
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Dr. E. Frederick Wh eelock: The objective is to manipulate tile host-dormant tu-
mor cell relationship in fa vor of the 1I0st.
L5178Y Transplantable
Murine Lymphomas
Th e second experi mental model that
we are study ing consists of a chemically
induced lymphoma of DBA/ 2 origin.
Thi s tum or, designated L5178Y, can
consistently grow out and kill DBA/ 2
mice following intr ap eri toneal implan-
tation of as few as 20 viable tumor cells.
Its suitability for study as a model for
tumor dormancy is based pr incipally on
the finding that DBA/ 2 mice tha t have
been immunized with mitomycin C-
treat ed L5178Y cells routinely resist tu-
mor chall enges that kill 100% of non-
immunized mice in less than 25 days.
ease. It has also been implica ted in Bur-
kitt lymphoma.
Because of the complement defi-
ciency in DBA / 2 mice, we have devel-
oped a second hypothesis for the dor-
mant FLV model.
2) Thi s hypothesis states that the in-
teraction of Virus-specific antibody with
newly made virus antigen at the cell
membrane results in inhibiti on (antige-
nic modulation) of the virus genome.
Dormant FLV infected cells may persist
with activation occurring at random
and viral cell surface anti gens being ex-
pressed and modulated until late in life
when antibody levels decl ine. At this
point, emergence of leukemia occurs.
One of our graduate studen ts, Eugene
Genovesi, has in the past yea r demon-
strated antigenic modulation in the
Fri end virus system in vitro. Dr . Preston
A. Marx, Assistant Professor of Micro-
biolo gy and Rosema ry Marano, gradu-
ate student, are analyz ing the FLV spe-
cific proteins on the surface of leukemic
cells in order to identify the proteins to
which a modulating humoral antibody
response is directed. Characterization of
the antibody which specifically sup-
pr esses the FLV infecti on and develop-
ment of ways to stimulate production of
this antibody to prevent eme rgence of
leukemia are major goals of this labora-
tory. Another graduate student, Julia
Wirth. is studying the host cellular im-
rnune mechanisms involved in leukemia
suppression and maintenance of dor-
mant leukemia.
antibody against cell surface leukemic
antigens were not resistant to out -
growth by those leukemic ce lls. Th e
mechanism of escape of the leukemic
cells from the immune response was in-
vestigated. Old found that leukemic
cells existing in the presence of leu-
kemia specific antibody lost their leu-
kemia specific cell surface antigen so
that the cells were no longer susceptible
to attack by specific antibody. Removal
of the se modulated leukemic cells to a
non-antibody containing environment
result ed in reappearance of the leuke-
mic-specific sur face anti gen.
This phenomenon has recentl y been
impli cated in several human diseases. In
subacute sclerosing panenc eph alitls , this
mechanism may account for the escap e
of measles virus-infected cells from the
high titered Virus-specific antibody
present in the blood for many years.
Modulation of cell surface measles virus
antigen by virus-specific antibody has
been demonstrated in vitro and may ac-
count for virus persistance in this dis-
Th ere is, however , one flaw in thi s
hypoth eti cal mech anism . The FV-spe-
cific antibody requires complement to
kill cells. In our in vitro assay we add
guinea pig complement. How ever in
vivo the antibody cannot kill leukemic
cells since the DBA/2 mouse is deficient
in complement components essential for
antibody mediated immune cy tolysis.
What then is the function of this anti-
body in the animal itself? Is it in some
way involved in suppression of uncon-
tro lled leukem ia cell division and estab-
lishme nt of the dorm ant sta te? Th e an-
swer may be found in the phenomenon
known as antigenic modulation, first re-
port ed in 1963 by T. Boyse and L. Old
and subsequently dem onstrated in a
number of immunolog ic systems. An-
tigenic modulation is a phenom enon in
which phenotypi c expression of anti gen
at the cell surface is modulated by the
presence of spec ifi c antibody in the ex-
tracellular fluid. Old mad e the unex-
pect ed observation that mice immu -
nized and containing complement and
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However , extended observations of
these immunized and chall enged mice
revealed that about 40% of them devel-
oped and succ umbed to asciti c tumors
within 18 months. The development of
ascitic tumors in normal aged DBA / 2
mice has never been observed.
Dr. Lester Go ldste in, post-doctoral
Fellow, and Kent Weinhold, graduate
student, have been studying the mecha-
nisms of tum or dormancy in this system.
One of our expe rimental approach es has
been to isolate tumor cells from mice
while they are in the prolonged clini -
cally normal sta te. W e hav e succeeded
in doing so by placing cells from various
organs of these mice into cell cultures in
vitro and have observed outgrowth of
tumor cells. Our current efforts consist
of atte mpts to reconstruct in the cell
culture syste m the immune and non-irn-
mune components of the dormant tu-
mor mouse. Our aim is to und erstand
why tumor cells remain dormant in vivo
but grow out rapidly in v itro. By adding
selec ted lymphoid cell populations and
rnacroph ages and solubl e serum factors
Studying Cardiovascular
Physiology and
Function
by Allan M. Lefer , Ph.D.
from tumor dormant mice to the culture
system together with tumor cells, we
hop e to identify those factors or combi-
nation of factors that maintain the tu-
mor cells in a dormant state in vivo. W e
do know that these tumor dormant mice
contain an antibody that binds to but
does not destro y tumor cells. We be-
lieve that maintenance of the tumor
dormant state may involve the loss of
exposed cell surface targets for host im-
mune mechanisms. The most likely ex-
planation for such loss is anti genic mod-
ulation. It is also possible that some
surface receptors responsible for regu-
lation of cell division are usually con-
cealed during tumor progression. These
receptors may become unmask ed dur -
ing antigenic modulation and lead to
the regaining of control of cell division
by the host. It is also possible that tumor
dormancy could be the result of the ac-
tion of cyto static rather than cytolytic
host mechanisms. Walter Carney, grad-
uate student, is studying this aspect of
the problem using L5178Y cells in
DBA /2 X C57/B6-Fl hybrids .
BeginninginJuly 1974 with the arrival of
several new staff members in the Depart-
ment of Physiology, cardiovascular phy-
siology became a major focus of research
on cardiovascular function in health and
disease stat es. These new staff members,
who are well trained in this area and have
established laboratory programs, are Dr.
Michael J. Rovetto and Dr. James A.
Spath, Jr., Assistant Professors. My own
appointment as Professor and Chairman
of the Department was effective that
July . Each has developed projects which
involve utilizing expertise and tech-
niques in several areas.
Following is a bri ef description of the
type of research work conducted in
each laboratory, the professional re-
searchers leading each project , and the
basic questions being asked by these in-
vestigative teams.
Ci rculatory Shock Research
Hesearch in this laboratory centers
around pathophysiology and therapeu-
tics of circulatory shock with particular
emphasis on the mechanisms of elabora-
Implicit in this line of research is the
hypothesis that modulation of both the
FLV leukemic cells and the L5178Y
lymphoma cells results in reestablish-
ment of normal cell division. The tumor
cells can, however, survive attacks from
immune cells and antibody since they
no longer have tumor specific targe t an-
tigens on their surfaces. In contrast with
other tumor systems, in which ant igenic
modulation is view ed as a mechanism of
tumor cell escape from attack by the
immune system, we believe that anti-
genic modulation can lead to tumor
dormancy. The animal model system
which we are studying in our laboratory
will enable us to characterize the host
tumor intera ctions that lead to the es-
tablishment of the dormant tu mor state
and the events that subsequently occur
to break this dormancy and permit tu-
mor emergence . An understanding of
the interaction involved in tumor dor-
mancy and emergence would greatly fa-
cilitate the development of methods of
prolonging the tumor dormant period
and eradicating all residual tumor cells.
tion of toxic factors during hemor-
rhagic, septic, cardiogenic, bowel is-
chemia, acute pancreatitis, and burn
shock. Efforts are being devoted to elu-
cidation of the chemical structure of the
toxic peptide Myocardial Depressant
Factor (MDF), and of the key roles of
lysosomal hydrolases, prostaglandins
and kinins in cardiovascular alterations
during shock and low flow sta tes. Stud-
ies are also conc erned with protease ac-
tivation and proteolysis in the pan creas
and liver during ischemia and othe r
conditions simulating shock.
Additional studies are concerned with
pathophysiologic mechanisms of devel-
opm ent of myocardial infarcti on. The
subcellular mechanisms of the spread of
ischem ic damage during acu te myocar-
dial infarcti on are being investigated.
Pharmacologic studies also are underway
in an effort to determine which agents are
useful in the preservation of myoca rdial
integrity during myocardial ischemia.
Dr. Lefer is Professor of Physiology and
Chairman of the Department.
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Dr. Allan M. Lefer: Since 1974 cardiovascular physiology has been a
maior fo cus of research on cardiovascular function in health and disease states.
One of the recent breakthroughs in
shock research has been the elucidation
of the role of shock factors, particularly
MDF, in the pathophysiology of shock.
Current activities thus include a sys-
tematic effort to determine the mecha-
nisms of formation and the amino acid
sequence of this peptide. The work is
microchemical in nature as MDF con-
centration in the plasma of animals and
patients in shock is in the range of one
nanogram/ml and this involves
the cooperation of protein chemists at
other institutions, both in the United
States and abroad. The work is coordi-
nated in Philadelphia by Frances Kuber,
a research technician specializing in
analytical chemical techniques, and me.
One of the new areas of research in
this laboratory concerns the role of the
prostaglandins in circulatory shock. Dr.
John T. Flynn, Research Associate, and
Mr. G. Alan Bridenbaugh, predoctoral
Fellow, are working with me in this
area. Part of the work is directed
toward the quantification of the syn-
thesis and release of the major prostag-
landins (e.g. PGE" PGE., PGF.a) in dif-
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ferent types of shock (e.g., hemorrhagic,
bowel ischemic, cardiogenic). These ex-
periments involve the use of pharmaco-
logic agents to block prostaglandin syn-
thetase, the enzyme largely responsible
for prostaglandin synthesis by means of
appropriate drugs (e.g., indomethacin,
meclofenamate) to determine the ef-
fects occurring in the absence of re-
leased prostaglandins. Other experi-
ments involve the infusion of archidonic
acid, the precursor of the bisenoic pros-
taglandins (i.e., PGE., PGF.a) to deter-
mine the effects of increased circulating
prostaglandin levels. In addition, the ef-
fects of exogenously administered pros-
taglandins are being studied in intact ani-
mals as well as in isolated organs (e.g.,
isolated perfused hearts and aortic strips).
When the results of these studies are inte-
grated, it isanticipated that it will be pos-
sible to ascertain whether prostaglandins
are mediators of the shock state or
whether they induce compensatory ac-
tions beneficial to the survival of the ani-
mal or patient in shock .
The role of platelets in circulatory
shock isbeing investigated by determin-
ing the effects of toxic factorssuch as
MDF and lysosomal hydrolases on the ag-
gregability of platelets by use of a record-
ing aggregometer .Studi es are also in
progress to determine the role of plate-
lets in obstructing the splanchnic micro-
circulation during shock and to deter-
mine the effect of removing platelets
prior to induction of shock on the devel-
opment of the shock state. Th ese throm-
bocytopenic animals represent an inter-
esting model in which to evaluate the
pathophysiologic mechanismsof shock.
One ar ea of great concern is the func-
tional status of the liver in shock. Rich-
ard Carlson, Research Associate, and
Genevieve Deutch, a research tech-
nician specializing in metabolic meth-
ods, are working in my group on this
timely problem. They are studying liver
performance in a multiplicit y of ways.
In addition to studying liver metabo-
lisms(i.e.,glucose metabolism), consider-
able emphasis isbeing placed on hepatic
integrity (i.e., both parenchymal and
Kupffer cells) and on reticuloendothelial
function (the latter by measurement of
clearance of colloidal suspensions of par-
The effec ts of exogenously administered prostaglandi ns are being studied in
intact animals as well as in isolated organs such as aortic strips.
ticles of known size). Although some of
the responses of the liver to circulatory
shock are studied in the intact animal,
many of the key experiments are con-
ducted in the isolated perfused cat liver.
This preparation allows the study of the
effects on liver integrity and function of
ischemia, hypoxia and acidosis. If a
clear picture of the response of the liver
to shock can be determined, therapeutic
regimens to normalize the pathophysio-
logic changes can be designed. Some of
the findings were recently presented by
me at an international congress of emer-
gency care medicine in Rio de Janeiro.
The other major area of interest in my
laboratory is the pathophysiology and
therapeutics of acute myocardial infarc-
tion . Two of the major questions being
asked are: (1) What are the early events
occurring in myocardial cells after the
onset of acute ischemia? and (2) How can
we preserve myocardial cell integrity af-
ter ischemia, and prevent either cardiac
failure or cardiogenic shock?
A recent breakthrough in this area
has been the realization that the ulti-
mate size of the developing myocardial
infarct is not fixed or predetermined at
the onset , but can be modified with ap-
propriate drug therapy. Recently, it was
found that synthetic glucocorticoids are
very effective in preventing the exten-
sion of infarct size. Tentative results in-
dicate that the mechanism of this pro-
tective effect is stabilization of myo-
cardial cell membranes (i.e., plasma
and lysosomal membranes).
Present studies underway with Dr.
Minoru Okuda, Research Associate on
leave from Defense Medical College in
Japan, focus on the mechanisms of myo-
cardial cell uptake of glucocorticoids
using isotopically labelled glucocorti-
costeroids. He is being assisted by Mr.
George Osman, a research technician
who is a specialist in isolated cardiac
and vascular preparations. Work in this
area involves the use of cardiac tissue
slices, isolated perfused hearts, and in-
tact animals. These studies indicate that
myocardial tissue passively takes up
large amounts of glucocorticoid. Using
cell fractionation techniques (i.e., den-
sity gradient separation coupled with
ultracentrifugation), most of the uptake
was found to be in the plasma and ly-
sosomal membrane fractions.
Clinical studies are also underway
with Dr. Leslie Wiener, Professor of
Medicine and Director of the Coronary
Care Unit, to determine the efficacy of
glucocorticoid therapy during myocar-
dial infarction in clinical settings. This
study exemplifies the application of
physiologic investigation to future
patient care.
Other important work in progress in
the area of pathophysiology of myocar-
dial infarction is devoted to determining
the early cellular and sub-cellular
events in acute myocardial ischemia.
These studies are in progress with the
help of Mr. Martin Ogletree, predocto-
ral Fellow, and Dr. Mario Feola, Assist-
ant Professor of Surgery. This group has
developed a technique for sampling re-
gional myocardial tissue and the coro-
nary venous effluent from ischemic
areas. Thus, tissue and blood samples
can be studied for the release of lysoso-
mal enzymes and prostagland ins, two
markers for early cellular damage to the
myocardium. Outgrowths of th is work
involve the effect of anti-inflammatory
agents in the infarction process. These
approaches have been very fruit ful in
the past two years, and are of great po-
tential in unraveling the mechanisms of
control of cardiac perform ance in ische-
mic states.
Myocardial Metabolism and
Myocardial Ischemia
The research pro grams in this labora-
tory ar e concerned with the way in
which the metabolism of the myocar-
dium is controlled and can be modified
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by hormones and other agents. This also
involves studying the relationship of al-
tered states of metabolism to the me-
chanical function of the myocardium. A
major interest is the effect of ischemia,
or reduced blood flow, on purine, car-
bohydrate and fatty acid metabolism.
Agents are being studied which may
protect the myocardium from perma-
nent damage during ischemia by pre-
serving or increasing the metabolic ca-
. pacity of the heart.
A variety of experimental techniques
are used in these studies. Much of the re-
search employs an isolated, perfused,
working-heart preparation which allows
the variables that influence mechanical
function and metabolism to be closely
controlled. Intact animal preparations
are also used in studies designed to test
potential therapeutic agents. These
preparations are coupled with many
analytic biochemical techniques which
include spectrophotometric and fluoro-
metric enzyme assays, radioactive tracer
techniques for determining utilization
rates of substrates, and chromatographic
techniques for separation of metabolites
and intermediates of interest. These and
other related techniques are used to de-
termine the rate-limiting steps in meta-
bolic pathways and the factors which
control these pathways.
Dr. Rovetto is assisted in this work by
Diane Reibel , predoctoral Fellow, and
Diane Ubele, a research assistant who
specializes in isotopic biochemical
methods. Thi s group has recently been
able to separate the effects of hypoxia
and ischemia on myocardial metabo-
lism. Surprisingly, hypoxia appears to
lead to an increase and ischemia, a de-
crease in the rate of anaerobic energy
production. These differences in the
rate of energy production are due to ac-
cumulation of metabolic products re-
sulting from the low blood flow during
ischemia. The studies are of fundamen-
tal importance for the understanding of
the response of the heart to preinfarct
stress states. They also point out the role
of myocardial intracellular hydrogen
ions and other metabolic products as key
factors in the control of myocardial me-
tabolism. These studies have prompted
Dr. Rovetto to investigate the influence
of these metabolic mechanisms on the
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coronary vasculature, a long neglected
aspect of the total control system .
Recently, Dr. Rovetto has teamed up
with Dr. Feola, of the Department of
Surgery, Dr. Wiener, of the Depart-
ment of Medicine, and Dr. Raymond
Soriano, of the Department of Pathol-
ogy, to study cardiac edema in myocar-
dial ischemia. Using electron micro-
scopy with special lanthanum staining
techniques, this fruitful collaborative
study has shown that edema is a real
phenomenon in acute myocardial is-
chemia. Moreover, this team has gone
one step further and showed that phar-
macologic doses of glucocorticoids are
beneficial in limiting the edema, reduc-
ing the severity of cellular injury and
stabilizing myocardial cell membranes.
Dr. Rovetto is also engaged in relat-
ing the hormonal control systems to the
regulation of cardiac function and me-
tabolism. In this area, he is currently in-
vestigating possible direct effects of thy-
roxine and long term stress, which
elevates a number of hormones, on vari-
ous energy producing processes in the
heart. These studies are primarily con-
cerned with trying to determine what
limits the rate of energy production
within a given pathway, how these rates
might be changed by hormonal mecha-
nisms and the relationship between the
hormonally-induced changes in energy
production and myocardial mechanical
function. Understanding of these proc-
esses and relationships will prove valu-
able for developing interventions to
protect the energy deficient myocar-
dium both during ischemia and failure.
Hemodynamics and Low Flow
States
The research activities in this labora-
tory involve studies of (1) pharmaco-
logic mechanisms of maintaining cellu-
lar integrity within the heart tissue in
states of low blood flow (2) the patho-
physiology of cardiogenic shock and
other low flow states and (3) factors or
mechanisms which regulate blood flow
within the organs of the body.
Research projects are designed to in-
vestigate normal and pathological mech-
anisms which may operate within the
circulatory system. The aim of each
study is to relate physiologic activities of
the total organ or organism to under-
lying activity at the cellular level.
Dr. Spath has designed some special
techniques in order to achieve these
goals. Recently, in this laboratory, a new
technique for studying pericardial tam-
ponade and sampling myocardial tissue
and pericardial fluid was devel oped in
order to study the development of card-
iogenic shock induced by pericardial
tamponade. Assisting Dr. Spath in these
studies are Patricia Gwirtz, predoctoral
Fellow, and Ernest Rivers, American
Foundation for Negro Affairs student .
Dr. Spath is also actively engaged in
studying the role of lysosomal hydrolases
in the pathophysiology of acut e myocar-
dial infarction and in the transi tion from
myocardial ischemia to cardiogenic
shock. These studies have yielded funda -
mental insight into the cellular aspects of
ischemic damage and have called atten-
tion to the role of acid hydrolases in
propagating the spreadof ischemic dam-
age from cell to cell after the initial is-
chemic insult. In this connection, lysoso-
mal proteases appear to be particularly
important in mediating cellular disrup-
tion and ischemic damage. A certain pro-
tease inhibitor has been administered in
experimental myocardial ischemia and
found to be effective in preventing the
spread of ischemic damage in the heart .
This agent, aprotinin, is being studied
further for additional information on its
mechanism of action.
In an attempt to interrelate myoca r-
dial ischemia with pulmonary dysfunc-
tion, Dr. Spath is currently working with
Dr. Marlys Gee, Assistant Professor of
Physiology, on pulmonary edema in
acute myocardial ischemia. By the use of
microanalytical fluorescent techniques,
they are investigating the occurrence of
significant degrees of pulmonary edem a
formation in this condition. This is an-
other example of bringing together two
important research areas.
As the cardiovascular physiology
group becomes well established, more
and more opportunities for interaction
will become apparent, and hopefully
others in the Jefferson community will
develop collaborative research studies
with the cardiovascular physiology re-
search team.
Dr. Allan ] . Erslev: Research at tile Cardeza Founda tion is primar-
ily applied and clinically orien ted.
Hematologic
Research at the
Cardeza Foundation
by Allan J . Erslev, M.D.
In 1939, Thomas Drake Martinez Card-
eza and his wife, Mary Racine Cardeza,
established the Cardeza Foundation as a
Hematologic Research Institute in the
Department of Medicine of the Jeffer-
son Medi cal College.
Th e Charter of the Cardeza Founda-
.tion specifies that it shall serve as the
Divi sion of Hematology in the Depart-
ment of Medicine and that its members
be teachers or clinicians as well as in-
vestigators. Its Director, The Thomas
Drake Martinez Cardeza Research Pro-
fessor of Medicine, is responsible for he-
matology teaching for all the affiliated
units of the Jefferson Medic al College of
the Th omas Jefferson University and he
reports dir ectly to the Chairman of the
Department of Medicine. How ever , the
Cardeza Foundation, because of its
broad academic responsibility to hema-
tolo gy, also serves the Blood Bank and
Blood Donor Center for the Hospi-
tal , as the D ivision of Hematology of
the Department of Pediatrics and as a
hematologic resource for the Depart-
ments of Biochemistry, Physiology and
Pharmacology. In short, it serves as an
interdepartmental Blood Center at
Thomas Jefferson University and its Di-
rector reports dir ectly to the Board of
Trustees through an Advisory Board
mad e up by members of the Board of
Trustees, the Administrat ion and the
Executive Council.
The Cardeza Foundation under the
Trusteeship of J. Harry Wagner , Jr . Esq.
and the Fidelit y Bank provides approxi-
mately one -half million dollars a year
for salaries of key research personnel.
Th e University, which receives 20% in-
direct cost allocation by the foundation,
provides space and physical faci lities.
On top of this "hard money" basis,
members of the Cardeza Foundation
bring in abo ut one mill ion dollars a year
in research grants and contracts. There
has been a steady increase in research
support and activities over the years
and the Foundation personnel now con-
sists of a staff of 16 fullt ime M.D.s and
Ph.Ds, five Fellows, two graduate stu-
dents and about 60 non-professional
members. In 1960 it moved from its
original quarters in the College Building
to a three-story building on Sansom
Street. After 15 years there it moved in
April 1975 into three completely reno-
vated floors in the Curtis Building. Here
it is located next to the oth er divisions
of the Department of Medicine and the
beautifully redecorated 16,000 square
feet of research space includes a small
library-conference room , a photo-
graphic laborat ory, animal house and
operating room, isotope rooms, work-
shops, offices and laboratories of indi-
vidual investigators.
Th ere are spec ial quarters for rotat-
ing residents and for clinical and re-
search Fellows and also laboratories for
routine and sophistica ted hematologic
tests used by the staff in their clinical
consultative serv ice at the Thomas Jef-
ferson Unive rsity Hospit al. The Cardeza
Hemophilia Center and the Cardeza
Dr. Erslev is the Thomas Drake Martinez
Cardeza Research Prof essor of Medicin e
and Director of Hematology.
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Donor Center are temporarily located
on other floors in the Curtis Building
and the Cardeza Blood Bank and Tissue
Typing Laboratory are located in the
Hospital buildings.
Research conducted at the Cardeza
Foundation is primarily applied and
clinically oriented. In most instances, it
is work made relevant by exposure to
patients and stimulated by constant
feedback from students, housestaff and
Fellows. In other words, research is part
of the teaching and clinical responsi-
bilities, a creative mixture only avail-
able in a medical university. Since he-
matology, as all medical specialties, has
become further sub-specialized, hema-
tologic research of necessity is primarily
carried out within certain units. Never-
theless , the physicians on the Cardeza
staff are all general hematologists and
have clinical and research interests
spanning most of these units, while the
Ph.D.s have an interdisciplinary range
of interests which include physiology,
pharmacology, biochemistry, immuno-
logy and pathology.
The Thrombotic and Hemostasis
Disease Unit
Immunologic characterization of
clotting proteins has revealed that dis-
eases formerly identified by a deficiency
in the biologic activity of such proteins
may be caused by many different ge-
netic or acquired abnormalities in the
protein molecules. Hemophilia, for ex-
ampl e, with low to absent Factor VIII
activity, can be caused by either a ge-
netic deletion of the Factor VIII mole -
cule or by numerous inherited changes
in its composition. Drs . Sandor S. Sha-
piro , Jose Martinez and associates have
been particularly interested in genetic
abnormalities of the prothrombin mole-
cule and have been involved in the
functional and immunologic characteri-
zation of several prothrombin variants,
one of these aptly nam ed Prothrombin
Cardeza . Th ese studies have led to an
improved understanding of the activa-
tion of prothrombin to the clotting en-
zyme, thrombin, and its subsequent
inactivation. Drs. Martinez and Shapiro
have also worked on abnormal fibrino-
gens. Using a procedure developed by
Dr. Louis A. Kazal at Cardeza in 1963,
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they have isolated a new fibrinogen,
Fibrinogen Philadelphia, and used a va-
riety of biochemical tools to dissect and
identify the biologically active frag-
ments which appear during the trans-
formation of fibrinogen to fibrin.
Of great importance to hemostasis
and thrombosis is the transformation of
a circulating " inert" platelet to a sticky
cell capable of arresting bleeding or in-
ducing thrombosis. This platelet aggre-
gation is initiated when blood vessels
are injured and it may be enhanced or
retarded by various drugs. The work of
Drs. Melvin J. Silver, J. Bryan Smith
and associates has demonstrated the im-
portance of prostaglandin synthesis in
platelet aggregation. Dr. Smith 's early
work has helped to explain why aspirin,
a prostaglandin inhibitor, is such a po-
tent inhibitor of platelet aggregation.
Since both excessive bleeding and exces-
sive thrombosis are life threatening
events, further elucidation of platelet
prostaglandin metabolism may have
wide reaching implications. The capa-
bilities of Cardeza to undertake re-
search into all aspects of hemostasis and
thrombosis will be enhanced by the ad-
dition of Dr. Scott Murphy who will
join the Cardeza Foundation in May
1976. Dr. Murphy is known for his
studies on platelet preservation and
platelet transfusion, and has been instru-
mental in developing the use of platelet
concentration in clinical medicine.
Through the tireless efforts of Dr.
Shapiro, a state and federally supported
Hemophilia Center has been established
at Jefferson. Thi s center, staffed by a full
time nurse , a social worker-coordinator,
and supported by clerical and labora-
tory facilities, provides comprehensive
medical, hematologic and social support
for about 120 patients with hemophilia
and for their familie s. Preventive man-
agement with medical, social and emo-
tional restoration is attempted through
home therapy with Factor VIII concen-
trates, surgical correction of joint defor-
mities and genetic and social counsel-
ing. The Hemophilia Center is also the
coordinating center and reference labo-
ratory for a national program aimed at
studying the natural history of hemo-
philia and its major complications, par-
ticularly the development of inhibitors
to Factor VIII. Thi s study will even-
tuall y include some 1500 pati ents.
The Red Blood Cell Unit
The effect ofabnormal hemoglobins,
such as sickle cell hemoglobin,on normal
physiology, is beingstudied in a number of
waysin order to obtain information useful
for the treatment and prevent ion of these
effect s.Th e identification and characteri-
zation of abnormal hemoglobins have
been hallmarks of research done by Miss
Jean Atwater , and several hemoglobins,
such as Hemoglobin Philadelphia were
first described and identified at Cardeza .
Studies of protein synthesis in reti -
culocytes have led Dr . EdwardJ. Burka to
propose that hemoglobin is produced by
ribosom es lying free in the cy toplasm
while membrane bound ribosomes are
more involved in the synthesisof enzyme
and oth er red cell proteins. Wit h Dr. Sa-
mir K. Ballas,he has studied the effect of
membrane injury on lipid synthesisand
has described a close relati onship be-
tween lipid turnover and red cell surviva l.
Th e relationship between red cell en-
zymesand red cell survival in the new-
born is the subject of a similar study by the
pediatric hematologist, Dr. Susan F.
Travis.
Th e Transfusion Unit ,dir ected by Dr.
Burka , is working on perfecting a blood
component preparation and treatm ent
and will shortly provide patientsat
ThomasJefferson University Hospit al
with leukocytes aswell aswith platelets,
red cells and plasma. In orde r tobe ofben-
efi t, leuko cytes have to be matched by tis-
sue typing and mixed lymphocyte cultur e
testing and thisservice isprovided for
leuko cyte recipi ent s as well as for kidney
transplant recipientsby the tissue typing
laboratory directed by Dr. Bulova,
ASickle Ce ll Cente r will be established
along the patterns of the Hemophilia
Cent er with emphasison treat ment, pre-
vention, counseling and research. Studies
of molecular adjustment of the sickle cell
hem oglobin by meansof cyanate and
oth er chemicalswill be pursued.
The Immunology Unit
The lymphocytes, which for years
were thou ght to be useless end-ce lls on
their way to finai elimination, have sud-
denly become the most exciting cells in
Dr. Lollis A. Kazal (riglit): studying
the mechanism of erythropoietin produ ct ion of the kidn ey
the body. They carry the immunologic
knowl edge of the body and are capable
of transforming into antibody producing
cells or into cells directly fighting in-
truders and abnormal, especially malig-
nant, cells. Th e surveillance of the body
with these cells is imperative for sur-
vival and numerous hematologic and
non-hematologic disorders have been
related to either over , under or dysfunc-
tion of these cells.
Dr. Stephen P. Hauptman and Dr.
Stephen I. Bulova are actively engaged
in the study of Band T cell function, an-
tibody synthesis and the effect of drugs,
such as cortisone. Dr. Hauptman has
discovered that albumin and antibody
of the IgA typ e are synthesized together
and released as a complex. This com-
plexing function of albumin may be of
great potential importance in the im-
munul ogic homeostasis in the body.
The Leukemia and Lymphoma
Unit
Dr. Farid I. Haurani was one of the
early Directors of Acute Leukemia
Group B, a cooperative IH research
unit studying the management of
patien ts with leukemias and lym-
phomas. Currently, 125 patients in vari -
ous affiliated hospitals of the Thomas
Jefferson University are undergoing
protocol treatments under close super-
vision and observation. The studies of
this group have played a major role in
our present, far more optimistic outlook
on patients with leukemias and
lymphomas.
Certainly, a 95% remission rate in
children with acute leukemia and a
hopeful anticipation that about 50% of
these children may be cured of their dis-
ease are results no one dared to dream
about 15 yea rs ago. Most of the clinical
memb ers of the Cardeza Foundation
both at Jefferson and at the affiliated
hospit als parti cipate in this research
program.
The Erythropoietic Unit
Elucidation of the physiologic control
of red cell production is a major re-
search aim at the Cardeza Foundation.
It is known that red cell production de-
pends on the presence of a number of
minerals and co-enzymes, and that it is
controlled by a renal hormone, eryth-
ropoietin. The interaction of these fac-
tors in the bone marrow can explain the
pathogenesis of a number of anemias,
but more importantly may throw a
light on the control of normal and ab-
normal growth. In addition, the study of
these factors has led to the identi-
fication of a specific deficiency syn-
drome, the anemia of chronic renal dis-
ease, an anemia caused in part by a lack
of erythropoietin and probably correc -
table by replacement therapy with this
hormone. Since it is anticipated that
within a few years , about 60,000
patients with chronic renal disease in
the U.S.A. will be kept alive by home
dialy sis, it is imperative to enhance the
quality of their lives by preventing the
anemia by replacement therapy.
The mechanism of erythropoietin
production of the kidney is studied by
Dr. Kazal, me and my associates. Al-
though isolated perfused kidneys will
produce large amounts of erythropoie-
tin , kidney extracts do not contain th is
hormone. It is hoped that this is not a
question of lack of storage, but rather
inactivation during the extraction pe-
riod. A lipid inhibitor of erythropoietin
has been demonstrated in renal extracts
and it is being identifi ed in order to de-
velop a way by which it can be re-
moved and permit isolation and mass
production of erythropoietin for clinical
use. Th e acti on of ery thropoietin on the
bon e mar row stems cells is being stud-
ied by Dr. Ruth Silver and me both in
vivo in pati ents and laboratory animals
and in vitro in cultures of normal and
abnormal bone mar row. Furtherm ore
the requ irement s of the bone marrow
for iron , vita min B1 2 and folic acid have
been studied by Dr . Haurani. Recentl y
he has demonstrat ed that vitamin B12
may act by producing a key enzyme
(thymidylate synthe tase) in folic acid
metabolism. Much dat a and many hy-
potheses have been produced but still
only few facts.
Many other studies are being carried
out at the Ca rdeza Found ation, some
pilot studies aimed at prospecting new
ideas, some opportunistic studies be-
cause of the chance availability of
patients with unusual clinical manifesta-
tions and some long-term evaluations of
frequ ently occ urring, but poorly under-
stood clinical problems. In all of these
studies, and in all of the activities of
members of the Cardeza Foundation,
the common theme is a desi re to under-
stand path ophysiologic mechanisms and
make new information available to sick
pati ents and future physicians.
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Extramural Jefferson Researchers
Alumni investigators are making
scientific contributions in a
variety ofdisciplines and settings.
by Joy Roff Mara
Pharmacologic Studies
in an Institute Setting
In assessing possible sources for basic
science research fundin g one would
probably think first of the Federal gov-
ernment and last , if at all , of private in-
dustry. With prominent exceptions like
Bell labs, industry-sponsored research
has been notoriously target ed and di-
rectl y self-serving. In 1967 Hoffman La-
Roche opened the drug industry's first
independent subsidized institute for fun-
dam ent al research, with the practi ce of
good science the only stated aim and re-
quirement for funding. One of the origi-
nal staff members, Dr. Sidney Spector
(Ph.D. '56), reports that Hoffman La-
Roche has kept its word and given the
Roche Institute of Molecular Biology a
susta ined and adequat e level of funding
with no interference and no quid pro
quo. Significantly, the test of good sci-
ence has not been administered by the
company. Peer review, by Institute as-
sociates and annually by a scientific ad-
visory board made up of academics and
IH staff (including since 1967 six No-
bel Laureat es), provides the scientific
qualit y control.
Working at the Institute has several
marked adva ntages, not the least of
which is freedom from want. Roche staff
membe rs are not permitted to receive
outside funding, and very few are senti-
mental about their former involvements
with the grant applications process.
Set up much like NIH, the Institute
has a small nucleus of permanent mem-
bers, with a larger complement of post
doctoral Fellows, visitors and scientists
on sabba tica l. Because most of the per-
manent members like Dr. Spector hold
appointme nts at nearby New York City
medical schoo ls and universities, gradu-
ate students and resident s also parti ci-
pate in Institute research projects. Cur-
rently, for example, Dr. Spector is
supervising a third year anesthesiology
resident on an optional rotation at
Roche from Columbia's College of Physi-
cians and Surgeons where Spector is an
Adjunct Professor. "The int ernational
background of the scientists and the
frequent turnover of personnel makes
the Institute a very exciting place to
be," Dr. Spector notes , "and the con-
stant influx of new ideas and enthusiasm
mak es a definite contribution to re-
search productivity."
The physical amenities at the Insti-
tute also are enviable. All the laboratory
and support facilities needed are con-
tained within an aesthetically pleasing,
modem design stru cture, including con-
ference, symposium and library are as.
Th e building has clearly been designed
for laboratory people as well as labora-
tory animals, and Dr. Spector says staff
interaction and socializing add to the
pleasant atmosphere.
Dr. Spector's particular research in-
terests are pharmacologic, and of his
three broad programs two are con-
ce rned with hypertension. He has
worked extensively, for example, with
the neurotransmitter norepinephrine,
which is elaborated by the central ner-
vous system. Studying the synthesis,
regulation of synthesis and the degrada-
tion of this mat erial in hypertensive ani-
mal models, Spector has follow ed the
neurotransmitter throughout the course
of hypertension, particularly in the
heart, the blood vessels and the brain.
One of the results of this work has been
to dem onstrate the presence of norepi-
nephrine and the enzymatic machin ery
necessary for its production in isolat ed
brain microvessels. This provides addi -
tional evidence for the neuronal regu-
lation of ce rebral microcirculation.
Collagen producti on has been an-
other focus of Dr. Spector's work in hy-
pertension. On the premise that hyper-
tension is an insult to the body, it
seemed reasonable to posit that syn-
thesis of the connec tive tissue protein,
collagen, might be indu ced during hy-
pertension. Spector discovered that ex-
traordinary collagen producti on does
occur in hypertension, and because its
deposition in the blood vessels produces
furth er impairment and rigidity, levels
of hypertension are thereby increased
and a self-pe rpe tuating cycle created.
Once this cycle was understood, Dr.
Spector found that antihypertensive
dru gs can reduce levels of new collagen
product ion, and he is now investigating
mechanisms to modify or remove the
tissue alr eady depo sited.
Immunopharmacology,specifically
generating antibodies to small molecu-
lar weight substances of pharmacologic
int erest , has been a third program of in-
ter est for Dr. Spector. Some agents,
such as the endogenous norep inephrine
and many drugs, are too small in them-
selves to promote antibody production.
When conjugated ont o a carrie r of suf-
ficient mass, however, they can attain
the critical size necessary for antibody
development .
Once antibodies have been generated,
they are immediately useful in quan-
titative studi es employing the radio-
immunoassay technique. Th eir produc-
tion with regard to exogenous agents
opens up the broader question of the pos-
sibility of modifying the phar macology of
dru gs.Dr. Spect or is curre ntly investiga-
ting antibodies that could be used thera-
peutically to reverse dru g toxicity in
cases, for example, of allergy or overdose.
Acorollary study is involved with the pos-
sibility of potentiating a drug or other
agent once an antibody has modified or in-
hibited its action.
Antibody production is also useful in
followin g the pharmokineti cs of a drug,
ascertaining where spec ifically in tissue
and subcellular regions a drug goes. Pre-
viously, radi oactivity was used in such
determinati ons, but th is has been an im-
perfect meth od. Because drugs are me-
tabolized during their course through
the body, the radioactive probe may be
att ached to what eve ntually becomes a
metabolite. Once antibodies are avail-
able, however , immunofluorescent tech -
niques can be employed. Immunofluo-
rescence is more sensitive and specific;
because it recognizes only the ant ibody,
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Dr. Sidney Spector: specializing in tmmunopharmacologq and
the pharmacologq ofhypertension
the course of the drug in question can
be more correctly and particularly fol-
lowed. Antibodies have already been
successfully generated for opiate alka-
loids, barbituric acids, catecholamines
and acetylcholine, among others.
A number of the permanent staff
members and the prime mover of the
Roche Institute are, like Dr. Spector,
alumni of the National Institutes of
Health. From 1956 to 1967 Spector
worked in the Laboratory of Chemical
Pharmacology at the National Heart In-
stitute and the Laboratory of Experi-
mental Therapeutics. He feels his close
work with clinicians and clinical prob-
lems during his stay at NIH has been of
lasting value and has made him wary of
losing perspective in work with animal
models. Some of the work he is doing
now had its inception at NIH.
Dr. Spector studied at Jefferson's in-
choate Graduate School from 1952-
1956 as the first student of Dr. Kwang
Soo Lee. Although his connections to
the rest of the institution were some-
what informal during those years, still
Dr. Spector has a strong feeling of alle-
giance to the new University. Dr. Lee
has since been proferred and accepted
another position, something which
seems to be endemic of the first rate sci-
entist. For the proven researcher there
seems always to be that Circean "other
offer" to be considered along with one's
quotidian responsibilities. Dr. Spector is
no exception, having received his quan-
tum of advances from other institutions.
For the moment, however, the Roche
Institute's own enticements seem at
least sufficient to make any such consid-
eration a very difficult one.
Clinical
Investigations in
Cancer
Immunology
Dr. Carl M. Pinsky '64 is a clinical re-
searcher at the Memorial Sloan- Ketter-
ing Cancer Cente r who takes his clini-
cal responsibiliti es as seriously as his
scientifi c. Mana gement of a cancer
patient, especially in the advanced
stages or"the disease, is emotionally dif-
ficult and , Dr. Pinsky feels, has been
poorly handled traditionall y. "Particu-
larly in my early training years the
pati ents we worked with had been
shunted to the back wards where the y
were largely abandoned. Even the lan-
guage of the cance r patien t's medical
history typically began, '111is unfortu-
nate 53-year-old doomed man .. .' We 'r e
trying now to get away from the hope-
lessness fixation, in part by keep ing an
individual as an outpatient as long as is
feasible. I encourage my pati ents to
make living as norm al a life as possible
their only conce rn and to let us worry
about the disease."
Approaching cancer research im-
munologically, Dr. Pinsky says he chose
this spec ialty because it was a young field
with ground floor opportunities. His ex-
perience has since confirmed that judg-
ment; the two-man team with whic h he
began his tenure at Sloan has now grown
to a group of medical oncologists, a sur-
geon, Fellows, nurses and a large staff of
support personnel. Pinsky att ributes this
in part to an administration, specifically
Director Robert Good, President Lewis
Thomas and Dr. Pinsky'sService Direc-
tor Dr. Herbert F. Oettgen, that sees
cancer immunology as a legitimate un-
dertaking rather than as the stepchild it
has sometimes been regarded.
One of Dr . Pinsky's areas of interest
has been immunodiagnosis, specifically
the use of the carcinoe mbryonic ant i-
gen (CEA) to det ermine the existence,
type and stage of cancer. In a test in-
volving 1200 pati ents, 800 of whom had
some type of can cer , CE A levels were
prov en unreliable indicators of the exis-
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Dr. Carl Pinsky: immunodiagnosis and immunotherapy
tence of cancer; some patients with be-
nign disease, for instance, had elevated
CEA levels, while levels remained nor-
mal in some with malignancies.
CEA levels have, however, been
shown to have prognostic value at later
stages of treatment. In a study of colon
cancer patients, for example, Dr. Oett-
gen's group, of which Dr. Pinsky isa
member, found that when the cancer is
surgically removed elevated CEA levels
invariably return to normal. The recur-
rence rate isalso closely tied to CEA level
elevation, a phenomenon which isespe-
cially useful diagnostically because it of-
ten occurs before the recurrence can be
observed clinically. Dr. Pinsky has shown
additionally that CEA levels are less
likely to rise with local tumor recurrence
than they are when liver metastases have
occurred. Since there is some evidence
that early detection and removal of liver
metastases can prolong life, this study has
obvious clinical significance.
In as yet inconclusive studies, how-
ever, routine laboratory procedures like
liver function tests have been projected
to be as reliable in predicting the stage
or progression of colon cancer as the
CEA test has proven to be. Investiga-
tion is now underway to determine
whether an expensive procedure like
CEA measurement actually is needed.
Evaluating the immunocompetency
of patients for prognostic purposes has
been another thrust of Pinsky's work.
Using the skin-sensitizer DNCB (2,4-di-
nitrochlorobenzene) in a group of
patients with various types and stages of
cancer, it has been shown that those
who respond positively to D CB have a
significantly lower recurrence rate after
definitive cancer surgery than those
who failed to respond. When patients
are grouped by extent of disease , where
there are no metastases patients who are
D CB positive progress better clini-
cally than those who are D CB nega-
tive. For the group in which metastases
have occurred, the trend still favors the
D CB positive patients, but Dr. Pinsky
feels that the evidence is less convinc-
ing. One explanation is that once metas-
tases have begun, the biological action
of the tumor becomes more important
than the immune response, although
Pinsky notes that there are any number
of other possible explanations as well. It
seems, however, that the prognosis for
patients who are DNCB negative with
no metastases is almost as bad as that for
patients in whom metastases have al-
ready occurred. Dr. Pinsky cautions
that from this study one cannot make
absolute conclusions applicable to all
types of cancer at all stages of progress-
ion. "There has been no evidence to the
contrary:' he says, 'out when we broke
our groups down by disease and extent
of disease, we did not feel the numbers
were statistically sufficient."
What Pinsky calls the Holy Grail of
cancer immunology, the consistently elu-
sive human tumor specific antigen, is the
subject of many studies despi te two dec-
ades of fruitless pursuit. Tumor specific
antigens, substances appearing only
when cancer or a specific type of cancer
is present, do exist in animals and are in-
valuable in analyzing tumor behavior.
Because techniques for finding spon-
taneous antigens in man are still crude, it
has been postulated that they might be
more profitably detected in patients
hyperimmunized with material from
their own tumors. This isknown as active
autologous immunization, a technique
that Dr. Pinsky feels will become increas-
ingly important in immunology's future.
Because animal studies indicated that
immunotherapy was most successful
when tumor specific antigens were
present, oncologists proceeded on the
assumption that these antigens would
eventually be found in humans and un-
dertook clinical trials with immunopo-
tentiators which had previously been
used in animal work. As far back as the
turn of the century it was reasoned that
even non-specific immunostimulants
might be effective in cancer treatment.
In 1935 a forgotten researcher named
Holmgren first reported some success
using the tuberculosis vaccine BCG on
cancer patients, but he was largely ig-
nored. Others have shown more re-
cently that percutaneous BCG vaccina-
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tion prolongs chemotherapy-induced
remission in patients with acute lym-
phoblastic leukemia.
Dr. Pinsky 's own studies have con-
firmed the value of BCG as a therapeu-
tic agent. In treating malignant mela-
noma, he found that the intralesional
injection of BCG usually induces tumor
regression in injected tumors, though
rarely in non-injected ones. Respons e
rate is best if a patient is immuno-
compe tent and if the disease is confined
to the skin. To translate the intralesional
success into a systemic effect, the group
injected BCG into the skin of melanoma
patients with lymph node metastases
from whom all tumors had been re-
moved. In a random group they found
that contrary to two other recent re-
ports, BCG did not prevent tumor re-
curre nce in this high risk group. Differ-
ences in techniques and patient
population could account for the con-
flicting test results, but the question of
BCG's e fficacy in this situation remains
as yet unresolved.
Complicating the use of BCG are its
sometimes conside rable side effects and
even occasional life threatening toxic-
ity. This has encouraged scientists to
look for other , non-living immunopo-
tenti ators and has led the MSKCC
group to experiment with the use of Co-
rynebacte rium parvum (C parvum ),
both intralesionall y and systemically.
While the systemic study is still ongo -
ing, intratumorally C parvum would ap-
pear to have no extraordinary advan-
tages over BCG. MER, a BCG extract, is
also being studied, with some positive
results beginning to emerge. Dr. Pinsky
stresses, however, that he has never seen
any of these agents cause regression in
advanced cancer in organ systems.
Immunotherapy trials have been
done empirically, and few efforts have
been made to determine optimal dose
and scheduling of the various agents. Al-
though the permutations found in dif-
ferent studies are infinite, scientists have
begun trial s of specific agents to estab-
lish these parameters definitively. Th e
group at MSKCC is now conducting
phase I clinical trial s on C parvum and
Levamisol, an antihelminthic reported
useful in preventing recurrence in cer-
tain high risk cancer patients.
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In addition to active autologous im-
munization, Dr. Pinsky feels that syn-
thesis or extraction of the active princi-
ple (s) from immunopotentiators to
minimize possible toxicit y will be a pri-
mary thrust of immunologic research in
the near future. He is also convinced
that multimodality studies, not done
currently because the risks and benefits
involved ar e largely unknown, would be
invaluable both to researchers and
pati ents alike. '1'd like to see us take
non-terminal patients who are ordinar-
ily consider ed inoperable, have a sur -
geon remove every bit of cance r he can,
and then begin chemotherapy and im-
munotherapy, taking into account the
immunologic effects of the combination
and timing the treatments accordingly.
Thi s is the direction in which I think
cancer research is going. "
While recent publications affectively
detailing the acrimony surrounding the
discovery of DNA would lead one to ex-
pect otherwise, Dr. Pinsky describes
collaboration with peers nationally and
internationally as common, amiable and
open. The friendly association Pinsky
outlines may seem like a closed club,
but he insists it is more properly a net-
work, running primarily from Sloan to
the NCI , to the M.D. Anderson Center ,
UCLA and Roswell Park , for the ear ly
and seemingly jealousy-free dissemina-
tion of information. He speaks enthu-
siastically and knowledgeably of the re-
cent discoveries in all areas of cancer
research, uncompromised by the spe-
cialist's proclivity to ignore or denigrate
the successes of another approach.
When Carl Pinsky attended Jefferson
it was viewed primarily as a clinician's
school , with a good deal less emphasis
on research or academic medicine.
While the way in which JMC was per-
ceived was no advantage for graduates
inter ested in high power ed post-gradu -
ate research training pro grams, Dr. Pin -
sky feels strongly that the clinical em-
phasis was a plus for his research
competence. "Being able to interact
with patients as a clinician gives me an
advantage in the clinical research set-
ting. If I'd had less clinical training and
exposure as a student, working with ani-
mal model s in the lab might have been
my only realistic option."
An Interdisciplinary
Approach to
Ophthalmologic
Research
Asking a researcher to explain the proc-
ess of scientific discovery is somewhat
like asking a poet to explain how a par-
ticularly apt phrase came about: hard
work and extensive preparati on are al-
ways credited first, but at a cer tain
point ente rs the almost mystical con-
cept of inspiration. Georgetown Univer-
sity Ophthalmology Professor Vernon
G. Wong '58, for example, was absent-
mindedly working on his backhand in a
tennis game with his son when the idea
for his most recent research project oc-
curred to him. Wh en an experimental
model was developed in the lab, his ini-
tial proposition proved valid and has
since opened up what promises to be at
least ten years of productive research.
In investigating retinal degeneration,
a common cause of blindness, Dr. Wong
postulated that blindness might be
caused by the body's inability to deal in
ce rtain cases with the molecule rhodop-
sin, the major biochemical mediator of
vision in the eye . Working with pri-
mates, he immunized rhod opsin system-
ically in low concentrations. He found
that at these levels the molecule which in
essence allows us to see is the most po-
tent retinal " poison" with which he has
ever worked ; and the blindness produced
is irreversible. Th e investigation is still in
its preliminary stages, but in its course
should involve many different disciplines
including biochem istry, histopathology,
immunology and elec trophysiology.
Th e interdisciplinary approach has
been some thing of a constant with Dr.
Wong, whose own background is well
suited to it. Initially interested in obstet-
rics and gynecology, W ong had a Fel-
lowship from Johns Hopki ns while he
was a student at Jefferson, spending
week-ends in Baltim ore to study vita-
mins and intrinsic factor. Afte r an oph-
Dr. Vernon Wong: The maier
biochemical mediator ofvision in
the eye can produce irreversible
blindness when immunized
systemically.
thalmology residency at the University
of Pennsylvania Graduate Hospital Dr.
Won g joined the full-tim e staff of the
Ophthalmology Branch of the National
Institutes of Health. One of his projects
there involved working with National
Cancer Institute researchers who were
studying the immune response and an-
titumor drugs in relation to the rejec-
tion phenomenon. Because some in-
flammatory eye diseases are related to
the immune disorders, he applied the
findings of the cancer study, particularly
the use of antimetabolites and immuno-
suppresive agents , to ophthalmology
and the treatment of inflammatory
blinding disease.
Anoth er research interest that has in-
volved Dr . Wong with scientists from
oth er disciplines has been the study of
cystinosis. This genetic disorder is a re-
sult of an amino acid abnormality in
which insoluble cystine crystals are de-
posited throughout the body. The most
pernicious result of this process is even-
tual renal failure.
Because deposits of these crystals also
occur in the eye, Dr. Wong was able to
contribute an ophthalmologic descrip-
tion of the disorder and to hel p improve
diagnostic methods. The earliest possible
and most reliable diagnostic procedure in
infants, in fact , isnow an ophthalmologic
one . Wong stresses the team nature of the
effort, which has involved geneticists and
specialists from many other fields. The
group has made diagnosis of cystinosis in
utero through amniocentesis a reality,
and genetic counselling and screening
can now alert carriers to the risksbefore
they conceive children. With kidney
transplants and dialysisavailable, cys-
tinosis isno longer invariably fatal. Dr.
Wong has found this project a particu-
larly rewarding one, because he has been
involved in its progression from theory to
clinical application.
Although members of the research
team are now located in different parts
of the country, the cystinosis study con-
tinues. In addition to attempting to un-
ravel the basis of genetic biochemical
disorder, researchers are also investiga-
ting specific agents which might reduce
the cystine content in the tissue. Dr.
Wong is participating in this work, and
has also become a sought-after clinical
consultant when cystinosis is suspected,
often traveling to different parts of the
United States for diagnostic purposes.
As a practicing ophthalmologist, the
inflammatory condition known
as presumed ocular histoplasmosis inter-
ested Dr. Wong, and he has recently
made it a research interest as well.
Using rabbits and monkeys in attempts
to develop an experimental animal
model for ocular histoplasmosis, he
hopes to be able to study the mecha-
nism of pathogenesis of the disease and
eventually a means of treatment.
Although Dr . Wo ng's primary orien -
tation is research, he is hap py with the
mix of teaching and clinical exposure he
has at Georgetown. As a teacher he is
primarily involved with residents, and
as a clinician 30 to 40% of his work is
referral. He also enjoys the opportunity
to perform ophthalmic surgery.
The chance for variety and for a uni-
versity atmosphe re was part of the rea-
son Dr. Wong left NIH in 1972 after ten
product ive years. As a measure of his
NIH achi evements, when Congress
created the special National Eye Insti-
tute in 1970, Dr. Won g was chosen its
first clinical Director. "N IH was an ex-
citing place to work," explains Dr.
Wong, "but the conditions at George-
town are optimal, and there is no ques-
tion that quality research can be done
here." Dr . Wong also notes that he has
always found his Jefferson training to be
second to none .
Vernon Won g isa gentle and very pri-
vate man whose enthusiasm for scientific
research consistently breaks through his
personal reserve. Although he sayshe en-
joys jogging, photography and being with
his wife , who isa pharmacist, and his two
sons in their Rockville home, when he
mentionsa desire to become involved
some day in cancer research, one can
somehow imagine that he will alsocon-
tinu e to work on his backhand.
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Pioneering
in
Cardiothoracic
Research
W ith the escalating costs of biomedi-
cal research and the government's in-
creasingly grudging allocation of funds
for the purpose, attempts to economize
where feasible, by building one's own
equipment for example, are of necessity
becoming more common. Dr. William
W.L. Glenn '38, however , was making
contr ibutions to cardiothorac ic surgery
that wouldn't offend anyone's sense of
budget long befor e budget was much of
an issue at all.
In 1948-50, for instance, Dr. Glenn , a
Professor of Surgery at Yale University
School of Medicine, help ed build the
first artificial heart with a pump to by-
pass one and subsequently both sides of
the heart. A prototype of the artificial
heart models currently being refined by
NIH and other investigators, it featured
a rubber ventricle driven by compressed
air . The technique of the right heart by-
pass developed in this regard and re-
ported in 1950 was the one lat er used in
the first successful open heart operation
in man , pulmonary valvulotomy. The
total materials cost of this significant
first step was $25.00.
A surgical technique for mitral val-
vulotomy originated by Dr. Glenn to-
tal ed a mat erials cost of only $.05. In
operations for mitral valvulotomy, sur-
geons had pr eviously int errupted the
fused commissures with the blunt force
of a finger or the cutt ing force of a
knife. The accidental discovery of an
open-ended tailor's thimble in a drawer
of a newly-purchased antique ches t sug-
gested to Glenn the idea of delivering
the necessary blunt force through the
op en end of such a thimble, pri ced at
one nick el. Clinical trial subsequently
revealed that the sequential use of tai-
lor 's thimbles of graduated sizes ensure d
a large valve orifice, and in 1969 Glenn
reported the use of the thimble valvulo-
tom e in more than 200 pati ents with
mitral stenosis.
Dr. Glenn has devised several othe r
surgical techniques for various cardio-
thoracic conditions. In the patent
du ctus operati on, for instance, he con-
trived the techn ique of suturing the
ductus prior to division, which has im-
proved the mort ality rate for this proce-
dure. In large artery surgery he began
deliberately lowering blood pressure
using hypotensive drugs, making oper-
at ions on the aorta and its major
branches less hazardous. Dealing with
open heart surgery, Glenn applied elec-
tri city to the heart to produce con-
troll ed cardiac fibrillation. In many
op en heart ope rations, th is procedure
has proven useful in preventing air em-
bolism, Seeking a better operative ap-
proach to the high-p ressured areas of
the blood vasculature system he ini-
tia ted the ap plication of a prosthetic
tube or graft to extend the chambers of
the heart and lumen of the vessels. (The
prot otyp e for the fabric dive rti culum
now used was a rubberized $.25 doll
stocking.) Th e use of the closed rubb er
diverti culum proved simpl er and safer
than previous methods of approach, and
as such enco uraged fur ther develop-
ment of digit al intracardiac surge ry.
In addition to surgica l techniques, Dr.
Glenn and his associat es have also con-
ceived orig inal ope rations. Since 1954,
when he first report ed success in dogs
with a superior vena cava -right pulm o-
nary artery anas tomosis, Glenn has been
involved with this procedure, which is
predicated on the fact that the arte rial
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Dr. William Glenn: Using radio
frequency stimulation of excitable
tissue clinically fo r cardiac and
diaphragm pacemakers
pressure in the lungs is lower than in
any other part of the body, and is not
great enough to require a pulsating ven-
tricle to produce blood flow. Glenn's in-
terest in bypassing the right heart en-
tirely stemmed from unsatisfactory
results with a systemic artery-to-pulmo-
nary artery shun t performed on several
patients with tricuspid atresia. With the
traditional shunts, congestive failure or
partial to complete closing of the shunt
were frequent complications.
The cava-pulmonary artery shunt,
generally referred to as the Glenn oper-
ation, was first applied clinically in 1958
and has proven a highly successful pal-
liative measure in numerous patients so
treated since that time. The shunt is
particularly well-suited in instances of
uncorrectable congenital malformations
of the right side of the heart and dimin-
ished blood flow to the lungs, the prin-
cipal such condition being tricuspid at-
resia. In some cases, however, after a
number of years of clinical improve-
ment following a cava-pulmonary ar-
tery shunt, symptoms of hypoxia recur.
To ameliorate this problem Dr. Glenn
made a carotid artery-jugular vein fis-
tula on animals who had undergone the
SVC-RPA procedure some years earlier.
After good animal results the creation
of an arteriovenous fistula between the
right axillary artery and vein was per-
formed on humans and has proven an
effective means of improving oxygen-
ation in patients with SVC-RPA
anastomosis.
Perhaps Dr. Glenn 's most important
contributions have been in the area of
stimulation of excitable tissue from the
interior by radiofrequency transmission,
i.e., the pacemaker. The group at Yale
was the first to use radiofrequency stim-
ulation clinically, and in 1959 his arti-
ficial cardiac pacemaker was the first
implanted unit to be used clinically in
the Western hemisphere. Since 1966
Dr. Glenn's group applied the principle
of electrical stimulation by RF trans-
mission to long-term ventilatory sup-
port by phrenic nerve stimulation. This
diaphragm pacemaker has enabled
quadriplegics and patients with the rare
Ondine's Curse to function without a
respirator for up to 12 hours a day. The
longest time respiration has been sup-
ported by the pacemaker is five years
for the quadriplegic and seven years for
patients with Ondine's Curse. While
Dr. Glenn points out the cost value this
research has returned to t.he taxpayer by
getting quadriplegics out of $300-a-day
intensive care units, he mentions first
the rewarding personal aspect, the revo-
lutionary improvement in the quality of
life for affected patients.
The pacemaker project, which has
been supported by the National Heart
and Lung Institute for 17 years, is now
investigating the application of radio-
frequency stimulation to emphysema to
prevent nighttime build-up of CO 2 , Al-
though more careful documentation still
is needed, the likelihood of benefit
seems good in emphysema patients with
hypoxia who also have good diaphragm
movement. The clinical use of radio-
frequency has opened up possibilities
for the stimulation of many kinds of ex-
citable tissue for medical purposes. Dr.
Glenn notes that the neural prosthesis
field might eventually become a billion-
dollar industry just as the cardiac pa-
cemaker field has.
In 1971 when Dr. Glenn assumed the
Presidency of the American Heart Asso-
ciation he caused something of a stir
with his inaugural remarks, which sug-
gested that bypass surgery for angina,
the subject of national publicity at the
time, should not prematurely be re-
garded as a panacea. He took this stand
in great measure because the number of
hospitals with proper cardiac operative
facilities was not nearly adequate for
the number of people suffering from
angina, should all of them demand by-
pass surgery. Although Dr. Glenn feels
that it will be another five or six years
before an authoritative evaluation can
be made, he says it has become clear
that the procedure does provide symp-
tomatic relief from angina; there is,
however, no evidence as yet that lon-
gevity is prolonged thereby except in
cases where partial or complete occlu-
sions of the left main artery have oc-
curred. He expects that the operation
will be clinically indicated for left main
lesions and intractable angina, but prob-
ably not for the majority of angina vari-
ations, and he plans to write a follow-up
when more conclusive facts are in.
Dr. Glenn, who received Jefferson's
Alumni Achievement Award in 1972,
has served as President of the Inter-
national Surgi cal Group, the Connecti-
cut Society for Medical Research, the
Connecticut Society of the American
Board of Surgeons and the Yale Medical
Society. Certified by the American
Board of Surgeons and the American
Board of Thoracic Surgeons, he is a
member of many organizations, the
American Surgical Association, the So-
ciety of University Surgeons and the
American Association for Thoracic Sur-
gery among them. He has published ex-
tensively in both journals and books.
Although animal research has been an
important facet of his work, Dr. Glenn
stresses that for him the most exciting
part of medicine is working out solu-
tions in a clinical se tting. In addi tion to
believing, as one would assume most do,
that there must be a reasonable chance
of good and little chance of ha rm for a
clinical researcher to undertake a proj-
ect, Dr. Glenn feels strongly that results
of every project should be reported and
that follow-up studies should be done,
without exception. "It is often 25 years
before we can appreciate all the ramifi-
cations of a new procedure," he notes.
"As a matter of fact , it has been more
than 200 years since electrical stimu-
lation of tissue was employed therap eu-
tically, and we are just now beginning
to realize how useful it can be."
Spending a day with Dr. Glenn it
soon becomes apparent that he is a
teacher and a physician as we ll as a re-
searcher. As the Charles W . Ohse Pro-
fessor of Surgery Dr. Glenn supervises
Fellows, residents and groups of medi-
cal students rotating through his service.
His referral patient roster is inter-
national in composition, though his qui-
etly friendl y manner with pati ent s has
overtones of the family physician as
well as the specialist. Teaching consulta-
tionsare frequ ent. As Dr. Glenn points
out, "Anyone who writes a textbook has
to enjoy teaching." Glenn is the co-au-
thor of Thoracic and Cardiovascular
Surgery with Related Pathology, now in
its third edition. He not es that their ma-
jor competition is a text originally writ-
ten by another Jefferson surgeon, Dr.
John H. Gibbon, Jr.
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The Type C
RNA Tumor
Viruses and
Acute
Myelogenous
Leukemia
The National Institutes of Health have
been the center of a great deal of con-
troversy in recent years, some of which
has been more political than scientific.
Dr. Robert C. Gallo '63, who has been a
staff member at the ational Cancer In-
stitute since 1965, an era that is now
considered to have been something of a
golden age for the NIH, has not felt any
effects personally from what some feel
is an increasingly political atmosphere
brought to the Institutes during the
Nixon administration when the NIH Di-
rector became a presidential appointee.
Gallo was a member of the search com-
mittee for the Scientific Director of
Cancer Treatment for the CI, for ex-
ample, and the man suggested by the
committee was appointed, seemingly
without political complications. This is
not to say he feels politicization is with-
out hazard, however.
As might be expected, Dr. Gallo does
not view the aggrandization of the NCI
under the National Cancer Act with the
same dismay many critics voiced at its
inception. "The public interest in can-
cer and the timeliness of the problem
make it reasonable to channel more
funds into cancer research than in some
other areas," he says. "It has already
produced better clinical care and will
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prove its worth in research findings as
well. Those who say that the so-called
'War on Cancer' is excessive research
targeting are probably partly right, but
in the long run cancer research is really
basic science research. Those making ef-
forts for funding should keep this in
mind. With the public attitude towards
science and research at this time, I think
it is a mistake to believe that money
now allotted NCI would otherwise have
been parcelled out equally to the differ-
ent disciplines. If it weren't given for
cancer studies, it probably would not
have been spent for biomedical research
at all."
Dr. Gallo is now Chief, Laboratory of
Tumor Cell Biology, Experimental
Therapeutics; his primary interest is in
acute myelogenous leukemia, and he is
investigating in this connection the
group of RNA tumor viruses classified
morphologically as type C.
Of the many possible approaches to
studying the etiology and pathogenesis
of the disease, Dr. Gallo chose to work
with the RNA tumor viruses for several
reasons. They are known, first of all, to
be a primary etiologic agent in the nat-
ural production of leukemia in mice,
cats, cows, sub-human primates and
chickens. It has also proven possible to
study them in the laboratory, where leu-
kemia has been produced in species
other than the original virus carriers.
Additionally, the very nature of all vi-
ruses seemed to oblige the study of type
C RNA tumor virus involvement in leu-
kogenesis: if it were infectious, perhaps
it could also be manageable.
Investigation has, in fact , shown that
the viruses can be infectious agents,
sometimes, as with cats and sub-human
primates, exogenous in the classic
manner. In other instances, for example
in the mouse, the virus is endogenous,
remaining in the animal's genetic infor-
mation and in this way transmitted to
progeny. But this duality has made the
RNA tumor viruses more rather than
less formidable to deal with, as has their
tendency to be slow viruses, difficult to
trace and characterize in the lab.
More importantly, not every animal
who is infected by virus contracts leu-
kemia. It has thus become clear that
while the viruses are involved in the
leukogenic process, they may not be by
themselves sufficient to produce the dis-
ease. Other factors such as chance (what
cell they "hit," what chromosome etc.),
genetic predisposition, environmental
insult or any combination thereof would
seem to be additionally required.
Although the viruses are complex
mechanisms, progress has been made in
their definition, and Dr. Gallo 's own
work has been some of the most signifi-
cant. In 1970 shortly after Temin and
Mizutani reported the discovery of
RNA-directed DNA polymerase (re-
verse transcriptase) in RNA tumor vi-
ruses, Gallo and his associates identified
reverse transcriptase in human leukemic
cells, the first demonstration of reverse
transcriptase in any cell. Dr. Gallo re-
fers to discoveries like these as foot-
prints, traces suggesting to the scientist
that he is on the right course, but always
demanding additional evidence and new
links.
Some new traces began to accumu-
late in 1972-74 when Gallo's lab, using
immunologic techniques, demonstrated
that the reverse transcriptase identified
in human acute myelogenous cells had
biochemical properties indistinguish-
able from reverse transcriptase found in
certain mammalian type C viruses, spe-
cifically related to the two known on-
cogenic primate type C viruses, the
woolly monkey and gibbon ape viruses.
The direction in which these foot-
prints seemed to be pointing was, of
course, the involvement of the RNA tu-
mor viruses in human leukemia. At-
tempts to isolate any human tumor virus
have been frustrating and controversial,
with many virologists prematurely re-
porting positive isolations that were
eventually compromised in some way.
Dr. Gallo attributes the difficulty to the
fact that cancers in man including leu-
kemias are not virus productive dis-
eases. If and when virus is released it is a
rare event and the virus may be defec-
tive. In 1975 Gallo and his associate
Robert Gallagher reported isolating a
human tumor virus from one patient
with acute myelogenous leukemia; as
would have been expected the virus
contained reverse transcriptase and
group specific antigen specifically re-
lated to the oncogenic primate type C
viruses, some of which have caused neo-
plasias in primates under natural condi-
tions. Additionally, a second virus was
found which was closely related to the
endogenous type C virus of baboons.
Th e isolation was made possible by the
discovery of new conditioned culture
media, produced from a strain of hu-
man embryo cells. For reasons un-
known, the isolation has not been suc-
cessfully rep eated with cells from other
pati en ts, though it was completed sev-
eral tim es over a 14-month int erval
with cells from the same pati ent. Pre-
sumably, this may be because of unusual
genetics in the one patient or a coinci-
dental environme ntal effect, e.g., the
presence of two viruses Simultaneously.
Dr. Ga llo was able subsequently to
carry the process one step further.
Through molecular hybridization tech-
niques he has found unambiguous proof
that the genetic information for a typ e
C RNA tumor virus was present in the
primary tissue of the same patient, as
present ed in the April , 1976 issue of the
Proceedings of the ational Academy
of Science.
Because every new development in
the study of type C RNA tumor viruses
seems to pose more questions than it an-
swe rs, Dr. Gallo is also involved in
studying the det ails of the virus life
cycle, particularly in gibbon ape leu-
kemia, a disease very similar to human
acute myelogenous leukemia. Primate
viruses have only been isolated since
1971, so there is still a good deal of ba-
sic information to be compiled that
could have interdisciplinary importance
as well as pertinence to Gallo 's particu-
lar work. While the subject could of
course have endless permutations, the
scientist's present goal with this proj ect
is to establish to his own satisfaction
that the primary genetic information
for human acute myelogenous leukemia
may involve information derived from
primate type C viruses.
As a staff member at IH , Gallo has
institutional responsibilities like grant
and contract review, and as a respected
scientist he is inundated with manu-
scripts and socie ty applications to
judge. Adding these tasks to his 160
published papers and numerous papers
presented at meetings and myriad edito-
rial involvements mentioned earlier, it
is not surprising he does not feel he can
spend as much time as he would like to
in the lab. But frequent visits to other
laboratories allow him to keep up with
the new techniques and other changes
from which it is dangerous to become
too far removed, and he insists he has
not become an administrator. "My day
is primarily spent discussing experi-
ments and meeting with scientists. Call
me a lab worker without a pipette."
Although postal rates make it impos-
sible to list all of Dr. Gallo 's societies
and accomplishments, a small sampling
includes his having presented the Bryan
Priestman Memorial Lecture at the
University of New Brunswi ck, his hav-
ing received the Dameshek Award from
the American Society of Hematology,
his Honorary Doctor of Science from
Providence College and his membership
on five scientific editorial boards includ-
ing the Yearbook of Cancer. He is a
member of the Scientific Board of
Trustees of the Leukemia Society of
America, Consultant at Roswell Park
Memo rial Institute and at the M.D. An-
derson Hospital and Tumor Institute,
and is a member of such learned so-
cieties as the American Socie ty of Clini-
cal Investigation and the American So-
cie ty of Biological Chemists.
Gallo's enthus iasm for research was
evident even in his Jefferson days when
he admits slipping out the side door dur-
ing fracture clini cs to spend extra time
at Cardeza. But the rigors of a success-
ful scie ntist's schedule have not been
without consequence for his family.
"For the first eight years of both of my
SOrIS' lives I was rarely home from the
lab when they were awak e. It's different
now, I'm making sure that it is." Still,
amidst describing his enjoyment of a
new hom e in Bethesda, tr avel and good
food, a certain single-mindedness inev i-
tabl y emerges. " I sta rted skiing with the
kids, and I expect to do a lot of skiing this
season . I tend, " he explains, "to pursue
things fanatically for awhil e."
Dr. Robert Gallo: In 1975 lie and his
associat es reported the isolat ion ofa
III/man tumor virus f rom one pati ent
with acut e myelogenous leukemia .
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the
jefferson
scene
interim president
At a special meeting of th e full Board of
Trustees on Monday, AprilS, Mr.
George M. Norwood, Jr. was named In-
terim President of Thomas Jeffer son
University. The appointment was made
following the unexpected death of Dr.
Peter A. Herbut the previous week (see
page 48).
Mr. Norwood, who came to Jefferson
in 1965 from the University of North
Carolina, served first as Vice-President
for Business and Finance and since 1970
as the Vice-President for Planning. In
that position he has been largely respon-
sib le for devising and th en implem ent-
ing Jefferson 's Master Development
Program. Prior to his Jefferson appoint-
ments, Mr . Norwood was the Chi ef
Business Officer of the Di vision of
Health Affairs at the University of
North Carolina. He is a Trustee of the
Phil adelphia Magee Mem orial Rehabil i-
tation Center in Philadelphia and
serve d as National Chairman of the
Planning Coordinators Group of the As-
sociation of Ame rican Medi cal Colleges
in 1973.
A resident of Society Hill in Phila-
delphia, Mr. Norwood is married and
has four children.
new trustee
Donald E. Meads, Chairman and Chief
Executive of Certa in-Teed Produ ct s
Corporati on, was elec ted to member-
ship on the Board of Trustees of Th omas
Jeffer son Unive rsity on March 1. In ad -
dition to Mr. Meads ' new position he
also serves as a Trustee of International
House, the Penn sylv ania Acade my of
the Fine Arts and the National Planning
Assoc iation and is a Board Member of
the World Affairs Counci l.
At age 55 Mr. Meads is a di rect or of
eight other major cor porations includ-
ing the Insurance Compa ny of Nor th
Ame rica, Western Savings Funds So-
ciety, Singer Company and the Qu aker
Oats Company.
A gradua te of Staunton Milit ary
Academy and Dartmouth Co llege Mr.
Meads receiv ed a Masters degree in
business administration from Har vard
University .
Cha irman of the Board William W.
Bodine in an nouncing the elec tion
stated, "Our goa ls in medical edu cation,
health care and research are certa in to
be fur the red with the help of such an
outsta nding business and community
leader."
Mr. Meads will serv e three yea rs as a
Term Trustee.
alumni president
At the Alumni Association's Annual Busi-
ness Meeting on Feb ruary 26, a special bi-
centennialga thering preceded by cock-
tail sat the Penn Mutual Tower and
followed by a performance of the Benja-
min Rush players,Dr. John Y. Templeton,
III took over the Presidency of the Associ-
ation from Dr.Frederick B.Wagner, Jr.
Dr. Templeton, whose father was a Jef-
ferson gradua te, received his degree in
1941. He took his internship at Jefferson,
and, after a four -yea r tour of duty in the
army, he ret urned to Jefferson for a resi-
dency in general and thoracic surge ry,
workin g with D r. John J. DeTuerk under
Dr. John H. Gibbon, Jr. After various Fel-
lowships and staff appointments at Jeffer-
son, D r. Temp let on became a Clinical
Professor of Surgery here in 1957. He was
a Professor of Surgery at the University of
Pennsylvani a Schoo l of Medicine from
1964 to 1967 but returned to Jefferson
in 1967 with the ran k of Pro fessor. He is
curre ntly a consultant in general sur-
gery at Chestnut Hill Hospital and Lan-
kenau Hospital, a cons ultant in thoracic
surgery at W ilmington Medical Cent er ,
and attending physician at Jefferson.
As a physician , Dr. Templeton per-
form s primaril y ca rdiac surgery, al-
though his group has a broad general
surgica l pr acti ce. His teachi ng responsi-
bilities are mainl y cl inical , as is his cur-
rent research , in which he is working
with medi cal ca rdiologists to det ermine
optima l methods of management for
those having or about to hav e myoca r-
dial infar cti ons.
D r. Templet on has held office in
many professional societies. Past Presi-
dent of the Philadelphia Academy of
Surgery, the Philadelphia County Medi-
cal Society and the Laennec Society of
Philadelphia, he has also been Governor
from Pennsylvania for the American
College of Surgeons. He is a member of
the American Surgical Associa tion,
the International Society of
Surgery, the American Association for
Thoracic Surgery and the American
College of Surgeons, among many oth-
ers. Dr. Templeton is certified by the
American Board of Surgery and the
American Board of Thoracic Surgery.
In Jefferson's Alumni Association, he
has been a Vice-President, a member of
the Executive Committee since 1954, and
a class agent for the Annual Giving Fund.
He says he thinks being elected Alumni
President isan honor, but that he does not
feel it isappropriate to try to put his per-
sonal mark on the Association while he is
in office; he hopes simply to continue the
Association's traditional role.
Other officers elected for a one year
term are: Gonza lo E. Aponte '52, Presi-
dent-elect ;John N. Lindquis t '43, Peter
A.Theodos '35, J. Woodrow Savacool '38,
Thomas B. Mervine '40, Vice-Presidents;
Samuel S. Conly.]r, 'S44, Treasurer; and
Norman J. Quinn, Jr. '48, Secretary. Dr.
Aponte is Pathology Chairman.
honored
Standing ovations greeted Martin J.
Sokoloff '20 and 1. Charles Lintgen '25
as they accepted engraved clocks at the
Annual Business Meeting of the Alumni
Association on February 26. The Execu-
tive Committee had elected to honor
them and colleagues Reynold S. Griffith
'18 and David R. Morgan '16 for their
many years of distinguished teaching
service to Jefferson. Dr. Griffith and Dr.
Morgan were unable to attend.
Dr. Morgan was appointed to the Jef-
ferson faculty in 1922 and was pro-
moted through the ranks to full Profes-
sor in 1955. In addition to his teaching
duties in the Department of Pathology
Dr. Morgan also served as cura tor of the
museum. He was a member of many
professional organizations including the
American Society of Clinical Patholo-
gists, the American Society of Bacte r-
iologists and Pathologists and the
American College of Pathologists. Dr.
Morgan, the author of over 20 pap ers,
presently is residing with a nephew in
Edwardsville, Illinois.
Dr. Griffith also has spent his entire
professional career at Jefferson. In re-
plying to President Wagner 's letter of
invitation he stated, "Incidentally, this
is my 63rd year at Jefferson. In the
event you attempt to figure the extra
year, 1913-1914 , I was a pre-medical
student in the first such class at Jeffer-
son. I am presuming you did not know
Dr. Templeton : Continuing the Alumni Associa tion 's tradit ional role
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that Jefferson had a pre-medical course.
As I recall it was short lived, one or two
years only. This honor from the Alumni
is a suitable climax to my medical ca-
reer ." Dr . Griffith , an internist, has of-
fices in Philadelphia and holds the rank
of Honorary Clinical Assistant Professor
of Medicine.
Dr. Sokoloff , an Honorary Clinical
Professor of Medicine at Jefferson, be-
gan his professional career at White
Ha ven Sanatorium in 1922. He re-
mained there as Visiting Physician and
later served as Medical Director, a posi-
tion he held to 1956. In 1951 he was ap-
pointed Director of the Barton Memo-
rial Division of Jefferson Hospital and
has served as consultant in pulmonary
diseases at several Philadelphia area
hospitals. Dr. Sokoloff has held office in
numerous organizations including the
Presiden cy of the Pennsylvania Thora-
cic Society, the Laennec Society of
Philadelphia, the Pennsylvania Chapter
of the American College of Chest Physi-
cians and in 1956 the Alumni Associ-
ation of Jefferson.
Dr. Lintgen at 84 still sees patients sev-
eral days a week at his center city office.
Presentl y he is Honorary Clinical Profes-
sor of Obstetrics and Gynecology. Dr.
Lintgen was promoted to full Professor in
1952 and served in this position until his
retirement in 1965. He also is a member
of numerous professional organizations
including the American College of Sur-
geons , the American Board of Obstetrics
and Gynecology and the American Col-
lege of Obstetricians and Gynecologists.
His son, Arthur, Jefferson '66, is an inter-
nist practicing in Abington.
parents'day 1976
Thi s year's traditional Parents ' Day at
Jefferson, sponsored by the Alumni As-
sociation in conjunction with the Dean's
Office, brought more than 200 mothers
and fath ers to the campus for guided
tours, lectures and a lunch hosted by
Dean William F. Kellow. The morning
program included presentations in both
the clinical and pre-clinical depart-
ments in addition to a showing of the
Sesquicente nnial film "Of Light and
Learning." Dr. John Y. Templeton, III ,
'4 1, Professor of Surgery, gave the after-
34
noon slide lecture on "Emergency Sur-
gery for Heart Attack Patients." As
Alumni President, Dr. Templeton also
brought greetings from the Association.
The sophomore class each year se-
lects a facu lty member to address them
at the Dean's Luncheon. This year's
well-received speaker was Dr. Laird G.
Jackson, Associate Professor of Medi-
cine, Obstetrics and Gynecology and
Pediatrics and Director of the Division
of Genetics.
Speaker for the sophomore class was
Mr. Duncan Salmon. Dr. Warren R.
Lang, '43 , Chairman of the Parents'
Day Committee, served as toastmaster,
black and blue ball
Jefferson's social fraternity, Kappa Beta
Phi, will sponsor its annual Black and
Blue Ball on Saturday, May 29 begin-
ning at 9 P.M. in Jefferson Alumni Hall.
Tickets for alumni are priced at $15.00
per couple and at $8.00 per couple for
students and house staff . All proceeds go
to the KB$ Student Loan Fund.
Music for the evening will be provided
by the Brian Pastor Orchestra. Each year
Kappa Beta Phi selects a favorite profes-
sor to be their guest of honor. This year
they chose Dr. Edward H. McGehee, Pro-
fessor of Family Medicine. For tickets and
information, contact Dick Buza , 1025
Spruce St., W A8-0739.
faculty changes
Dr. Norman N. Cohen promoted to
Clinical Professor of Medicine (MCMC)
Dr. Lawrence W. Davis appointed Pro-
fessor of Radiation Therapy and Nu-
clear Medicine
Dr. George F. McInness promoted to
Professor of Surgery (W ilmington)
Dr. Diran O. Mikaelian promoted to
Professor of Otolaryngology
Dr. Dewey A. elson promoted to Pro-
fessor of Neurology (W ilmington)
Dr. Frances C. Schaeffer appointed
Clinical Professor of Obstetrics and Gy-
necology (Daroff)
Dr. William E. Stass, Jr. promoted to
Clinical Professor of Rehabilitation
Medicine
alumni trustee
Ballots for the election of the Alumni
Trustee were mailed to the entire mem-
bership on May 4. Chairman of the
Alumni Trustee Committee, Dr. Paul A.
Bowers, '37, noted in his message that
Dr. Joe Henry Coley, '34, has served the
University extraordinarily well during
his first term of office. Th e committee,
followin g lengthy discussion, recom-
mended to the Association 's Executive
Committee that he be nominated for re-
election to a three-year term. The Com-
mittee endorsed this recommenda tion at
the April meeting.
Serving with Dr. Coley, whose term
will expire in June , are Dr. Robert L.
Evans , '52 and Dr. Thomas F. Nealon,
Jr ., 'S44.
Results of the balloti ng will be an-
nounced in the summer issue of the
Alumni Bulletin.
Dr. Coley
class notes
1913
D r.J. WaIl ace Hurff, 45 Woodland Ave.,
Summit, N.J., retired in 1972. He is85 years
old.
1915
Dr. Joseph Aspel, 409 Maplewood Ave.,
Merion, Pa ., writ es th at he has not prac-
ticed since 1971.
Dr. Warren S. Reese, 2118 Locust St.,
Philadelphia, writ es th at he was honored by
th e Athl etic Club of Philadelphia as one of
its surviving founders and because he was a
pioneer in intraocul ar implant surgery in
the United Stat es.
1917
D r. William G. Flickinger, Foxcroft Apts.,
Jenkintown, Pa., writes, " My famil y ganged
up on me and made me retire. This is what
I never advised my patients."
1919
Dr. Samuel R. Lu ster, 169 S. Form osa Ave.,
Los Angeles, is semi-reti red, still see ing
patients at his home. He sends regards to all
his class mates .
1920
Dr. Edward W. Schoenheit, 25 Eastwood
Rd., Asheville , N.C., has retired. An int er -
nist with a spe cialty in cardiology, Dr.
Schoe nhei t is a form er President of the
North Carolina and Buncombe County
Medi cal Societi es. He is a FeIlow of th e
Ame rican CoIlege of Physicians and the
American CoIlege of Ches t Physicians.
1923
Dr. Benjamin HaskeIl, 1427 Spruce St.,
Phil adelphia and Mrs. HaskeIl, spent the
week of the Nobel Pri ze presentations in
Stoc kholm. This was at th e invitati on of Dr.
Howard Temin, a long ti me friend and now
Professor of Virology at the University of
Wisconsin, who had been named laureat e
in medicine and physiology. " It was a truly
memorable experience" Dr. Haskell sta ted
upon h is return. "We we re included in all
activities, even th e annual ball sponsored
by the med ical stude nts, who were by th e
way extremely hospitabl e."
Class Historian Dr. Ernest L. Noone for-
warde d the following abou t his classmates,
"Dr. W . Emory Burnett expected to host
Dr. George J. W illa uer at a joint four city
surgical meeting in Philadelphia last
March. Emory forgot th e date altogeth er
and George, waiting for Emory, saw five
inches of fresh snow instead, winced and
reached for his overcoat. Em ory enjoyed a
Florida winter and visits with his Alabama
kinsfolk. Geor ge, whose culinary skill is
well known, also occupies his spare tim e
making soap. 'First' says George, 'take
thirty pounds of fat .. .' "
1924
Dr. Lawerence Shinabery,212 Three River s
N., Ft. Wayne, In. , spent Christmas in In -
diana but most of th e winter in the Florida
Keys.
1925
Dr. Sigmond J. Shapiro, 550 Butl er Rd.,
Warren , Oh ., was honored by the Ohio
Stat e Medi cal Association for 50 years of
servi ce in medicine. Dr . Shapiro was a gen-
eral practitioner in Warren and delivered
hundreds of babies in th e area. He spent
some years running the Anesth esia Depart-
ment at St. Joseph's Hospital and is now
semi-reti red, spending three aft ernoons a
week specializing in all ergy . His son, Rich-
ard, is an ophthalmologist in Warren and
his son, Mark, is an ophthalmology resident
at Jefferson.
1926
D r. Philip B. Davis, 807 Florham St., High
Point, N.C. , retired in Jun e, 1967. He and
his wife spend th e winters in Florida and
summe rs in High Point. Th ey hope to at-
tend th e 50th reunion in Jun e.
Dr. James H. Tate, 1174 Hilltop Rd., Eri e,
Pa. , retired from gene ral practice in 1971.
He and his wife of 40 years hav e three ch il-
dren , all college gradua tes , and both boys
hav e th eir master s degrees. Th ey spe nd the
winters in Florida.
Dr. Max L. Weimann, 10 First Ave., Had-
don Height s, N.J., has retired from his pr ac-
tice of med icine.
1927
Dr. Samuel M. Dodek, 5480 W isconsin
Ave., W ashin gton , D.C ., has had his por-
trait presented to th e Library .of th e School
of Health Sciences of Geo rge Washington
University, along with th e first tocodyna-
momet er used in th e Western Hemi sph ere.
Th e instrument wasdevised , and used by
class notes
him in 1930 to study hum an myometrial phy-
siology and th e effec t of ce rtain dru gs and
agents up on ut erine con traction sduring la-
bor. It also became th e prot otype ofexte rnal
tocodynamomet ers used today to monitor la-
bor and the oxytocin cha llenge test.
D r. Dodek is Professor Em eri tus of Clinical
Obstetricsand Gynecology at G.W. U.
Dr. L. Paul Ralph, 11223 N.I03rd Ave.,Sun
City, Az., is in hisseco nd year of retirement
aft er 43 years of practice as a cardiologist in
Grand Rapids, Michi gan . He and his wife
have a surnmer home near there bu t reside in
Sun Ci ty six months of the year.
1928
Dr. Charles W. Lighthizer , McCauslen
Manor, Steubenville ,Oh., had joined a group
of six" re tired physicians" in May of 1969 to
man the Em ergen cy Department of the Oh io
Valley Hosp ital. "We may be reti red but we
treat ed 40,000 pat ient s last year ." Last June
he received the "Outsta nding Ohi o Team
Physician Award," presented by the Ohi o
Sta te Med ical Socie ty and the Ohi o High
School Athletic Associa tion .
1929
Dr. Joseph C. Hudson, 11608 Balboa Dr.,
Sun City , Az., is a member of th e Th eodore
Roosevelt Co unc il of the Boy Scouts and
each summe r goes to camp as physician to
th e Scouts. He also has joined the sheriff's
posse of Sun Ci ty .
Dr. James P. Ward, 320 Lemoyne Dr. , Pass
Christian, Ms., and his wife drov e through
Mexico and Ce ntral Ame rica to the Panama
Ca na l last Oct ober. They flew home and
shipped th e car. Th e trip was 3500 miles
from th e U.S. bord er.
1930
Dr. Leon L. Berns, 1300 Knox Rd., Wynne-
wood, Pa., has been promoted to Clinica l
Professor of Ana tomy at Jefferson.
1931
Dr. Edward Gipstein , 181 Broad St., P.O. Box
3 10, New London, Ct. , is pract icing clin ical
ca rdiology on a semi- retired basis. He is st ill
Cha irma n oft he Departm ent of Medicine
and the Div ision of Medical Education at Me-
morial Hospi tals in ew London.
Dr. William H. Newman , 251 E. Grove
Ave., Cla rks Sum mit, Pa., and his wife are
looking forw ard to th eir reunion in Jun e
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and hope to travel to Europe with the
alumni tr ip .
Dr. Nathan Ralph, 2047 Spruce St., Phila-
de lph ia, isserv ing as chai rman for th e 45th re-
un ion. "I am lookin g forward to a big
tu rnout."
1932
Dr. Nathan S. Schlezinger, 8378 Glen Road ,
Elkins Park, Pa., and Mrs. Schl ezinger were
gues ts at th e New Delhi wedding of the
grandson of Dr. Amar D. Matta '31. The
Schlez ingers were on a round the world trip
inco rpo rati ng med ical meetings and lec-
tures with pleasure.
Dr. Burchard E. Wright, Old Orchard Es-
tate, Ijamsville, Md., retired in July, 1975
from th e Food and Drug Administr ation af-
te r 11 yea rs as the Agency's senior biostatis-
tician and epide miologist in the Bureau of
Dru gs. He rece ntly returned from th e An-
dean highlands of Peru visiting the arch-
eological ruins at Lima, Cu zco , Macchu
Pichu and othe r sites .
Dr. Amar D. Matta '31 (far right) attended the wedding ofhis grandson (center) in New Delhi,
1ndia. Dr. Nathan S. Schlezinger '32 (lef t) and his wife were also wedding guests.
1933
Dr. Richard I. Barstow, Th e Village Green,
Norfolk, C t., has begun his 40th year of
prac tice , associa ting with an oth er physi-
cian . He is enjoying cross country skiing
and curling and hopes to join th e Jefferson
tr ip to Europe in April.
1935
Dr. Albert J. Blair , Sr.,409 Franklin Heights
Dr., Monroeville, Pa., has retired as Chi ef
Medi cal Direct or ofConsolidated Natural
Gas Co mpany. He has been th ere since 1956,
prior to which he had a priv at e practi ce in
Waynesburg. He is past President of the
Gree ne Co unty Mem orial Hospital and th e
Gree ne County Med ical Socie ty. He is also
past Director of the Amer ican Occupational
Med ical Associati on. He and his wife, Hel en ,
have thr ee children.
Dr. R. Marvel Keagy, 35 10 Baker Blvd., Al-
toona, Pa., is pract icing ped iatrics with two
junior partners, Rodney L. Sponsler '62 and
John L. Berardinelli '68. He is now Emeri -
tus Cha irman of th e Dep artment of Pediat-
rics at th e Altoona Hospital , and Dr . Spons-
ler is Chairman .
1936
Dr. Edmund J . Brogan , 1020 Ce dar Grove
Rd., Wynnewood, Pa., has ret ired as Med i-
cal Direct or of Provident Mutual Life In-
surance Com pany of Philadel phia. Dr. Bro-
gan will con tinue his privat e practi ce.
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Dr. Oliver E. Turner, 825 Eisenhower Dr.,
Pittsburgh, and his wife plan to attend th e
reunion in June. He has just completed a
three-year research project correlating glu-
cose tolerance versus insulin assay tech-
niques for diagnosis of diabetes, obesity , hy-
poglycem ia, etc.
1937
Dr. Carl G. Whitbeck, Box177, RD 2, Hudson,
.Y., gave up his private practice in 1970.
He now works for th e State of New York
and parttime as Medical Director of a nurs-
ing hom e.
1940
Dr. Rogcr B. Thomas, 8 Vining La., Wil -
mington, De., writes that his son, Roger, [r.,
is a pra cticing int erni st in \Vilmington and
is married with two children . His son, Rob-
ert, is a tax lawyer in Wilmington, marri ed
with no children.
1941
Dr. Louis C. Blaum, 244 Scott St., Wilkes-
Barre, Pa., writes that his son, Louis Jr. , is a
th ird-year reside nt in surgery at Jefferson.
" If any of th e class has occasion to visit Jeff,
look him up and say hello."
Dr. Clyde C. Greene, jr., 140 ew Mont -
gomery, San Francisco, wr ites that he was
sorry to miss th e recent American College
of Surgeons Jefferson reception, but he is
"s t ill laid up by the neurosurgeons. Hope to
be ambulatory and able to attend the 1976
reunion...
1944J
Dr. John H. Bland, Uppe r Valley Rd., Cam -
bridge, Vt., is an Associa te Professor of
Medicine at the University of Vermont. He
and Dr. Leon Sokoloff, a Professor of Pa-
thology at the Sta te Unive rsity of New
York, Stonybrook, have published a book,
The Musculoskeletal System.
Dr. John A. Martin, 2037 Crys tal Spring
Ave., S.W ., Roanoke, Va., has been elected
alte rna te delegat e to the AMA from Vir-
ginia. He is a Clin ical Professor of Radiol-
ogy at th e Universi ty of Virginia Medical
School.
Dr. Arthur B. Van Gundy,843 N. Columbus
St., Lan caster, Oh., writes tha t his second son,
Greg, is now a sophomore at Jefferson.
19448
Dr. Charles V. Dolan, 128 . Mill St., Birds-
boro, Pa., hasbeen accep ted for membership
in the Berks County Medical Society. He
pract ices family medicine and isan emer-
gency room physician at Ephrata Hospital.
1945
Dr. J. Elder Bryan , Jr. , 7926 3rd St.,
Downey, Ca. , is the princip al au thor of HR
10562, a bill for basic health insurance and
tax credit.
Dr. John J . Cox, SOl Haddon Ave., Had-
donfield , .J., writes that his eldest son,
Jonathan, has been accepted at Jefferson
and will begin in September, 1976.
1946
Dr. Charles E. Bickham, Jr., 5920 Searl
T er. , Washington, D.C ., ha s been appointed
Chairman of Suburban Hospital Depart-
ment of Radiology. Prior to thi s appoint-
ment he was Chairman of the Department
at Doctors Hospital. He is a Fellow of the
Ameri can College of Radiology and a mem-
ber of numerous societ ies.
Dr. F. William Henderson, 135 Oak Ave .,
Lak e City, FI., still has two children in col-
lege. Hopes to attend reunion in June.
1947
Dr. Lewis E. Jones, 1752 Morris Landers
Dr., Atlanta, has been promoted to Assist-
ant Professor of Medicine at Emory Univer-
sity . He is Chief of Staff at th e Atlanta Vet-
erans Administration Hospital.
Dr. John A. Koltes, 530 Spring La. , Phila-
delphia, complete d two years as President
of th e Medi cal Staff of Chestnut Hill Hospi-
tal and one year as the first physician ap-
pointed to the Board of Trustees of the
sam e hospital.
Dr. Martin M. Mandel, Benson Manor, Ste.
110, Jenkintown, Pa ., has been elected the
91st President of the Philadelphia Neuro-
logical Societ y for 1976. Many other Jeffer-
son neurologists have held this position. He
is also chief of the Department of Neurol-
ogy and Director of the Electrodiagnostic
Laboratory at Jeanes Hospital.
Dr. Laurance A. Mosier, 10510 Chapman
Ave., Garden Grove, Ca. , spent an evening
with Gail Li '47 and his wife, ani, during
th e recent AMA meeting in Honolulu. "He
is well and prospering."
Dr. Leonard Rosen,5 Arthur Ci. , Wall-
ingford, Pa. , has contributed his services to
the free care of indigent patients in Chester.
He has been praised by the community for
thi seffort , notes cla ssmate Martin Mandel.
Dr. Samuel Younger, 5109 Genesta Ave. ,
Encino. Ca. , writes that his son, Joel , is a
second year student at Jefferson.
1948
Dr. Velio E. Berardis, 632 Prospect Ave. ,
Scranton, Pa .• writes that he enjoyed him-
self a t th e 27th reunion at Skytop. He is
looking forward to th e next one. His son,
John, is a freshman at Jefferson.
Dr. Ralph Lev , 4 Ren ee C t., Edi son, T.J.,
was recently elec te d to the Board of Direc -
tors of the American Committee for the
Weizmann Institute of Science at Rehovot,
Israel. He is also Chairman of the Physi-
cians Co mmittee for the Institute. Dr. Lev
is practicing cardiovascular and thoracic sur-
gery in Edison and is a Clinical Associate
Professor of Surgery at the New Jersey
Medical School.
1949
Dr. John E. Mills, 123 Congress sr., Pasa-
dena, Ca.• announces the birth of a son, Pe-
ter Thomas, on November 24, 1975.
Dr. She ldon Rudansky, 520 Franklin Ave .,
Garden City, N.Y., writes that he visited Is-
rael in the summer of 1975 and presented a
paper at the Ichilov Hospital in Tel Aviv.
"Quite pleased that my son, Max, is a fresh-
man at Jefferson."
1950
Dr. Charles L. Saunders, 523 Wildwood La.,
Burlington, .C., writes that after 20
years he has started limiting his practice to
gynecology.
1951
Dr. Douglas F. Brady, 160 McLaughlin Dr.,
ew Kensington, Pa. , is practicing solo gen-
eral surgery and is on the staff at Citizens'
General Hospital and Allegheny Valley
Hospital. He has two boys, John, a senior in
high school, and James, a pre-med student
at the University of Pittsburgh.
Dr. Victor F. Greco, Greco Memorial Med-
ical Arts Bldg., R.D. Drums, Pa ., has been
appointed Medical Consultant for the Com-
prehensive Health Planning for the State of
Pennsylvania. His oldest son , Vic, is a stu-
dent at Philadelphia School of Optometry,
hoping to get into medical school. His old-
est daughter is studying to become an oper-
ating room technician and his second son is
in his first year of pre-med. " W e have three
more children coming up , all of whom have
an interest in medicine."
1952
Dr. Nelson P. Aspen, 633 N. Church St., West
Chester, Pa. , writes that his five children have
become eight by marriage, "andsix grand-
children bring us to middle age. " He is Chief
of Orthopaedics at Paoli Hospital.
Dr. Jerome I. Brody, 3300 Henry Ave.,
Philadelphia, is a Professor of Medicine at
the Medical College of Pennsylvania.
Dr. Raymond L. Cunneff, 30 Alston Ct.,
Red Bank, N.J., is President of the ew Jer-
sey Orthopaedic Society, Director of Ortho-
paedics at Riverview Hospital in Red Bank,
and Associate Attending at New York Or-
thopaedic Hospital. He continues as sur-
geon to the ew York Giants.
Dr. Robert L. Evans, 144 Sherburne Ci.,
Weston, Ma. , will receive the M.S.M. de-
gree from M.I.T. in May, 1976 after com-
pleting the Alfred P. Sloan Fellowship in
management science. He received th e Joh n
C. Leonard Award for contributions to
medical education at the Congress on Med-
ical Education in Chicago in January.
Dr. Howard Fugate, Jr., 633 Maple Ave.,
DuBois, Pa. , is practicing internal medi-
cine. His oldest son is a senior at Phila-
delphia Osteopathy School and his other
three sons are pre-med at Penn Stat e. He
and his wife have four grandchildren .
Dr. George C. Godfrey, 112 Glenside Ave.,
Linwood, .J., practices gene ral surgery at
Shore Memorial Hospital and has an office
in Somers Point. He recently saw class-
mates James Carroll and James Comerford
at a meeting of the American Coll ege of
Surgeons. Dr. Carroll is a urologist in the
Oakland area and Dr. Comerford an anes-
thesiologist in San Jose .
Dr. Jerome J. Lebovitz, 5650 Aylesboro
Ave., Pittsburgh, writes that his son, Mark ,
is a freshman at Jefferson . He is Vice-Pr esi-
dent of the Southwest Chapter of Je fferson
Alumni. His second son will start a pre-med
program in September.
Dr. Herbert A. Saltzman, Duke University
Medical Center, Box 2904, Durham, N.C., is
well and busy. He has one child in college
and two still at home.
Dr. Robert M. Zweig, 2936 McAll ister St.,
Riverside, Ca ., is studying hydrogen as an
alternate fuel and has presented pap ers in
connection with this topic.
1953
D r. Franz Goldstein, 707 Arlington Rd.,
Penn Valle y, Pa., has been named the Hu-
manitarian Doctor of the Year by the Phila-
delphia Chapter of the ational Founda-
tion for Ileitis and Colitis, Inc. He is Chi ef
of Gastroenterology at Lankenau Hospital
and Professor of Medicine at Jefferson.
Dr. August F. Herff, Jr., 8711 Village Dr. ,
San Antonio, Tx. , writes that his eldes t
Phi Alpha Sigma
Cordially Invites its Alumni
to a
COCKTAIL PARTY
4 P.M. Jun e 9th
313 S. 10th St.
Alumni planning to attend their cla ss re-
union are invit ed to stop by and ha ve a
drink, meet the new brothers, see the
hou se, and reminisce.
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child graduated from Texas University and
is working. The second child is in 10th
grade and seems to want to attend the Na-
val Academy.
Dr. Willard S. Krabill, 120 Carter, Goshen,
In., is college physician at Goshen College,
Medical Director of the High Park Clinic
and Medical Staff representative to the
Board of Trustees of Goshen General
Hospital.
Dr. Robert M. Mead, 3015 El Corte Way,
Erie, Pa ., writes that two children in col-
lege at the same time are keeping him
"hopping financially."
Dr. Robert Poole, 419 N. Franklin si., West
Chester, Pa., is Chief of Staff of Chester
County Hospital. He is President of the
Board of Health of Chester County, and
Chairman of the Council on Professional
Relations and Services for the Pennsylvania
Medical Society. One daughter has finished
college and is working as a probation offi-
cer; two daughters are in college; and one
daughter in high school.
Dr. Raymond P. Seckinger, 4285 Tilghman
St., Allentown, Pa., is practicingpsychiatry
utilizing the team approach with correlative
therapy. Treatment iscoordinated to the
client's needs utilizing psychoanalytically-
oriented psychotherapy as the core
technique.
1954
Dr. Thomas Aceto, Jr. , McKenna Hospital,
Sioux Fal1s, S.D., has been appointed Chair-
man of th e Department of Pediatrics at the
University of South Dakota School of Medi-
cine. A pediatric endocrinologist, Dr . Aceto
Dr. Aceto
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had been Professor of Pediatrics and Dep-
uty Chairman of the Department at the
University of Virginia. From 1962 to 1974
he was affiliated with Buffalo Children's
Hospital as Director of Pediatric Endocri-
nology and Director of Postgraduate Edu-
cation, and he was also an Associate Profes-
sor of Pediatrics at the State University of
New York at Buffalo. He is Board certified
in pediatrics and a member of the Society
for Pediatric Research, the Endocrine So-
ciety and the American Federation for
Clinical Research. Dr. Aceto was also Act-
ing Director of the National Pituitary
Agency in Baltimore and Director of a col-
laborative project on the effects of human
growth hormone from 1965 to 1974. He has
many scientific publications to his credit.
1955
Dr. William A. Anthony, Jr., 1016 Charles-
ton Ci. , Roseville , Ca. , writes that he and
Paul Dugan '56 continue to be employees
of a five-man family practice corporation.
"W e soon plan to enlarge to seven men ."
Dr. Burton S. Benovitz, 425 Tioga Ave.,
Kingston, Pa. , writes that "Madge is now a
member of the Pennsylvania State Board of
Education, while my daughter, Jane , is a
sophomore at Brown ."
Dr. Frederick Lytel, 117E. Fourth Ave., Con -
shohocken, Pa., isan Assistant Professor of
Family Medicine at Jefferson. "It's a great
program and I'm pleased to be part ofit."
1956
Dr. Joseph L. Magrath, Ashby Rd. & Chest-
nut St., Upper Darby, Pa ., is an Assistant
Professor of Surgery at Jefferson.
Dr. Wallace B. O. Wong, 1354 McBain
Ave., Campbell , Ca. , is Chairman of the
Ob-Cyn Department at Santa Teresa Hos-
pital in San Jose. His eld est child, Gregory,
is attending Northwestern Universit y. " In
th e case of classmates travelling in Califor-
nia , stop by."
1957
Dr. T. Clark Corson, 10Penn si., Blooms-
burg, Pa., is still in the private pra ctice ofobI
gyn. He isPresident of the Board of Edu cation
at the Central Columbia School District.
Dr. Stephen J. Kendra, Box 143 aval Sta-
tion , San Diego, Ca ., is Commanding Offi-
cer of the Navy Environmental and Preven-
tive Medicine Unit #5 in San Diego. His
son, Stephen, Jr. , is a sophomore in pre-med
at Notre Dame.
Dr. Ronald M. Match, 10 Medical Plaza,
Glen Cove, N.Y., writ es that he enjoyed at -
tending the Jefferson Orthopaedic Society
Meeting in De cember and presen ting two
papers. He is a member of th e American So-
ciety for Surgery of the Hand.
Dr. Sanford M. Miller, 6BO W. End Ave.,
New York, is an Assistant Professor of
Anesthesiology at New York University
Medical Center. " Marcia and the two boys
(now 12 and nine) are all fine."
Dr. Joseph F. Rodgers, 1723 Sylvan Ln.,
Gladwyne, Pa. , was installed as President of
the Volunteer Faculty at Jefferson at the
Annual Meeting in January. A Clinical As-
sistant Professor of Medicin e, he succeeds
Dr. Paul J. Poin sard '41.
Dr. Rohert H .Schwab,632 Montgomery
School Ln ., Wynnewood, Pa.,has two chil-
dren,Jennifer , age four , and Daniel, age two.
1958
Dr. Edwin R. Concors,5009 Oxford Ave.,
Philadelphia, has joined with several other
phy sicians to open a group pract ice of pediat-
rics. Dr. Concors is affiliated with Frankford
and Nazareth Hospit als and isa Clinica l Asso-
ciate Professor of Pediatricsat Hahn emann.
Dr. Carter N. Davison, Oxford Ci rcle, Ta-
maqua, Pa ., ha s opened an office for general
practice in Hometown , Pennsylvania. He
practi ced pr eviously in Mah anoy City.
Dr. Donald N. Dubrow, 6536 Crestmere St.,
Dallas, writes that despite th e rigors of inter -
nal medi cine pra cti ce, "we harvested a
bountiful crop ofcom, beans,summer squash,
cucumbe rs, melon s and tom atoes.We live for
thewinterl Nancy and I continue tobreed-
boxers-andshow th em. Daught ers Fran,
Eve, Karen busy with piano,school, soccer. I
have been recertified by the American Board
ofInternal Medicine."
Dr. Edward Fine,43 Kings Highway W.,
Haddonfield , N.J., is Director of Medica l Ed-
ucation for Our Lady of Lourdes Hospital in
Camden, one ofJefferson 's affiliates. Dr. Fine
is a Clinical Assistant Professor ofObstetrics
and Gynecology at Jefferson.
Dr. Marvin Z. Rotman, 59 E. BOth St., New
York, is Professor ofRad iology and Director
of Radiation Therapy at New York Medical
Col1ege.
Dr. William J. Warren, RRl , Box 149, Fur-
long, Pa., has formed th e War ren Medica l
Laboratories, Inc., locat ed in Lansdale,
Pennsylvania. Full services are offered.
1959
Dr. TrevorD.Glenn, 5072 N. Van NessBlvd.,
Fresno,Ca., isa memb er of the American Col-
lege of Physicians, and on its Advisory Panel
on Nati onal Heal th Insurance.
Dr. William A. Steinbach, 1120 North-
eastern Bank Bldg., Scranton, Pa., is an or-
thopaedic and hand surgeon. He is Assistant
Chief of Surgery at the Community Medi-
cal Ce nter.
Dr. Samuel L. Stover, Box 435, Helena, AI.,
is Professor of Rehabilitation Medicine and
Associate Professor of Pediatrics at the Uni-
versity of Alabama School of Medicine.
1960
Dr. William R. Fair,4960 Audubon Ave.,St.
Louis, Mo., isa Professor ofSurgery and
Chairman, Division of Urology, at Washing-
ton University School of Medicine and Uro-
logist-in-Chi ef, Barnes and Allied Hospitals.
He isalso a member of the Scien tific Advisory
Board of the National Kidney Foundation.
1961
Dr. Lewis H. Dennis, 13809 Vintage La.,Sil-
ver Sprin g, Md., has taken an associate into
his practi ce ofhemat ology and oncology. He
continues on the Executive Committee of the
Washington Adventist Hospital.
Dr. Paul G. Pentz, 42 Kenneth Dr ., Glas-
tonbury, Ct. , is a staff psychiatrist and Di-
rect or of Student Mental Health at the In-
stitute of Living in Hartford.
Dr. John G. Starr, 326 E. 2nd Ave., #3, An-
chorage, AI., is establish ing a small pediat-
rics practi ce in Anchorage, and hop es to
continue his public health work as well.
1962
Dr . George A. Blewitt, 21 Patriot Ci. , De-
von, Pa., has returned to the east to become
Associate Director of Clinical Services, Ne-
phrology, at the Smith , Kline Corporation
in Philadelphia.
Since its inaugurati on in 1967 the Annual Art
Show by the Facult y Wive s Club ofJefferson
Medical College hasbecome one of the an-
ticip ated events ofeach school year. Open to
all members of the University including Med-
ical School alumni and their famili es the show
con tinues to draw entries from across the
country incl uding theSOth state, Hawaii. Th e
ninth exhibi tion isscheduled again this year
to coincide with reun ion activities. Dates:
May26 through June9.
Everyone and eve rything qualifies. Media
entries range from oils to watercolors to ce-
ramic s, sculptures, photographs, graphics,
D r. Robert M. Glazer, 1358 Drayton La .,
Wynnewood, Pa. , is on the faculty of the
University of Pennsylvania School of Medi-
cine in Orthopaedic Surgery. In addition to
a private practice at HUP , he is Acting
Chief of Orthopaedics at the Philadelphia
Veterans Administration Hospital.
Dr. LouisE. Levinson, 515 Westbank Expy.,
Gretna, La., ispracticing obstetrics and gyne-
cology. "Phyllis,Tracy and Dara are all well.
Tracy is a freshman in high school. Give usa
call when you visit New Orleans."
Dr. Robert J. eviaser, 14620 Seneca Rd.,
Germantown, Md., received tenure at
George Washington University School of
Medicine as an Associate Professor. He will
be promoted, effective July 1, 1976 to Pro-
fessor of Orthopaedic Surgery.
Dr. William E. Staas, Jr., 323 Mimosa Dr. ,
Cherry Hill , N.J., has been promoted to
Clinical Professor of Rehabilitation Medi-
cine at Jefferson.
1963
Dr . Thomas S. Patricoski, 12210 S. 86th
Ave., Palos Park , II., writes that a daughter ,
Joy Marie, was born on November 8, 1975.
She has five brothers and three sisters.
1964
Dr. James C. Barton, Rte. 1, Chambersburg,
Pa., writes that h is wife , Anne , and children
Beth , Leah and Sarah are enjoying life and
working on family projects. "Our four-man
family practi ce is doing well. "
Dr. AlfredJ. Cooke, Jr., 650 Church St.,
Landisville, Pa., is practicing orthopaedics in
Lancaster, andhe and his partner recently
took on two new associates. He and hiswife
have three sons, ages 10,eight and seven.
Dr. William A. Freeman, P.O. Box 130,
Shippensburg, Pa., writes that his wife ,
Jefferson ArtShow
metallics, carvings and even needlepoint. It
is a noncompetitive, non-judged exhibit and
serves as FWC's annual gift to Jefferson.
Out of town entries may be mailed to the
Alumni Office,Jefferson Alumni Hall, 1020
Locust Street, Philadelphia, 19107,by May
24. FWC will return them toyou by June 14.
Please be sure to include information such as
yourreturn address, title of work , class or
affiliation.
Exhibitors are invited to a special recep-
tion the aft ernoon of June 2.
Mrs. John H. Hodges, Chairma n
Joan, recently returned to her social work
caree r parttime in his family practice group
as a psych iatric social worker.
Dr. Philip R. Hirsh, Jr., received consulting
privil eges in psychiatry at Memorial Hospi-
tal in Easton, Maryland, and has begun a
practice in Easton as well .
Dr. Stephen C. Kauffman,3301 Goldsboro
Ct. , FallsChurch , Va.,has added two more
men to hisgroup in family practice. He writes
that he is looking forward to seeing those who
visit Washin gton for the bicentennial.
Dr. Harvey M. Tucker, 3292 Havel Dr .,
Beachwood, Oh., is Professor and Chairman
of the Department of Otolaryngology and
Communicative Disorders at the Cleveland
Clinic Foundation.
1965
Dr. Merrill A. Anderson, 731 Conestoga
Rd., Rosemont , Pa., is the Associate Direc-
tor of the Family Pract ice Residency Pro-
gram at Bryn Mawr Hospital.
Dr . Edward R. Corcoran, j-, 4211 La Dega
Ct .,Tampa, Fl., and his wife grea tly enjoyed
seeing old friends and new buildingsat the re-
union last Jun e. He is in a pathology residency
at the UniversityofSouth Florida.
Dr. James R. Dingfelder, 2003 Fireside Dr.,
Chapel Hill, N.C., is Assistant Professor of
Obstetrics and Gynecology at the Univer-
sity of North Ca rolina. He has presented
papers rece ntly in Kuala Lumpur, Ma-
laysia; Buenos Aires; Las Vegas; Daytona
Beach , and othe rs. He is married and has
three sons, ages six, seven and 11.
D r. Jay M. Grodin, 104-D8Great Arbor Dr.,
Potomac, Md., hasbeen elected President of
the D.C. chapterof the Jefferson Alumni
Association.
D r. Will iam F. Pharr, R.D. 5, Dan ville, Pa.,
has joined the medical staff of Geisinger
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LifeinJerusalem is Remarkably Normal
Dr. Gordon: A new life
in the same lifetime
40
It is difficult for most Americans to envision
life in a country where the continued exis-
tence of the nation as a political entity is a
matter of everyday concern. Yet Dr. Milton
H. Cordon '37, a recent emigre to Israel,
says that day-to-day life in that beleaguered
area of the world is remarkably normal, per-
haps intentionally removed from the cata-
clysmic issues debated in Ceneva and ew
York. And despite the frequent incidence of
terrorist activities the Cordons feel safer
walking the streets of Jerusalem at night
than they did the streets of Philadelphia.
That probably says less about th e perceived
quality of life in Philadelphia than it doe s
about the compelling sense of community
and inter-identification that hav e attracted
so many to th e Israeli way of life.
Dr. Cordon's first trip to Israel was on a
1935 tour with a musical group, "The Jeffer -
sonians," with fellow medical student Mor-
ton S. Pearl '36. He next returned one week
after the Six-Day War in 1967 for a two-
month volunteer stint at Hadassah Hospital,
accompanied by his wife who lived with him
in a nearby Nurses' Residence. He treated
non-surgical, non-casualty patients in the
Hospital's clinic until the staff physicians re-
turned to normal duty. After the Yom Kippur
War in 1973 he again volunteered his serv-
ices, this time working for six weeks at Ka-
plan Hospital in Rehovot. The Cordons had
become emotionally involved with Israel's
people and fortunes through these visits,
through Dr. Cordon's ham radio contacts and
through Mrs. Cordon's enthusiastic work in
the United States with the United Jewish Ap-
peal and the Jewish Federation of South Jer -
sey. "We became knowledgable about condi-
tions in th e country, both the good and the
bad. We wanted to make a change in our
lives, and we wanted to help if we possibl y
could."
The change is a major one, but not as
drastic as it might first appear. The Cordons
sold their home in Haddonfield, New Jersey
and bought a condominium in Jerusalem's
central residential area, a 15-minute walk
from the business district. In terms of com-
fort and cost it is comparable to those avail-
able in center ci ty Philadelphia, and since
they had the furnishings from their Had-
donfield residence shipped over, the new
home looks remarkably like the old .
Neither has their diet had to cha nge in a
marked way. Staples, especially fresh fruits
and vegetables are available in abundance,
and th e cost of vital foodstuff s is at this time
subsidized by the government. Imported
foods are very expensive; a box of U.S. ce-
real costs more than twice as much as its Is-
raeli competit ion, which according to Dr.
Cordon is just as tasty. Red mea t is expen-
sive and inferior in qualit y to that found in
the States, and, with th e exception of frozen
vegetables, prepared and convenience foods
do not exist. Casoline is $1.90 a gallon , but
prices for the most part are not notably
higher than they are in Amer ica; the major
economic differen ce is th e salary scale ,
about two-thirds lower in Israel.
Israelis work a six-day 45-hour week, and
the work day begins at eight A.M. Co nse-
quently people tend to rise and retire earlier
and usually have their largest meal in the af-
ternoon. Ent ertaining is generally done over
coffee in the lat e afternoon; din ner parties
and restaurant dining are not common. Since
entertaining is less formal th ere is more of it ,
and the Cordons find th e mix of backgrounds
makes social life in Isra el very stimulating.
The cultural and intellectual life can be stim-
ulating as well, with a variety of musical
events, theatre and lectures from which to
choose. Dr. Cordon not es that , "Country
clubs are unh eard of in Israel. There is one
golf course, but it is only a golf course ." Ten-
nis and soccer are the most pop ular Israeli
sports, and the Cordons find that there are al-
ways opportunities for new aesthe tic and
spiritual experiences.
Perhaps th e greatest change for Dr. Co r-
don has been occupational. Previously a
full-time practitioner of int ern al medicine,
Dr. Cordon went to Israel with no intention
to retire but with no specific job situation in
mind. He is now Civil Air Surgeon for the
State of Israel thanks to a lifelong avoca-
tional interest in aviation medi cine. Him-
self licensed as a commercial pilot and an
instrument instructor, Dr. Cordon logged
4500 hours of flying time while in private
practice, including flights to various parts
of the United States, Mexico and Canada.
He had also served for 20 years as senior
Flight Examiner for the Federal Aviation
Administration and had been trained in ac-
cident investigation. His new job encom-
passes these areas but includes others as
well. Naturally th ere is a good deal of ad-
ministrative detail with which to contend,
and he coordinates a team of specialists
from many fields in dealing with problems
of passenger transport, health and standards
for air crew and ground support people.
Dr. Gordon is on boards of enquiry for all
aviation accidents, investigating the human
factors involv ed such as fatigue, emotional
stress, extreme heat, etc. His int ernal medi-
cine background and his own flight experi-
ence are useful in evaluating grounding sit-
uations for pilots and air crews under most
medical conditions. He is also conce rned
with agr icultural avia tion, enforcing safet y
and flight time regulations for those in-
volved in spray ing agricultural chemicals.
"The pilo ts think they're indestructible,
and it isn' t easy to make th em understand
what these che micals can do to th em. "
Working with enginee rs regarding use of
oxygen at 40,000 feet plus altitudes and th e
effects of pr essurization loss is anothe r re-
sponsibili ty of th e Civil Air Surgeon .
In Dr. Gordon's opinion, th ere is a great
deal of int erest in medical research and
medica l problems in Israel, but not as much
in th e patient himself. Medi cin e is socia l-
ized to a great extent, wi th virtually no pri-
vate pr acti ce as we know it : people simply
cannot afford it. Depending on one's will -
ingness and abil ity to pay, different med ical
plans are availab le, some allowing th e right
to choose one's own physician, so me using
only clinic physicians with conside rable
wait ing tim e the rule. The qu alit y of care is
excellent, with all mod em methods avail-
able and free ly used . " Medical men read a
grea t deal," Dr. Gordon notes, "and ma ny
belon g to journal clubs to keep curre nt of
medi cal ad vances."
Wi thin th ree years the Gordons, as Jews,
will be gran ted Israeli ci tize nship under th e
"Law of Return," Since thi s process is au to-
mat ic, the ir U.S. ci ti zensh ip can be simulta-
neously retained. Each yea r th ey spend a
month in the U.S. visiting family and
friends, and their options are op en if th ey
decide not to make th e move a permanent
one. Dr. Gordon notes that most people
who leave Israel do so for economic rather
than securi ty reasons. If peopl e make less of
the danger th an might be expec ted it is per-
haps because most of tho se now living in Is-
rael either were born th ere or have immi -
grated from countries in whi ch the y could
not live freely as Jews. "People like us from
the free world," .says Dr. Gordon, "have a
cho ice . But most Israelis come to accept
danger as a part of life, because th ey have
no choi ce. Th ere is nowh ere else to go,"
Medical Center , in the Department of
Cardiac Surgery. Dr . Pharr has been on th e
staffs of Charlotte Memorial Presbyterian
and Mercy Hospitals in North Carolina and
Hampton General Hospital in Newport
News, Virginia. He is certified by th e Amer-
ican Board of Surgery and has been an In-
structor in Surgery at Rush Medical Center
in Chicago.
Dr. Thomas J. Schneider, 4212 Oak St.,
Palm Beach Gardens, Fl ., was appointed
Chairman, Division of Medicine, at St.
Mary 's Hospital in We st Palm Beach . He is
in his fifth year of practice in a 35-man
multi-specialty group in gastroente rology.
"Family loves Florida,"
Dr. GarryH. Wachtel, 7l00S.W. 7th St.,
Plantation, Fl ., is practicing in Tamarac,
Margate,and Lauderdale Lakes with an asso-
ciate. He and his Wife,Linda hav e three
children .
Dr. William B. Wood writes that his family
hasgrown. Th ey now have "our third beau-
tifullittle girl, Kaaren Susanna. My practice
in anesthesiology has grown rap idly as has our
clinic dealing with chronic pain problems."
He and his famil y reside in Mankato, Mn,
1966
Dr, Joseph B. Doto, Jr., 320 Sinkler Rd.,
Wyncote, Pa., is a Clinica l Assistant Profes-
sor of Anesthes iology at Jefferson.
Dr. Robert H. Kirschner, 6822 S. Euclid
Ave., Chicago, was appointed th e first Ben
Horwi ch Scholar of Medi cal Sciences at the
University of Chicago . Th e appoin tment
provides salary and researc h support for a
two-year period. He is doing research on
the st ruc ture of leuk emia viru s RNA with
funds from NCI and ACS.
Dr. Daniel Lovrinic, 17 Brookhill Rd., Co-
nyngham, Pa., recently passed his orthopae-
dic Boards. He is in priv ate pr act ice in Ha-
zelton. "Kathy and th e kids are fine,"
Dr. Gerson B, Rothman, Tenbyt owne Apt .,
Rte. 130N., Delran, N.J., has joined th e Ra-
diology Dep artment at Rancocas Valley
Hospital in Willingboro, New Jersey.
1967
Dr. Robert M. Friedlander, Litt le Sunapee
Rd., New London, N.H., writes th at his
third child, Rebecca, was born on Oct ober
25,1975.
Dr. Matthew White is in a group practi ce
with four othe r famil y physicians at th e Na-
val Hospital in Bremerton, Washington. He
passed his boards in family practi ce and is
now a Fellow of th e Acade my.
1968
Dr. Joel M. Barish , 1988 Calle Madrigal, La
Jolla , Ca ., is p racti cin g gastroentero logy in
San Diego and his wife is practicing pediat-
ric s. They have a son, Doug, age two.
Dr. Wayne H. Braverman,44 Tradd St.,
Ch arleston,S.C., wri tes that Lana and he are
happily enjoying life in Charleston where he
pra cti ces psych iat ry. He isnow a Diplomate
of th e Boards of Psychia try and Neurology.
Dr. Clifford A.Gordon, 1777 Hamburg
Tpke., Wayne, N.J., ispracticinggastroenter-
ology. Hehas two daught ers and anew son.
Dr. Robert A. Jacobs, 2615 N. Vermont
Ave., Los Angeles, is an Assistant Professor
of Pedi atrics at th e USC School of Medi-
cin e. He is also working at Children's Hos-
pital in Los Ange les.
Dr. Joel A. Kaplan, 1175 Gunnison Ct .,
Cla rkston, Ga ., has been appointed Direc-
tor of Cardio thoracic Anesth esia at Emo ry
Univers ity Hospital in Atlanta.
Dr. Martina Mockaitis Mar tin, 17 Dar t-
mouth La., Haverford, Pa., was ce rtified by
the American Board of Internal Medi cine in
rheum at ology in 1974.
Dr. Morris L. Orocofsky has been ap-
point ed staff internist for the Philadelphia
Psychiatry Center . Dr. Oroeofsky is a Dip -
loma te of the American Board of Int ernal
Medicin e. He finished his medical residency
in June, 1975.
1969
Dr. Robert L. Arkus, 5600 S. Willow Dr.,
Ste . 116, Hous ton, is pra cticing intern al
medicine and gastroenterology at the above
address. He and his wife adopted two chil-
dr en while in the Air Force in New Mexico,
Lisa and Rebecca.
Dr. Rich ard C. Gross, 4391 26th St ., San
Francisco, is in his final year of residency in
diagnostic radiology at th e University of
Ca lifornia, San Franci sco Medical School
and will remain there next year on the jun-
ior staff. His wife, Carrol, has received her
Masters degree in Nursi ng from the UCSF
and is now an Associate Professor of Nurs-
ing at San Francisco State University.
Dr. Barry S. Smith, 702 Lexington PI.,
Louisville , Ky., passed his specialty boards
and is now certi fied by the Amer ican Board
of Physical Medicine and Rehabilitation.
1970
Dr. John A. Azzato has been appoint ed to
th e staff of the Orthopaedic Surgery De-
partment at Methodist Hospital. He served
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orthopaedic residencies at the University of
Illinois and Jefferson.
Dr. Edward B. Bower,3 McIntosh PI., Ft.
Stewart,Ca., completed his general surgery
residency at Jefferson and isnow a surgeon in
the Army for two years. He and his wife and
their two children are living on post at Ft.
Stewart. Before leaving Philadelphia, Dr.
Bower had a one-man art exhibition and re-
ception in the Jefferson Commons Callery.
Dr. Larry S. Cohen, 16800 N.W. 2 Ave.,
Ste. 204, N. Miami Beach, Fl., announces
th e birth of twin daughters on October 19,
1973. He is in the private practice of cardi-
ology in North Miami Beach.
Dr. Douglas B. Hagen, 1370 Byron Dr. ,Sa-
lina s, Ca .,has joined Medical Associates of
New Paltz as a family physician. Dr. Hagen
completed his family practice residency at
the Natividad Medical Center in Salinas,
California.
Dr. Steven A. Klein, 8916 Data Point Dr.,
San Antonio, Tx., graduated from an
N.Y.U.-Bellevue residency in obstetrics and
gynecology. He is on the ob-gyn staff at
Wilford Hall Medical Center of the
U.S.A.F. He announces the birth of a son in
Decemb er , 1975, Barak Matthew.
Dr. James R. LaMorgese, 1960 Williams-
bridge Rd., Bronx, N.Y., and his wife,
Nancy, announce th e birth of a son, Robert
Scott, February 9. They have two other
sons, James, III and Brad. Dr. LaMorgese
will complete his residency in neurosurgery
at Albert Einstein College Hospital, Ye-
shiva University, in Jun e and enters the Air
Force in July.
Dr. Robert M. Lumish, 7106 S.W. 112th PI.,
Miami , finished an infectious disease Fel-
lowship at the University of Pittsburgh and
joined the epidemiology intelligence serv-
ice of the Center for Disease Control. He
will be stationed with the Dade County
Health Department until June, 1977. He
and his wife, Saundra, expected their sec-
ond child in March.
Dr.JohnT.Martsolf,307-671 William Ave.,
Winnipeg, Manitoba, isenjoying his stay in
Canada, where he will continue his clinical
genetics training until December,1976.
Dr. Lawrence S.Miller, 1842 Roscomare Rd.,
LosAngele s, has begun a practice of physical
medicine and rehabilitation in Beverly Hills
and at the Cedars-Sinai Medical Center. He is
a Clinical Instructor of Medicine at UCLA ,
and isenjoying California with his wife, An-
ita, and two children:Justin Todd, four
months and Torrey, 22 months.
Dr. Richard L. Nemiroff, 748 Stonehouse
Rd., has opened an office for the practice of
obste trics and gynecolo!,')' in Moorestown,
New Jersey. A Clinical Instructor of Obi
Cy n at th e University of Pennsylvania, he is
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a contributing author to the book "Inter-
ruption of Pregnancy."
Dr. Allen C. Richmond, 135 Crosshill Rd.,
Overbrook Hills, Pa., announces the birth of
a daughter, Robyn , September 19. He is
completing a residency in ophthalmology at
Scheie Eye Institute. He and his wife also
have a son, Philip, age four.
Dr. Martin A. Tobey, 802 Pecan Ct., Belair,
Md., will complete his duty in the army in
July, after which he will begin a Fellowship
in cardiology at the University of Texas
Southwestern Medical School in Dallas.
1971
Dr. Donald A. Bergman, 305 E. 86th St.,
New York, is in the first year of an endocri-
nology Fellowship at Mt. Sinai Hospital
where he just finished his internal medicine
residency. He and his wife, Susan, became
parents in June, 1975 with the birth of their
daughter, Melissa.
Dr. Delvyn C. Case, Jr., 430 E. 67th St.,
New York, will complete his Fellowship at
Memorial Sloan-Kettering Cancer Center
in June, 1976 and will move to Portland,
Maine to join a group in the practice of he-
matology/oncology. He will be on the staff
of the Maine Medical Center and the Tufts
University School of Medicine.
Dr. Harry R. Cramer, 2362 Thompson Ct. ,
Mountain View,Ca .,began a residency at
Stanford Medical Center in July, 1975 after a
three-year tour with the Navy asa flight sur-
geon in CorpusChristi,Texas . His wife,
Cayle, is involved in a Master's program at
Stanford.
Dr. Paul M. Fernhoff, 2592 Briarcliff Rd.,
N.E. , Atlanta, and his wife, Deborah, an-
nounced the birth of a daughter, Shana Mi-
riam , on May 31, 1975.
Dr. Bruce M. Fishbane, 21 Strabane Ct.,
Baltimore, will be Chief Resident in or-
thopaedic surgery at Johns Hopkins in July .
His wife Marsha '72 is on the fulltime clinic
staff at Johns Hopkins after finishing her pe-
diatric training there. She is also a parttime
student at their School of Public Health and
Hygiene. Their daughter, Alissa Michele,
was born on June 24, 1975.
Dr. William C. Hamilton, 23 E. Homestead
Ave., Collingswood, N.J., isa senior orthopae-
dic resident at Jefferson and expects to en-
ter the service in July, 1976. His second
daughter, Amy, was born in August , 1975.
Dr. David W. Jones, P.O. Box4523, Boulder,
Co. , has been appointed DirectorofEmer-
gency Services at Boulder Community
Hospital.
Dr. Barry R. Klein has completed his resi-
dency in emergency medicine at the Uni-
versity of Louisville and is now Director of
Emergency Services at Parkridge Hospital
and President of Emergency Medical Asso-
ciates, Chattanooga, Tennessee.
Dr. Gerald M. Klein, U.S. Naval Hospital,
Box 19, F.P.O., New York, passed his Boards
in Radiology in June 1975 and is now
serving a two-year tour in the U.S. Navy as
Chief of Radiology at th e Navy Medical
Center in Naples, Italy.
Dr. Michael J. Lechman, 819 Montgomery
Ave., A202, Bryn Mawr, Pa. , is in his second
year of surgical residency at Bryn Mawr
Hospital.
Dr. Elizabeth London Rogers , 1904Elmore
St., Louisville, Ky., isAssistant Professor of
Medicine at the University of Louisville Med-
ical Center, while her husband "is protecting
our country at Fort Knox.Our son, Bradley, is
a healthy,happy 13 months of joy."
Dr. Edward B. Ruby, 468 W. Chocolate
Ave., Hershey, Pa., announces the bir th of a
baby girl , Alisa Melane, on July 25, 1975.
He is doing a Fellowship in endocrinology
at Hershey Medical Center.
Dr. Augustin J. Schwartz III, 705 N. Olive
Ave., P.O. Box 3167, W. Palm Beach, Fl .,
has become a Diplomate of the American
Board of Medical Oncology and a Board
certified medical oncologist. He invit es his
classmates to visit if the y are in the Palm
Beach area .
Dr. Stephen C. Silver, 4082 Wil mington Rd.,
S. Euclid, Oh. , has returued to the Cleve-
land Clinic as a senior resident in gene ral
surgery after two years as a general surgeon
in the Air Force. He plans to finish in gen-
eral surgery in 1977 and take a Fellowship
in colon and rectal surgery. "Looking for-
ward to our reunion."
Dr. J. Stanley Smith, Jr., 1139 Loop Dr.,
Harrisburg, Pa., finished a general surge ry
residency at the Harrisburg Polyclin ic Hos-
pital and is now doing a Fellowship in
trauma at the Maryland Institute for Emer-
gency Medicine.
Dr. C. Thomas Spigel, 1424 10th Ave., S.E.,
Apt. 2, Rochester , Mi., married Cecelia M.
Mulone on September 13, 1975. "Jim
McBride '71 and Hank Feder '71 were
among the ushers. I started a dermatology
residency at the Mayo Clinic on October I,
and my wife, who is an R.N., started work
at St. Mary's Hospital."
Dr. James O. Van Bavel ,53 W estmoreland
Ave., Longmeadow, Ma., isDirector of the
Psychiatric Inpatient Unit at the Medical
Center of Western Massachusetts in
Springfield.
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Dr. Syrek: Emergency medicine often is like general practice.
Dr. Susan J. Syrek ' 68, a n emerge ncy room
ph ysician at Bryn Mawr Hospital, says that
contra ry to th e television image of th e acci-
dent ward, ER medicine today ofte n is like
a bi g ge neral practice. "Of course we do ge t
household and auto acciden t victims and
many true medical eme rge ncies, but we are
mor e likely to tr eat cu t fingers, sprains,
bell y a nd c hes t pains, many chronic condi-
tions. W e even had someone come in last
week who wanted hi s ears irrigated."
After a residency in int emalmedicine at
Brvn Mawr, Dr. Syrek 's accident ward
tr;ining was at Doylestown Hospital , where
physicians wer e more likel y to see a patient
wh o had caugh t his hand in a thresher than
one with a spra ined hip. Still , some of th e
pr obl ems of eme rge ncy roo m work arc co n-
stan ts. " It is d iHicult," Dr. Syr ek not es, " to
esta b lish any rapport with th e patient on a
one- time visit. W e have little background
information and less follow-up. This same
distance is ev ident in our relationsh ip with
th e pat ients' families. It' s a p roblem in
tr eating patients and it has overto nes for
our ma lp rac tice vulnerability. If th er e is
somc person al connection betw een doct or
and pati ent, a malpractic e su it is less likel y
to seem a ttract ive ."
Because an e me rge ncy roo m has no ap-
pointment book, patient volume can at
timcs be virtua lly unmanageable. Dr. Syr ek
finds that from May to Oct ob er is her bus-
iesttime , positing that th e lon ger hours of
daylight givc peopl e more of a chance " to
destroy th em selv es." Bryn Mawr saw 24,<X>o
emerge ncy patients last yea r, with a staff of
four fulltim e physicians and residents. The
four fulltime sta ffe rs rotate , with each of
three covering an e ight-ho ur shift for a
week and th e fourth with a we ek off. This
puts much responsibility on the one non-
resident physician in attendance , and when
there is a 20-patient backlog it can be a
st ressfu l, highl y pressured position.
This pressure situa tion makes the acci-
dent ward physician especially vulnerable
to criticism by referral physicians and th e
rest of th e staff. Dr. Syrek feels th ey are of-
tcn judged from an unfair perspective, be-
cause the referral do ctor ha s not seen the
pr e cise condition that th e e me rge ncy room
physician had to tr eat on th e spo t.
For a person who ca n face stress without
ge tt ing flust ered, however, ER work has
some notable advantages as well. Men-
tion ed first is th at , unlike private practice
there is no adm ini stration, and an eigh t-
hour day is gua ranteed. Although th e group
at Bryn Mawr changes sh ifts weekl y, so that
each ph ysician will work seven days of each
eight-ho ur shift e very month , once one ad-
justs to th e sche du le that full week off each
month becom es a distinct ben efit . Dr. Syrek
usually insists that at least tw o days of th at
week are hers enti re ly, and ofte n gocs to
ew York for th e op era she so mu ch enjoys .
The grea te st satisfactions of her work ,
however , are th ose occasional chance op-
portunities for follow -up, such as with
patients whom she Il<L~ treated previously
who return for another reason. "W hen
someone rem embers us and lets us know
that our tr eatment was successful, that ev-
ery th ing turned out well , it is extremely
rewarding."
Although th e standard ized hours of an
eme rge ncy room positi on would seem to
make it a likely professional choice for a
woman with a family, Dr. Syrek notes that
in this area few women have ente re d th e
field. As a mother of four he rsel f, she feels
that her career obligations hav e made her
children very indep endent. "Since our first
ch ild was born wh en I wa s in co llege and
th e second th e we ek before so phomore Na-
tional Boards in medical schoo l, none of
th e children has ever known any other way
of life ,"
A Board-c ertifi ed int ern ist, D r. Syre k
feels that in her pa rti cular c ircumstance,
wh er e she refers a great many of he r
patients to spe cia lists on th e Hospital staff,
her training in int ernal medi cine, which
gave her a b road background, is p robab ly
more valua b le th an a resid ency in the new
eme rge ncy medi cine specialty would have
been. She beli eves, however, tha t the ad-
vent of th c EH specialty will inevitably im-
provc th e quality of e me rge ncy care.
"W hile th e e mc rgc ncy roo m is an excellen t
educ at ional expe rie nce in eve ryday medi-
cin e for medical stude nts and resident s
alik e , too oftc n lack of sta ffing puts th e resi-
dents in virtual co mmand of th e ac ciden t
ward. The ER spe cia lty should ma ke th is
work mor e attractive and bring more full-
time physicians into service."
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Dr. William H. Brubaker, Camp Casey,
Korea , APO San Francisco, completedhis in-
ternal medicine residency at Presbyterian
Medical Center in Denver. After he finishes
his tour of duty with the army he plans to re-
turn to Denver to practice internal medicine.
Dr. Anna M. D'Amico, 2223 E. Prior Rd.,
Wilmington, De., has completed a resi-
dency in obstetrics and gynecology at the
Wilmington Medical Center and will begin
private practice in Wilmington.
Dr. Anthony P. DeNoia, 20 Avenue at the
Common, Shrewsbury, N.J., passed his in-
ternal medicine Boards in June, 1975 and is
now practicing internal medicine. He and
his wife, Marianne, have a son, Christopher,
one and one-half.
Dr. Philip J. DiGiacomo,Jr.,513 Paddock
Rd., Havertown, Pa.,writes that his first
child, Heather , was born July 14,1975. His
wife , Anita, received her B.A. in psychology
from Villanova two weeks before Heather's
birth.
Dr. Gregory J. Edinger, 115 Craven Dr.,
Havelock, N.C ., is serving two years with
the Navy at Cherry Point, North Carolina
after completing a family practice resi-
dency at Wilmington Medical Center.
Dr. Richard L. Fieo, 825 Windermere Ave.,
Drexel Hill , Pa.,writesofthe birth of adaugh-
ter, Megan Ann, on November 5,1975.
Dr. Marsha J.Fishbane, 21 Strabane ci,
Baltimore, finished her pediatric training at
Johns Hopkins and is on the fulltime clinic
staff there. She is also a parttime student at
th eir School of Public Health and Hygiene.
Her husband Bruce '71 will be Chief Resi-
dent in orthopaedic surgery at Johns Hop-
kins in July. Th eir daughter, Alissa Michele,
was born on Jun e 24, 1975.
Dr. Sanford Fitzig, Thomas Jefferson Hospi-
tal , Department of Urology, and hiswife ,
Elly, announce the birth of a daughter, Devon
Meredith,born at Jefferson Hospital August
22,1975. He isa second-year urology resident
at Jefferson and will join the Air Force after
completing his training next year.
Dr. Gene H. Ginsberg, 1735A Clarion Lp. ,
Cannon AFB, Clovis, N.M., is spending two
years in the Air Force in int ernal medicine.
He and his wife were expec ting their sec-
ond child in March.
Dr. Charles A.Gordon, 51C Glen Mead Dr. ,
Port smouth, R.I., passed his Boards in inter-
nal medicine in 1975 and isnow at the U.S.
Naval Regional Medical Center in
Portsmouth.
Dr. James T. Hay, 14202 Recuerdo Dr.,
DelMar, Ca., writes that he finished a Iam-
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ily practice residency in July. He will be on
the staff of the Naval Hospital at Camp
Pendleton for the next three years, and has
bought a new house in DelMar.
Dr. Philip C. Hoffman, 1468-D, Druid Val-
ley Dr., Atlanta, is spending a U.S. Public
Health Service commission in hospital
epidemiology at the Bureau of Epidemiol-
ogy, Center for Disease Control, Atlanta.
Dr. DavidP. Hughes, 16Williamsbur Manor,
Edwards Rd., Greenville, S.C., writes that his
wife and son, John, are spending a year in
Greenville as part of his orthopaedic resi-
dency at Duke University.
Dr. Stanley R. Jacobs, 1321 W ingolrocktng
St., Philadelphia, iscoming on staff at Jeffer-
son as an Instructor in rehabilitation
medicine.
Dr. Gail Tenikat Jacoby, 66 Corwin St., Apt.
20, San Francisco, writes that theirdaughter,
Suzanne Nichole Tenikat, was born Septem-
ber 25. "She and our residencies have kept
David and me quite busy. When our resi-
dencies are completed in June, we plan to
move to Belmont, California, and will be
practicing on the peninsula, David, in inter-
nal medicine and I, in dermatology."
Dr. Mark Josephs is running an emergency
room in Merced, California, near Yosemite
National Park.
Dr. Susan C. Judson, R.D. 3, Box 159, Wil -
liamsport, Pa., is Boarded in internal medi -
cine and currently is completing a two-year
hematology Fellowship at Geisinger Medi-
cal Center.
Dr. Alex B. Juhasz,93 Brightwood Ave., Pitts-
burgh, isa third year resident in general sur-
gery at Mercy Hospital in Pittsburgh.
Dr. Myles K. Krieger, 747 NE 6Ist St., Apt .
101, Miami , will complete an otolaryngol-
ogy residency at Jackson Memorial Hospital
of the University of Miami in June, 1977.
Dr. Helen A. Leibowitz, 1206 Rodman St.,
Philadelphia, is a second-year radiology
resident at Pennsylvania Hospital. Her hus-
band, Paul Hoyer, graduates from Jefferson
this June.
Dr. Charles J. Locke, 465 N. Harlem Ave.,
Oak Park, II., is a third-year surgical resi-
dent at Cook County Hospital.
Dr. Robert D. McKay has completed his
graduate medical training at the Mayo Grad-
uate School of Medicine and presently is at
the Naval Hospital in Bethesda, Maryland.
Dr. Rosalie K. Marinari, 149 Briar Ct .,
Marlton, N.J., is finishing a dermatology
residency at Hahnemann in June, 1976. She
will then enter private practice in Cherry
Hill with another physician.
Dr. Carol A. T. Rivera, Edificio Oliver
#308, Arecibo, P.R., passed her Boards in
internal medicine. She continues in private
practice in Arecibo.
Dr. James R. Roberts, 85 Bedford St., Forty
Fort, Pa., is finishing a residency in emer-
gency medicine at the Medical College of
Pennsylvania in June. He will take a three-
month trip to Central America by truck th is
summer.
Dr. Anthony R. Rooklin,566 Vallejo St., # 23,
San Francisco, finished his pediatrics resi-
dency as Chief Resident at Oakland Chil -
dren's Hospital in June, 1975.He isnow
studyingfor a Master's degree in public
health and will return to Jefferson to begin a
Fellowship with Dr. Herbert C. Mansman '51
in pediatric allergy and immunology.
Dr. Michael S. Roth, 9845 Wisteria St.,
Philadelphia, is Chief Resident in ob-gyn at
Temple University Health Sciences Center.
He will begin a two-year Fellowship in re-
productive endocrinology at th e University
of Miami in July, 1976.
Dr. Marshall A. Salkin, Key W est Naval
Hospital, Key West, Fl. , is on the staff of
the above hospital in internal medicine.
Dr. Bruce S. Saltzman, 7860 S.W. 147th St.,
Miami, is practicing anesthesia at Doctor's
Hospital in Coral Gables. He and his wife
have one daughter, Stephanie, two.
Dr. Barton L. Schneyer, 212 Brookley Ct.,
Loring AFB, Me., has completed an inter-
nal medicine residency at Montefiore Hos-
pital in the Bronx and he and his wife Elin
("and assorted pets") will be at Lorin g AFB
until July, 1977.
Dr. Susan E. Staniels, 1333 Old Gulph Rd.,
Villanova, Pa., is completing a Chief Medi-
cal residency at Jefferson and will begin a
Fellowship at Cardeza in July.
Dr. Thaddeus R. Szydlowski, 885 Easton
Rd., Glenside, Pa., and his wife had a
daughter, Kristen Ann, on August 19, 1975.
He is doing a hematology Fellowship at the
New Jersey College of Medicine and Dent-
istry. In July he will begin a gastroenterol-
ogy Fellowship at Lankenau.
Dr. William M. Wixted, 604 Meado w Rd.,
Pine Hill, N.J., writes that he and his wife,
Jean, now have two sons with the arrival of
Thomas in December, 1975.
1973
Dr. John W. Cochran, 1718 W . Flournoy
St., Chicago, completed his inte rnal medi-
cine residency at Presbyterian-St. Luke 's
Hospital and began a neurology residency
there. His wife, Arlene, will receive her
Master's degree in special education from
the University of lllinois in March.
Dr. Joseph A. Jacobs, 6902 Bonnie Ridge
Dr. , Baltimore, is doing a urology residency
at the University of Maryland. He was mar-
ried in August , 1975 to Linda Anne Goz-
zetti, who is getting her M.S. at the Univer-
sity of Maryland in community health
nursing.
1974
Dr. Louis T. Broad, 2991 School House La.,
Oak 14E, Philadelphia, "who has been hap-
pily married to the former Andrea Rosen-
baum since April, 1975, is proud to an-
nounce that he has no children or pets."
Dr. Joel M. Brown, Methodist Hospital of
Dallas, Dallas, is in the second year of a
medical residency at the above hospital. He
has a daughter, Jennifer, age one, and is
buying their first house in Mesquite, Texas.
Dr. John J. Karlavage, 1417A Confederate
Ave., Columbia, S.C., has coauthored a pa-
per on methylphenidate and Gille de la
Tourette's disease that will be published by
the Journal of the Academy of Child Psy-
chiatry. He has also been accepted by the
University of Chicago for a psychosomatic
medicine elective.in 1977.
Dr. Scott I. Lampert, 2485 Morosgo PI., At-
lanta, Ga ., will begin an ophthalmology
residency at Jefferson in July, 1976.
Dr. Anthony D. Molinaro, Jr., 1927 Queens-
wood Dr ., York, Pa., is happily married and
in the middle of a three-year family prac-
tice residency at York Hospital.
Dr. Martin D. Mollen , 8572#E E. Indian
School Rd., Scottsdale, Az., is presently in
his second year of postgraduate training in
internal medicine at the Good Samaritan
Hospital of Phoenix , Arizona. He and his
wife Joan proudly announce the birth of
their first child, Rochelle Ilona, on August
18, 1975. "Also ofnote , is that Marty became
interested in jogging since in Arizona, and
ran his first marathon, 26 miles, 385 yards
on December 20, 1975 in the Fiesta Bowl
Marathon in Phoenix. He plans to be the
first physician from Arizona to run in the
Boston Marathon this spring: '
Dr. John P. Morton, 624 7th St., Imperial
Beach, Ca. , is practicing family medicine at
the above address, and announces the birth
of a son, Hank, who is now 15 months old.
Dr. James D. Plumb, 1018 Spruce St.,
Philadelphia, is a second-year resident in
Jefferson 's Department of Family Medicine.
Dr. Jay S. Schinfeld, 474 W. 238th St., Apt.
2F, Riverdale, N.Y., is a second-year resi-
dent at Albert Einstein College of Medi-
cine. His wife, a recent graduate of Colum-
bia School of Public Health, works for
Planned Parenthood.
Obituaries
George F. Lull, 1909
Died February 7, 1976 at the age of 88.
Dr. Lull attained the rank of major gen-
eral in the United States Army and from
1943 to 1946 served as Deputy Surgeon
General. He was Secretary General
Manager of the American Medical Asso-
ciation. In addition Dr. Lull served as
Medical Director of Cook County De-
partment of Public Health, President
and Executive Administrator of the Il-
linois State Medical Society and Vice-
President of the Chicago Medical So-
ciety from 1970 to 1976. Dr. Lull held a
Master's degree from Harvard Univer-
sity and a Doctor of Public Health from
the University of Pennsylvania. Surviv-
ing are his wife, Mildred, and a son, Dr.
Lull, Jr., '40.
Herbert C. Oelschlegel, 1911
Died July 21, 1975 at the age of 88. Dr.
Oelschlegel, a family practitioner, re-
sided in Torrington, Connecticut. He
was a past President of the Torrington
Medical Association.
Enrique G. Matta, 1912
Died October 29, 1975 at the age of 90.
Dr. Matta served as a Municipal doctor
in Puerto Rico for 34 years. In the early
years of his career he was elected
Mayor of his village , a Senator in the
Puerto Rico Senate and a Trustee at the
University of Puerto Rico. He retired in
1944 and devoted his time to his 538
acre coffee plantation and writing. His
son, Dr. Enrique, Jr., graduated from
Jefferson in 1940.
James R. Reuling, 1914
Died December 27,1975 in Winder-
mere, Florida where he had been resid-
ing for the past 18 years. Prior to his
move he was an internist in Bayside,
New York. In 1953 Dr. Reuling was
awarded the Will Ross Medal by the
National Tuberculosis Association for
his work in fighting the disease. He was
President of the Queensboro TB and
Health Association and served as Presi-
dent of the national organization in
1947. He also is a past President of the
Queens County Medical Association.
Surviving him are his widow, Roberta,
and two daughters.
Sheldon A. Saunders, 1914
Died April 7, 1975 at the age of 88. Dr.
Saunders was a family practitioner re-
siding in Aulander, North Carolina.
Holbert J. Nixon, 1914
Died December, 1975 at the age of 85.
Dr. Nixon, an obstetrician, pract iced in
Uniontown, Pennsylvania for 50 years.
He served as Chief of the Department
at Uniontown Hospital.
Alexis T. Mays, 1915
Died February 17, 1976. Dr . Mays, a
cardiologist, resided in Brooklyn with
his wife , who survives him.
Horace B. Anderson, 1917
Died January 29, 1976 at the age of 85
in Delray Beach, Florida. Dr. Anderson
specialized in cardiology and pathology
in John stown, Pennsylvania. He served
as both Medical Director and Presiden t
of the Staff of Memorial Hospit al there.
Isidor Hendel, 1917
Died May 14, 1975 at the age of 79. He
was a family practitioner who resided in
New London, Connecticut.
William B. Fort, 1918
Died November 19, 1975 in Pompano
Beach , Florida, where he resided since his
retirement in 1959. Dr. Fort was agyne-
cologist in Plainfield , New Jersey and was
senior staff member in that Department
at Muhlenberg Hospital. He hadserved as
President of the Plainfield Board of
Health and the Plainfield Medical So-
ciety. Surviving are his widow, Marion, a
son,a daughter and two stepdaught ers.
John M. Tyson, 1918
Died October 10, 1975 at the age of 81.
Dr. Tyson was an otolaryngologist who
resided in Dubois, Pennsylvania.
Francis C. Hartun~, 1919
Died June 30, 1975 at the age of 88. He
was a general practitioner in the Phila-
delphia area.
Ira H. Hurt, 1919
Died February 7,1975 at the age of 84.
A general practitioner in Roanoke, Vir-
ginia, Dr. Hurt · Iso served as a Director
of the Shenanr' .ah Hospital for 20
45
years. He is survived by his wife , Edith,
a daughter, Phyllis, and a son, Ira, Jr.
Paul A. Bishop, 1920
Died January 6, 1976 at the age of 79.
Dr. Bishop, Professor of Radiology at
the University of Pennsylvania School
of Medicine and its Graduate School of
Medicine, had served as Director of the
Department of Radiology at Pennsylva-
nia Hospital until his retirement in
1962. He served as President of the Staff
from 1951 to 1953. Dr. Bishop was a
Diplomate of the American Board of
Radiology, a former President and Trea-
surer of the Philadelphia Roentgen Ray
Society and a Vice-President of the
American Roentgen Ray Society. He
was the author of a book and numerous
papers on radiological diagnoses. Dr.
Bishop also served as Secretary of the
Philadelphia Lyri c Opera Company.
Surviving is his wife, Ruth.
Lewis G. Woodson, Jr., 1920
Died May 25, 1975. Dr. Woodson was an
internist who resided in Birmingham,
Alabama.
Wesley S. Miller, 1922
Died June 3, 1975 at the age of 78. Dr.
Miller was a family practitioner in Jean-
nette, Pennsylvania.
Maurice Saltzman, 1922
Died February 1, 1976 at the ageof81 .
Dr. Saltzman wasan ear, nose and throat
specialist with officesin Philadelphia. He
issurvived by his wife,Sophi e, and two
sons, Dr. Edward], Saltzman '49 and D r.
Herbert A. Saltzman '52.
Herman H. Hostetter, 1923
Died Decemb er 6,1975 at the age of
81. Dr. Hostett er served as personal
physician to Milton S. Hershey for
many years and was school physician
for the Milton Hershey and Derry
Township School systems. A charte r
membe r of the Keystone Area Council
of the Boy Scouts of Amer ica he had re-
ceived outstanding service awards from
the Hershey Rotary Club and Lions
Club. Surviving are his wife, Sayra, a
son, Dr. Glenn H. Hostetter '60 , and a
daughter , Joanne.
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Alfred H. Diebel, 1925
Died February 7, 1976 in Fort Lauder-
dale where he had been residing since
his retirement. Dr. Diebel, an obstetri-
cian gynecologist in the Philadelphia
area, was a member of the American
College of Surgeons and the American
College of Obstetricians and Gynecolo-
gists. His wife, Amanda, survives him.
Roy E. Nicodemus, 1927
Died January 3, 1976 at theageof72. Dr.
icodemus served as Director of the De-
partment of Obstetrics and Gynecology
at Geisinger Medical Center from 1930
to his retirement in 1965. He was a Fel-
low of the American College of Sur-
geons, a Diplomate of the American
Board of Obstetrics and Gynecology
and a founding Fellow of the American
College of Obstetricians and Gynecolo-
gists. At Bucknell, his undergraduate
school, he was President of the Alumni
Association and a member of the Board
of Trustees. Surviving are his wife , Ger-
aldine, a son and three daughters.
Marshall Kerry, 1929
Died December 11, 1975 at the age of
77. Dr. Kerry was an anesthesiologist at
the Reading Hospital in Reading, Penn -
sylvania from 1950 to 1970. He also
served as Director of the Department
there. He is survived by his wife.
Russell W. Rummell, 1929
Died October 7, 1975 at the age of 72.
Dr. Rumm ell served as Medical Direc-
tor of the Youngstown (Ohio) Hospital
Association from 1948 to his retirement
in 1966. He was a member of the Amer-
ican College of Hospital Administrators.
David B. Karr, 1930
Died January 7,1976. Dr. Karr, a gen-
eral surgeon, resided in Chattanooga,
Tennessee. He served as Vice-President
for his state for the Jefferson Alumni As-
sociation. His widow survives him .
Joseph M. Brown, 1933
Died january 16, 1976. Dr. Brown wasa
general practitioner in Santa Rosa,
Ca lifornia.
David O. Helms, 1936
Died December 30, 1975 at the age of
67. Dr. Helms, a general practit ioner,
resided in Bethlehem, Pennsylvania.
Surviving are his widow, Gertrude, and
two sons and a daughter .
Lindon L. Davis, 1937
Died November 29, 1975. Dr. Davis
practiced internal medicine in the East
Williston ar ea of New York .
Richard H. Fenstermacher, 1937
Died January 7, 1976 at the age of 63.
Dr. Fenstermacher was Director of Pa-
thology at the Street Clin ic in Vicks-
burg, Mississippi. He is survived by his
wife, Mary , and a son.
Albertus C. Wyker, 1940
Died November 25, 1975. Dr. Wyker
was a general surgeon practicing in
Pleasantville, Ohio.
John J. Wydrzynski, 1945
Died February 19, 1976 at the age of 56.
Dr. Wydrzynski, a general practitioner,
servedon the staffsat Mercy Ca tholic
Medical Center and Delaware County
Memorial Hospital. He is survived by his
wife, Valeria, and three sons.
JosephF. Devenny, 1946
Died January 24, 1976 at the age of 55. Dr.
Devenny, a resident of ewtown Square,
Pennsylvania,was an obstet ricianlgyne-
cologist and served on the staffsof Fitz-
gerald Mercy and Riddle Memorial
Hospitals. He was a Clinical Instructor at
Jefferson. Surviving are his wife, Mary
Catherine, a son and daughter.
David 1. Biser, 1949
Died December 28, 1975 at the age of
52. Dr. Biser was a psychiatrist/neuro-
logist who worked primarily with chil-
dren at the Children's Rehabi litation
Cent er at St. Agnes Hospital and the
Mental Retardation Institute of New
York Medic al College. He was a resi-
dent of Cro ton-on-Hudson, New York.
Joseph B. Shaw, 1960
Died May 1, 1975 at the age of 41 in an
accident. Dr. Shaw was the psychiatrist
for the Department of Correction in
Reading, Verm ont , and also maintained
a private practi ce. He is survived by his
wife, Gretchen, and thr ee children.
EdwardL. Bauer, M.D.
1891-1976
Dr. Edward L. Bauer, Emeritus Professor of Pediatrics, died on February 13 at the age of
85. He had served as Chairman of that department from 1926 until his retirement in 1961. It
was Dr. Bauer who introduced modern methods of diphtheria prevention to the Phila-
delphia area and who served as immunologist for the city, beginning with an appoint ment
to the Department of Public Health in 1918. During his 14 years as Chief Immunologist, he
virtually eliminated outbreaks of diphtheria which at that time was a dreaded and some-
times fatal disease.
Dr. Bauer's contributions to medical literature comprise some 300 articles on children's
and communicable diseases as well as several important contributions to medical textbooks.
Through his writings he contributed greatly to preventive pediatrics which was a relati vely
new concept at the time of their publication. Dr. Bauer also was the author of the Jefferson
history "Doctors Made in America."
The Professor had served on the state's Certified Milk Commission for 25 years and was
Director of Health Services at Girard College for nearly the same length of tim e.
He served as consulting pediatrician to Philadelphia General, Germantown, St. Chri sto-
pher's and Memorial Hospitals and the Children's Seashore House in Atlantic Cit y. Dr.
Bauer was a Fellow of the American Academy of Pediatrics and the College of Physicians of
Philadelphia, a past President of the Philadelphia Pediatric Society and a past Chairman of
the Pediatric Section of the Pennsylvania Medical Society.
His son, Dr. Richard D. Bauer, '45 , represents the eighth generation of physicians in the
family , four generations of whom are graduates of Jefferson Medical College. He served the
Alumni Association as President in 1941.
Paul D. Zimskind, M.D., Ph.D.
1932-1976
Dr. Paul D. Zimskind, one of the youngest men ever to head a medical department at)effer-
son Medical College, died Sunday, February 29 after a sudden illness. .
Dr. Zimskind, age 44, had been appointed the Nathan Lewis Hatfield Professor of Urol-
ogy and Chairman of the Department in 1967. His teaching career began in 1964 when he
became Assistant Professor of Urology.
A magna cum laude graduate of Princeton University , he was named a Markle Scholar in
Academic Medicine in 1966. He received his Doctor of Medicine degree from Jefferson in
1957 and a Doctor of Philosophy degree in physiology in 1964.
Several years before his appointment as Chairman, he wrote to his colleagues, in part: "I
continue to derive enormous satisfaction from planning and carrying out research and stim-
ulating and encouraging the research efforts of others. I intend to continue in research and
teaching both for the enjoyment they afford and because the exclusion of eithe r would not
fulfill my goal of a true academic career."
Dr. Zimskind was a member of approximately 20 professional societies, including the
American Association of Genito-Urinary Surgeons, the American Association for the Ad-
vancement of Science, the ational Research Council and the American Urologica l Associ-
ation. He was the author of 43 scientific papers and 77 presentations throughout the world.
His honors included the Francis W. Shain Surgery Prize while a student at Jefferson and
First Prize, Basic Research Essay Competition, given by the Philadelphia Urological Society
in 1961.
Dr. Zimskind is survived by his wife, the former Gay Mann ; a son, Jeffrey, age 13; and a
daughter, Wendy, age 9. They live in Penn Valley.
He is also survived by his brother, Nathaniel H. Zimskind, a Rabbi; his fath er , Dr . Joshua
N. Zimskind, a 1927 graduate of Jefferson ; and his mother , Sadie.
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Dr. Peter A. Herbut at his May, 1967 inauguration at the Academy of Music
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Peter Andrew Herbut, M.D., C.M.
1913-1976
In the summe r of 1939 there came to Jefferson a yOlmg Ca-
nadian physician, graduate of McGill , to complete his train-
ing in pathology under Virgil Moon. Th e following year he
was appoin ted Assistant Director of the Clinical Labora-
tor ies. Before a decade had passed, he was Professor and
Chairman of the Department, uniting und er one head the
divisions in the Medical College and Hospital. It was a re-
markable achieve ment, but Peter Andrew Herbut was an
extrao rdinary man. And bigger things were yet to come.
Like he worked he supervised, rigorousl y and almost all
the time. Th e department showed improvement from the
start despite the fact that the budget was meager and the
space very cramped. A complete residency program was or-
gani zed. Those of us who were trained under his tutelage
think back fondly of that time and recollect many amusing
incidents related to long hours of ha rd work, immediate
deadlines, careful photographing of specimens and vaca-
tions that would end barely aft er their start. Tardiness and
pro crastination were deeply frowned upon. Excellence and
dedi cation were acknowledged quietly, perhaps with a care-
ful smile as a reward, but he would not forget to say many
nice th ings about you behind your back. W e recall how in-
tense was his love for music, particularly for Mozart. Among
the things he planned for the years of retirement were writ-
ing essays on composers and a definitive history of Jefferson.
He was a fan of sports. The Phillies and the Flyers of Phila-
delphia were his special love, and he follow ed their games
closely and with charac teristic enthusiasm. And we remem-
ber best of all how cha rming were the visits to his home and
how deep was the love he shared with his wife Margaret,
the swee t lady he married a year after he cam e to Jefferson,
and with his daught ers Linda and Paula. Years later, his for-
mer trainees remain strongly united by that experience, a
bond that undoubtedly arose not merely as an Alma Mater
tie but from the power and magnetism of the man .
He lectured regularly to sophomores, with sonorous voice
and very , very well organized. Pathogenesis was clearly out-
lined, stepwise and invariably beginning with "number
one." His voluminous textbook of general pathology was
called "jolly green giant" by the class, and the students,
sharp critics that they are, recogniz ed and thanked the out-
standing teacher by selecting him to membership in three of
their socie ties, including Alpha Omega Alpha. In 1961 his
portrait was painted upon the wish of the senior class. At
the weekly clinicopathologic conference and Tumor Clinic,
which were superb and eage rly awaited by the staff, he was
a steadying force because his knowl edge of pathology was
diffuse, his approach very practi cal and his powers of per-
suasion stro ng. During those years he wrote, longhand, sci-
entific pap ers ga lore and gained national renown among his
peers. Th e first paper in which he was a senior (and only) au-
thor was on diabetic glomerulosclerosis, a disorder originally
described by Dr. Paul Kimmelsteil, und er whom Dr. Herbut
had his first yea r of training in pathology. Most not eworthy
were his contributions to the cytologic diagnosis of cance r,
for which he received the Ward Burdick Award, the highest
honor bestowed by the American Society of Clinical Pathol-
ogists. For a long time he was in the editorial Board of Acta
Cytologica and consultant in pulmonary cytology to the In-
ternat ional Academy of Gyneco logic Cytology. His research
on substances which inhibit tum or growth, begun some
years lat er , also achieved Widespr ead recognition. He wrote
four textbooks Virtually alone. Th e one on Urological Pa-
thology, which was translated into Spanish, is still the only
treatise on the subjec t. His reputat ion as an educator of un-
common skill and administrator par excellence led him to
serve as advisor or consultant to a long list of organizations
of sundry natures and intents, including the Nat ional Li-
brary of Medicine, the Council of Education of the Com-
monwealth of Pennsylvania, the Pennsylvania Society for
Advancing Medical Research, and the National Association
on Standard Medical Vocabulary. In 1970, Dr. Herbut was
presented with the Shaffrey Award by the Medical Alumni
of St. Joseph's College, and on that occasion he spoke on
tre nds in medical education.
As a member of the Executive Faculty, of which he was
Chairman for ten years, Dr. Herbut helped to formulate
many of the plans from whi ch emerged the remarkable
changes that have taken place here over the last two dec-
ades . His participation was never casual for he was too
much a man of vigorous determination and, above all, be-
cause he was completely Jefferson. Those qualities would
bring him to the inner circles of action in planning and de-
velopment and eventually to the Presidency of the institu-
tion. The organization of a College of Gradua te Studies he
supported strongly. His was one of the most compelling
forces in the creation of the Jefferson-Penn State Program of
accelerated medical education. He backed without equivo-
cation the admission of femal e applicants to Jefferson Medi-
cal College. Far more than anyone else he promoted and
brought to fruition the concept of a College of Allied Health
Sciences, and through it university status for Jefferson. After
that, he kindled the idea to set up graduate training in
dental sciences and educational pro grams for dental tech-
nologists. And so he went, constantly seeking ways here and
the re to improve and expand the institution to which he
gave unconditionally all the years of his fruitful life. The
connections that we now have with the Franklin Institute
and the Philadelphia College of Pharm acy are two more in-
stances of his far-sighted driv e. He lived to see the realiza-
tion of yet another of his stout-hearted projects- the almost
total replacement of our health care facilit ies by a
$100,000,000 new Hospital-Clini cal Teaching Facility. He
was accessible to all the men and women in the University,
at all levels, and invariably willing to lend an ear to our
problems, suggestions or complaints. Having been first a
member of the Facult y, he felt part icularly close to its mem-
bers during his years as President. We sensed that readily
and appreciated it a lot. He was also close and accessible to
alumni of Jefferson throughout the country and in distant
lands. The Alumni Associati on also apprec iated that a lot,
and expressed its thanks by granting him honorary member-
ship in 1974.
Nearly a decade of growth and developm ent . Then, on
the last afternoon of March 1976, suddenly and very unex-
pectedly Peter Herbut died. Oh , what a heavy loss for Jef-
fersonl Whence will come such another leader? Forever and
a day will live the memo ry of that man.
Gonzalo E. Aponte, M.D. '52

